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Abstract 
Passive samplers can play a valuable role in monitoring water quality within a legislative 
framework such as the European Union’s Water Framework Directive (WFD). The time-
integrated data from these devices can be used to complement chemical monitoring of 
priority and emerging contaminants which are difficult to analyse by spot or bottle 
sampling methods, and to improve risk assessment of chemical pollution. In order to 
increase the acceptance of passive sampling technology amongst end users and to gain 
further information about the robustness of the calibration and analytical steps, several 
inter-laboratory field studies have recently been performed in Europe. Such trials are 
essential to further validate this sampling method and to increase the confidence of the 
technological approach for end users. An inter-laboratory study on the use of passive 
samplers for the monitoring of emerging pollutants was organised in 2011 by the 
NORMAN association (Network of reference laboratories for monitoring emerging 
environmental pollutants; www.norman-network.net) together with the European DG 
Joint Research Centre to support the Common Implementation Strategy of the WFD. 
Thirty academic, commercial and regulatory laboratories participated in the passive 
sampler comparison exercise and each was allowed to select their own sampler design. 
All the different devices were exposed at a single sampling site to treated waste water 
from a large municipal treatment plant. In addition, the organisers deployed in parallel 
for each target analyte class multiple samplers of a single type which were subsequently 
distributed to the participants for analysis. This allowed an evaluation of the contribution 
of the different analytical laboratory procedures to the data variability. The results 
obtained allow an evaluation of the potential of different passive sampling methods for 
monitoring selected emerging organic contaminants (pharmaceuticals, polar pesticides, 
steroid hormones, fluorinated surfactants, triclosan, bisphenol A and brominated flame 
retardants). In most cases, between laboratory variation of results from passive 
samplers was roughly a factor 5 larger than within laboratory variability. Similar results 
obtained for different passive samplers analysed by individual laboratories and also low 
within laboratory variability of sampler analysis indicate that the passive sampling 
process is causing less variability than the analysis. This points at difficulties that 
laboratories experienced with analysis in complex environmental matrices. Where a 
direct comparison was possible (not in case of brominated flame retardants) analysis of 
composite water samples provided results that were within the concentration range 
obtained by passive samplers. However, in the future a significant improvement of the 
overall precision of passive sampling is needed. The results will be used to inform EU 
Member States about the potential application of passive sampling methods for 
monitoring organic chemicals within the framework of the WFD. 
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1. Introduction 
1.1 EU legislation for control of chemical pollutants in aquatic 
environment 
The Water Framework Directive 2000/60/EC (WFD) [1] provides for the protection of 
European water bodies from contamination by chemical pollutants. For surface waters, 
this protection is partly achieved by the identification of Priority Substances and the 
establishment of Environmental Quality Standards at European level in the daughter 
Directive 2008/105/EC [2], as recently amended by Directive 2013/39/EU [3]. In 
addition, the WFD includes the obligation for Member States to identify pollutants of 
national concern as river basin specific pollutants and to set environmental quality 
standards for them at national level. According to their analysis of pressures and 
impacts, Member States need to set up monitoring programs for surface waters covering 
a wide range of contaminants in order to characterise the risks, and the need for action. 
The new Watch List mechanism, introduced by Commission Decision (EU) 2015/495 [4] 
requires the monitoring of substances that might pose a risk at EU level for which 
monitoring data are not yet sufficient to confirm the risk.  
1.2 Directives on Environmental Quality Standards 
The Environmental Quality Standards Directive (EQSD) 2008/105/EC [2] of the European 
Parliament and the Council on environmental quality standards (EQS) in the field of 
water policy, amending and subsequently repealing Council Directives 82/176/EEC, 
83/513/EEC, 84/156/EEC, 84/491/EEC, 86/280/EEC and amending Directive 
2000/60/EC, was published in the Official Journal on 24 December 2008. 
The EQS directive established: 
 in Annex I, limits on concentrations of 33 priority substances and 8 other historic 
pollutants in surface waters; 
 the list of 33 priority substances in Annex II as Annex X of the WFD, including the 
identification of priority hazardous substances; 
 the possibility of applying EQS for sediment and biota, instead of those for water; 
 the possibility of designating mixing zones adjacent to discharge points where 
concentrations of the substances in Annex I might be expected to exceed their 
EQS; 
 a requirement for Member States to establish an inventory of emissions, discharges 
and losses of the substances in Annex I; 
 an obligation to review the list of priority substances every 4 years. 
The identified 33 substances or group of substances were shown to be of major concern 
for European waters. Within this list, 11 substances were identified as priority hazardous 
substances and are therefore subject to a requirement for cessation or phasing out of 
discharges, emissions and losses within an appropriate timetable not exceeding 20 years. 
The recently published Directive 2013/39/EU [3] added the following 12 substances to 
Annex X of the WFD: 
dicofol, perfluorooctane sulfonic acid and its derivatives (PFOS), quinoxyfen, dioxins and 
dioxin-like compounds, aclonifen, bifenox, cybutryne, cypermethrin, dichlorvos, 
hexabromocyclododecanes (HBCDD), heptachlor and heptachlor epoxide and terbutryn. 
In addition, Article 8b of Directive 2013/39/EU introducted the requirement for a watch 
list of substances for which Union-wide monitoring data are to be gathered for the 
purpose of supporting future prioritisation exercises in order to break the so-called 
vicious cycle of no monitoring – no regulation. The first watch list, in Commission 
Decision (EU) 2015/495 [4], includes the following substances: diclofenac; 17-beta-
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estradiol (E2); 17-alpha-ethinylestradiol (EE2); estrone (E1); 2,6-ditert-butyl-4-
methylphenol; 2-ethylhexyl 4-methoxycinnamate; macrolide antibiotics; methiocarb; 
neonicotinoids; oxadiazon; and tri-allate. The Directive also highlights 11 priority 
substances for which an EQSbiota has been derived. 
The Directive 2013/39/EU [3] recommends further development of passive 
sampling techniques as a promising tool for future application in compliance 
checking and trend monitoring of priority substances. 
This interlaboratory study represents an important step in evaluating the performance of 
currently available passive sampling (PS) techniques with the main focus on polar 
(emerging) organic pollutants (pharmaceuticals, polar pesticides, steroid hormones, 
fluorinated surfactants, triclosan, bisphenol A) and brominated flame retardants and 
provides a basis for identifying tools that could be suitable for regulatory monitoring. It 
also should help the scientific community to identify further research needs to improve 
performance characteristics of PS in the aquatic environment. 
1.3 Method performance criteria 
The method performance criteria and technical specifications for analytical 
measurements in chemical analysis and monitoring of water status have been set in the 
Directive 2009/90/EC [5]. In the directive, minimum performance criteria for all methods 
of analysis applied for WFD compliance checking are based on an uncertainty of 
measurement of 50 % or below (k= 2) estimated at the level of an EQS and a limit of 
quantification equal or below a value of 30 % of an EQS. 
1.4 Chemical monitoring and emerging pollutants (CMEP) expert 
group 
During the years 2011-2012, technical discussions with Member States delegates on 
chemical monitoring issues were held in the then Chemical Monitoring and Emerging 
Pollutants (CMEP) expert group in order to harmonise the approaches and guarantee 
comparable results, starting from the setting up of the monitoring networks, via the 
sampling and sample preparation to the chemical analysis, to arrive at a common view 
on the necessary monitoring for the WFD. Chemical water analysis is done on a routine 
basis in the Member States according to their national regulations and it is crucial that 
currently applied approaches merge into a common strategy which results in comparable 
assessments throughout Europe. The CMEP's mandate was established in the context of 
the work of WG Chemicals (under the Common Implementation Strategy for the WFD). 
1.5 Previous Chemical Monitoring on-site exercises 
1.5.1 First on-site chemical monitoring and analysis exercise (CMA on-
site 1) 
A first field trial, “chemical monitoring and analysis” (CMA on-site 1) was organised by 
JRC IES in 2006 on the Po River in Ferrara, Italy [6]. 
1.5.2 Second on-site chem. monitoring and analysis exercise (CMA on-
site 2) 
While the first trial had been limited to 7 invited laboratories, the second CMA on-site 
event in 2008 was open to all laboratories nominated through the CMA group. In the 
second CMA on-site exercise 27 analytical laboratories from 11 EU Member States and 2 
non-EU countries  participated in a technical on-site event during which sampling and 
analytical methodologies for chemical monitoring according to proposed WFD provisions 
were compared [7]. Coordination of the project was provided by the European 
Commission Joint Research Centre in collaboration with the Italian Water Research 
Institute, the Hungarian Ministry of Environment and Water and the Serbian Ministry for 
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Environment and Spatial Planning. The laboratories had been invited to take samples 
from the Danube River according to their standard protocols and to analyse them for 
PAHs, PBDE and nonyl-, octylphenols. It was shown that even some of the most 
challenging WFD priority substances, selected specifically for this exercise, can be 
measured at WFD relevant concentrations (0.3 × EQS) with methods currently applied in 
Member States. Depending on the analyte group, the obtained results were, however not 
within proposed data quality criteria for some participants and therefore further 
development of methods and harmonisations of efforts was suggested. 
1.5.3 Third on-site chemical monitoring exercise (CM on-site 3) 
In 2010 the European Commission Joint Research Centre organised, together with the 
Italian Water Research Institute IRSA and the Rijkswaterstaat Centre for Water 
Management in the Netherlands, the third edition of the CM on-site campaign. The scope 
was to give Member States an opportunity to compare their monitoring approaches for 
WFD compliance checking. The campaign took place on 5/6 October 2010 in Eijsden at 
the Meuse River. The event was hosted at the Rijkswaterstaat Measuring Station Eijsden. 
Member States were invited to send laboratory teams for a joint sampling on the Meuse 
river. The laboratories were expected to measure EU priority pollutants of their choice in 
the river water and to share their measurement results, including data quality metadata. 
For selected pollutants (PAHs and PBDEs) standards were distributed and also 
homogenised river water extracts were available for intercomparison [8]. 
1.6 Emerging substances  –  NORMAN network 
Out of several million known substances, over 150,000 substances are produced in 
amounts over 10 t/year (REACH registry), which may enter the environment and 
eventually penetrate the food chain. An understanding of which of these substances or 
their mixtures are potentially harmful to the living environment or humans represents 
one of the biggest challenges for present environmental research. From a legal point of 
view, the WFD is requesting each EU Member State to list so-called river basin specific 
pollutants (not regulated by the WFD at the EU scale), which are recognised to pose a 
risk to river biota and monitor them next to the WFD PS. The NORMAN database of 
emerging substances [9] lists over 700 non-regulated environmental contaminants with 
potentially harmful effects. The NORMAN prioritisation scheme ranks compounds based 
on their occurrence (local or European problem), toxicity (PNEC and EQS values from 
laboratory studies/ literature or predicted by Read Across QSAR-based models) and use 
(amounts produced/applied). In the NORMAN scheme none of the substances is 
discarded from the prioritisation because of lack of monitoring or toxicity data. 
Categories of substances are defined with a clear indication of which substances need, 
e.g., more occurrence or more toxicity data or improved analytical performance, etc. 
Each of the basic parameters (occurrence, toxicity and use) and numerous sub-
parameters (e.g. information on whether the substance is an endocrine disruptor, 
belonging to the category of persistent, bioaccumulative and toxic (PBT)) has a “weight” 
factor contributing to the final ranking.  
The JRC as the European Commission’s in-house science service took on in 2014, led by 
DG Environment, the technical work on the prioritisation process under the WFD. 
Chemical substances are being ranked according to their production volumes, use 
patterns, intrinsic properties, concentrations in the environment, toxic effects, and 
relevance to drinking water.  
1.7 Passive sampling 
The potential of PS to support WFD monitoring requirements was recognized in an ad hoc 
expert meeting organised by the NORMAN association in 2009 [10]. This resulted in a 
position paper on PS of emerging substances in 2010 [11], followed by the performance 
of the inter-laboratory study presented in this report in 2011.  
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Other initiatives to investigate the possible application of PS in screening and compliance 
monitoring were the “Utrecht workshop” organized by Deltares [12], the SETAC Pellston 
workshop on PS methods in sediments, [13] and the ICES Workshop on Passive 
Sampling and Passive Dosing [14].  
The general outcome of these workshops was that partition-based PS for 
hydrophobic substances is sufficiently mature to play a role in regulatory 
monitoring for quantitative compliance checking. In contrast, it has been 
recognised that PS of hydrophilic substances using adsorption-based samplers 
needs further development.  
An ISO standard has been published that specifies procedures for the determination of 
time-weighted average concentrations and equilibrium concentrations of dissolved 
organic, organo-metallic and inorganic substances, including metals, in surface water by 
PS, followed by analysis [15]. 
The recently published EU Technical report on aquatic effect-based monitoring tools [16] 
highlights that by combining passive sampling with effect based tools an integration of 
exposure and effects monitoring can be achieved. Such approach is considered to 
facilitate more cost effective monitoring programmes as well as forming the basis of a 
risk-based pollution control strategy. 
Two working principles of PS must be considered, partitioning and adsorption. 
Partitioning-based PS devices (p-PSD) are made from hydrophobic polymeric 
materials with high permeability for the compounds to be sampled. p-PSDs absorb (or, 
more accurately, dissolve) substances from water because of much better solubility of 
the substances in the sampler material compared to water. Consequently, hydrophobic 
substances with low solubility in water are strongly accumulated in p-PSDs, while 
hydrophilic substances are concentrated to a much smaller extent. Following a 
sufficiently long exposure in the environment the absorbed concentration in the p-PSDs 
will eventually attain equilibrium with the concentrations outside the sampler, e.g. water. 
From the equilibrated concentration in the p-PSD an aqueous phase concentration can be 
estimated using the sampler-water partition coefficients (KPW). This is a freely dissolved 
concentration (Cfree) that is not influenced by variable concentration of the substance 
bound to the suspended particulate (organic) matter (SPM). Cfree is considered to play a 
key role in chemical uptake by aquatic organisms and its distribution between 
environmental compartments, since it is proportional to the chemical activity in water. 
Equilibrium is assumed for the partitioning PS but, in practice, with application of p-PSDs 
in water, equilibrium is only attained for substances with a log KPW up to 5.5. For more 
hydrophobic substances the uptake is too slow (or actually the sampler uptake capacity 
too large) to attain equilibrium in typical exposure periods (2-8 weeks). In that case the 
estimated Cfree relies on the measurement of the in-situ water volume extracted by the 
p-PSD during the exposure period. This volume (or the sampling rate, when expressed 
per time unit) is derived from the release of selected substances dosed to the p-PSD 
prior to exposure. Basically, the rate of release, controlled by the diffusion through the 
water boundary layer at the sampler surface, is determined. The first order rate constant 
of the release under the given sampling conditions (temperature and turbulence) is equal 
to that of the uptake and can consequently be used for calculating Cfree also in situations 
when equilibrium is not attained. Models and methods have been developed to estimate 
sampling rates [17] [18], as well as KPW [19], to derive Cfree from sampler uptake. 
Uncertainties in results obtained by application of p-PSDs are believed to range by a 
factor 2 depending on the level of experience of the laboratory. Different aspects of 
uncertainty are discussed in (Lohmann et al., 2012). 
Adsorption PS devices (a-PSD) generally contain adsorptive materials that are also 
applied in solid phase extraction of hydrophilic substances from water. In an a-PSD a 
thin layer of such material is applied separated from the water phase by a filter or a 
membrane. As for a p-PSD the substances diffuse through the water boundary layer and 
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the membrane or filter, but accumulation in the binding material is by an adsorption 
process and not by dissolution. Adsorption of strongly hydrophilic substances is possible 
since binding can take place by a number of interactions between the surface of the 
material and the chemical, e.g. van der Waals, π−π interactions, hydrogen bonding, and 
Coulomb forces. After extended exposure, the uptake rate is reduced not only by 
equilibration but it can be limited also by saturation of the sorption sites of the adsorbent 
applied. Also uptake of non-target compounds and other interfering natural compounds 
contributes to saturation and competes for sorption sites with target substances. To 
avoid or reduce this effect, exposure periods are kept shorter than with partition PS. 
Although extensive laboratory derived calibration datasets have been reported for a-
PSDs, literature shows limited agreement (Harman et al., 2011, 2012). The uptake 
process is not yet well understood, nor is translation of laboratory calibrations to the 
field, which complicates the determination of water concentrations for compliance 
checking. In spite of these shortcomings, a-PSDs samplers can give valuable results with 
regards to substance screening to determine whether water bodies are potentially at risk 
and as an alternative method in situations where classical monitoring approaches based 
on low frequency spot sampling fail, or. in situations where the classical monitoring 
approaches have insufficient low LOD. 
2. Study objectives 
In comparison with a typical collaborative trial, this interlaboratory study can be 
characterised by several specifics. The study ambition was not to validate the passive 
sampling method or to demonstrate the fitness of the method for routine monitoring 
under the regulatory framework, but rather to identify the current weak points and needs 
for future development of adsorption based passive samplers (a-PSD) in particular and 
also for development of procedures for future method validation. Thus, the overall 
performance of passive sampling technology must not be judged based on this single 
exercise. For example, it is known that the uncertainty of partition based passive 
samplers (p-PSDs) is lower than that of a-PSDs (Lohmann et al., 2012). The study was a 
learning exercise with the objective to assess the current variability of passive 
sampling methods for a range of emerging pollutants. The study addressed a relatively 
wide variety of emerging pollutants from several substance classes that are (with 
several exceptions) not yet regulated, and also some priority compounds that are 
problematic in terms of sampling and analysis, or compounds that are currently on the 
WFD watchlist. The focus of the study was thus intentionally on those compounds for 
which the current performance of passive sampling has not yet been fully explored.  
The exercise addressed sampling in treated wastewater, which is a highly relevant matrix 
for future monitoring of the compounds of interest, but also a complex matrix that 
presented another challenge for methods used in analysis. 
When taking into account the ambitious selection of target compounds, analysed 
matrices and the rather limited number of laboratories that currently apply passive 
samplers, organisers decided that the participation in the study was not restricted based 
on the level of laboratory expertise. The main objective of the present study is to 
characterise the variability of results when using PS for estimating aqueous 
concentrations of several groups of emerging polar contaminants and brominated 
diphenyl ethers. 
3. Design of the study 
The core of the study was a sampler comparison exercise that has been extended to 
include several steps covering individual aspects in the PS process, including analytical 
comparability and comparison of PS with spot sampling. All samplers were exposed in 
parallel to water at a single site. The levels in the study design were: 
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1. To verify that analytical standards applied in each laboratory agree with each other. 
For this purpose a standard solution of target analytes was distributed to the 
participating laboratories to be analysed in parallel with the various sampler 
extracts. 
2. For each target analyte class, in parallel with the various types of participant 
samplers (PPS), passive samplers of a single type “NORMAN provided samplers” 
(NPS) were exposed, that were also provided to each participant. These provided 
samplers needed to be analysed together with their own “Participant’s Passive 
Samplers” (PPS). 
3. These steps were performed to support the interpretations of the main activity of 
the exercise to evaluate the present data variability from various passive samplers 
selected by the individual participating laboratories. 
4. Data from the analysed passive samplers were (with exception of brominated 
diphenyl ethers) compared with contaminant concentrations in composite spot 
water samples collected at the study site during sampler exposure.  
The stepwise design helped to identify sources of variation such as instrumental 
analytical bias (step 1) and the analytical component of variability in the presence of 
matrix (step 2). Variation additionally to that of sampler processing + analysis, can be 
attributed to the variability/differences between samplers. 
4. Standard solution 
The comparison of the participant’s analytical standards with a common analytical 
standard provided by the central laboratories showed the variability of applied 
instrumental methods, bias in analysis of standards, and was the first simple step to 
identify analytical variability. 
 
Figure 1  Analysis of standard solution. Result shows the variability of applied instrumental methods 
and is a first simple step to allow correction of data for analytical deviations. 
4.1 Provided passive sampler 
The replicate (3 replicates + blank) provided samplers and their analysis by participating 
laboratories allowed an intercalibration of the analysis of passive samplers and an 
estimate of the contribution of the analytical (sampler extraction + analysis) component 
to total variability. 
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Figure 2  Provided passive sampler. The replicate (3 replicates + blank) provided samplers and their 
analysis by participating laboratories allows an intercalibration of the analysis of passive 
samplers. An estimate can be made of the contribution of the analytical (sampler extraction 
+ analysis) component to total variability. 
4.2 Participant passive samplers 
The study consisted of passive samplers (3 replicates + blank for each laboratory) 
deployed to sample the water phase at a single sampling site. Participating laboratories 
were free and encouraged to deploy all recently available types/designs of passive 
samplers that are suitable for sampling selected target analytes at the sampling site. For 
this step in the exercise participants were requested to supply for each target compound 
the amount sampled by their sampler and the aqueous phase concentration they derived 
(using a calculation method of their choice) from the sampler uptake. 
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Figure 3A Participant passive samplers. The study consisted of passive samplers deployed to sample 
the water phase at a single sampling site. Participating laboratories were free and 
encouraged to send all recently available types/designs of passive samplers for deployment 
that are believed to be suitable for sampling the selected target analytes. 
 
 
 
Figure 3B Participant passive samplers. Following exposure samplers were sent to participating 
laboratories for analysis. 
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4.3 Composite water sample 
The average value of concentration of analytes measured in collected 2 weekly 
composite samples of water (for all target analytes excepting brominated diphenyl 
ethers) during sampler exposure provides the comparison with a conventional sampling 
approach. Uptake of passive samplers is proportional to the dissolved concentration in 
water and, provided the sampling rate is accurately known, a direct comparison with the 
water sampling (filtered composite water samples) is possible for polar compounds. This 
step could not be performed for brominated diphenyl ethers since alternative methods 
(other than PS) for measurement of their dissolved concentrations in water are not 
available. 
 
 
 
Figure 4  Spot sampling in water. The concentration of analytes measured in 2 weekly composite 
samples of water during passive sampler deployment provided the comparison with a 
conventional sampling approach. Spot sampling was not performed for PBDEs. 
5. Target compounds 
Selection of the target compounds was performed based on results of a questionnaire 
that was circulated in April 2010 to the participants of the NORMAN expert group 
meeting in Prague 2009 and laboratories that have experience with application and 
analysis of passive samplers.  
The questionnaire contained a broader list of potentially interesting compounds, which 
was based on the NORMAN list of the most frequently discussed emerging substances. 
This has been published also in the NORMAN position paper on PS [11]. 
The list contained also basic information on 
a) The potential applicability of passive samplers for the compounds 
b) Stage of development of passive samplers for the compounds – based on the 
literature 
c) Availability of passive sampler calibration data for the compounds 
d) Whether the substances were detected at the sampling site intended for the inter-
laboratory study in previous research and monitoring projects 
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To simplify selection compounds were highlighted in the questionnaire that fulfilled at 
least two of the criteria below: 
a) There is published evidence about passive sampler performance in the field 
b) Data from laboratory calibration studies are available 
c) Substance was found at measurable concentration in surface water or wastewater in 
the area around city of Brno 
The correspondents were asked to select from the list substances of interest. The final 
selection of 29 compounds was based on the response of nine expert laboratories from 
Europe and one from Australia. The target compounds are listed below.  
Many of the selected compounds are regulated as priority substances under the WFD and 
related Directives on Environmental Quality Standards [2], [3]. Those include atrazine, 
diuron, PFOS and pentabromodiphenylether. Moreover, diclofenac, 17-alpha-
ethynilestradiol and 17-beta-estradiol are compounds from the watch list established in 
Article 8b of Directive 2013/39/EU. 
 
Table 1 Target analytes : Polar pesticides 
 Compound CAS Usage 
1.  Atrazine 1912-24-9 triazine herbicide 
2.  Carbendazim 10605-21-7 benzimidazole fungicide 
3.  Desethylatrazine 6190-65-4 triazine metabolite 
4.  Desethylterbutylazine 30125-63-4 triazine metabolite 
5.  Diuron 330-54-1 phenylurea herbicide 
6.  S-metolachlor 87392-12-9 chloroacetanilide herbicides 
7.  Terbutylazine 5915-41-3 triazine herbicide 
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Table 2 Target analytes: Pharmaceuticals 
 Compound CAS Usage 
8.  Alprazolam 28981-97-7 benzodiazepine drug 
9.  Atenolol 29122-68-7 beta blocker drug 
10.  Carbamazepine 298-46-4 anticonvulsant drug 
11.  Diazepam 439-14-5 benzodiazepine drug 
12.  Diclofenac 15307-86-5 non-steroidal anti-inflammatory 
drug 
13.  Ibuprofen 15687-27-1 non-steroidal anti-inflammatory 
drug 
14.  Naproxen 22204-53-1 non-steroidal anti-inflammatory 
drug 
 
Table 3 Target analytes: Steroid hormones 
 Compound CAS Usage 
15.  17-alpha-Estradiol 57-91-0 steroid hormone 
16.  17-alpha-Ethinylestradiol 57-63-6 contraceptive 
17.  17-beta-Estradiol 50-28-2 steroid hormone 
18.  Estriol 50-27-1 steroid hormone 
19.  Estrone 53-16-7 steroid hormone 
 
Table 4 Target analytes: Brominated flame retardants 
 Compound CAS Usage 
20.  BDE 28 41318-75-6 Flame retardant 
21.  BDE 47 5436-43-1 Flame retardant 
22.  BDE 99 60348-60-9 Flame retardant 
23.  BDE 100 189084-64-8 Flame retardant 
24.  BDE 153 68631-49-2 Flame retardant 
25.  BDE 154 207122-15-4 Flame retardant 
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Table 5 Target analytes: Fluorinated surfactants 
 Compound CAS Usage 
26.  PFOA 335-67-1 fluorosurfactant 
27.  PFOS 1763-23-1 fluorosurfactant, fabric protector 
 
Table 6 Target analytes: Bisphenol A and Triclosan 
 Compound CAS Usage 
28.  Bisphenol A 80-05-7 monomer to make plastics 
29.  Triclosan 3380-34-5 antibacterial and antifungal agent 
6. Steering group 
The steering group was established from a group of laboratories with expertise in PS of 
selected groups of compounds. A meeting of steering group members was held on 
24/11/2010 in Bratislava, where the study design and its practical realisation was 
discussed. Tasks were assigned to members of the steering group. Laboratories and 
other organisations involved in planning and organisation of the study are listed in Table 
7.  
 
Table 7 Steering group of the inter-laboratory study 
Role Organisations and contact 
persons 
Activity 
Coordinator Masaryk university, RECETOX  
Water Research Institute 
(VUVH) 
Branislav Vrana 
vrana@recetox.muni.cz  
study desing, coordination, 
sampling activities, on-site 
measurements, preparation of 
provided samplers, sample 
distribution 
Central laboratory 
for PBDE 
Deltares 
Foppe Smedes; 
Foppe.Smedes@deltares.nl  
study design, preparation of 
provided samplers (silicone 
rubbers) 
Central laboratory 
for 
pharmaceuticals 
ISM-LPTC, University of 
Bordeaux 1 Hélène Budzinski;  
h.budzinski@epoc.u-bordeaux1.f 
r 
study design, preparation of QC 
standards, analysis of water 
samples 
Central laboratory 
for steroid 
hormones 
Irstea Lyon 
Marina Coquery, Cecile Miege, 
Nicolas Morin 
marina.coquery@irstea.fr  
study design, preparation of QC 
standards, analysis of water 
samples 
Central laboratory 
for PFOA and 
PFOS, standard 
solutions of PBDE 
European Commission DG 
JRC 
Robert Loos 
study design, preparation of QC 
standards, analysis of water 
samples 
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robert.loos@jrc.ec.europa.eu 
Central laboratory 
for bisphenol A, 
triclosan 
Environment Agency Wales 
UK Environment Agency 
Anthony Gravell 
David Westwood 
anthony.gravell@environment-
agency.wales.gov.uk  
study design, preparation of QC 
standards, analysis of water 
samples 
Participant 
interface for 
results reporting 
QUASIMEME 
Steven Crum 
Ann-Marie Ryan 
steven.crum@wur.nl 
Ann-Marie.Ryan@wur.nl  
setup of sharepointsites  
Introduce the lab specific 
contact information into the 
database, help desk facility with 
respect to data-transfer 
Sampling support 
+ 
Data 
interpretation 
Masaryk university, RECETOX 
Foppe Smedes 
Branislav Vrana 
smedes@recetox.muni.cz  
vrana@recetox.muni.cz  
participant registration, , data 
assessment data and 
interpretation, report 
preparation 
Consultant + 
Screening 
Eawag 
Etienne Vermeirssen 
Etienne.Vermeirssen@eawag.ch 
study design, screening of the 
sampling site 
Sampling support IPH Ostrava 
Tomas Ocelka 
providing sampling materials 
Logistic support + 
study 
dissemination 
European Commission DG 
JRC 
Robert Loos 
Bernd Gawlik 
robert.loos@jrc.ec.europa.eu  
bernd.gawlik@jrc.ec.europa.eu  
study design, sampling logistics, 
host a meeting for the 
participants to discuss study 
results 
7. Participants 
7.1 Registration  
The study was open for participants from commercial, academic and regulatory 
laboratories. Potential participants were informed by e-mail from the NORMAN network 
to its members. The study was announced on 9.3.2011 with a deadline for participant 
registration on 31.3.2011. Participants were asked for participation on their own 
expenses.  Registration of participants was done online on a website setup by RECETOX, 
Masaryk university [24]. 
The organiser provided participants with detailed information on the study design and 
time schedule. The exercise manual contained information on important dates for the 
exercise (deadline to send equipment to the organiser, sampler deployment period, 
expected date to receive materials for analysis), general information for the participants 
(samplers to be sent to the organiser, deployment device to be sent to the site, 
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“NORMAN provided sampler” to be received from the organiser, information on protocol 
for sampler deployment, requirements for the solvent of the QC check solutions as well 
as general information on the result reporting and data evaluation and information about 
registration fees.  
Table 8  Self assessed level of expertise in analysis of target compound groups in passive 
samplers. 
Labora-
tory 
Polar 
pestici-
des 
Pharma
ceuti-
cals 
Steroid 
hormo-
nes 
Fluori-
nated 
surfac-
tants 
Triclo-
san 
Bisphe-
nol A 
Bromi-
nated 
flame 
retar-
dants 
16 A1  A A C3 A A 
17 A A       
18 A        
19 A B2 B B B B B 
20   C  B C B 
21 C   C   C 
23 A A B A A A A 
25       B 
26   C   C C 
29  A  A   A 
30 A      A 
31  A A      
32 B B       
33   A      
36 B B B    B 
37 B  C C   B 
38       C 
39 B B B B  B   
40 A A       
42 C        
43 B B B    A 
44 C C C C C C C 
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Labora-
tory 
Polar 
pestici-
des 
Pharma
ceuti-
cals 
Steroid 
hormo-
nes 
Fluori-
nated 
surfac-
tants 
Triclo-
san 
Bisphe-
nol A 
Bromi-
nated 
flame 
retar-
dants 
45   B   B   
46  C       
47 B B   B B   
48 A A       
49 B B A  A B   
50 C C C  C C C 
51         
52       A       
1A - expert laboratory that routinely analyses target compounds in passive samplers 
2B - laboratory with some experience with analysis of analytes in passive samplers 
3C - laboratory with a limited experience with analysis of target compounds in passive 
samplers but wants to test the performance of their samplers 
 
Participants had the option to register for individual groups of compounds (4.1-4.6), 
which means that not all laboratories participated in the exercise for all groups of 
compounds.  
During the registration participants provided following information: 
a) Identification of the participant laboratory 
b) Name and contacts of the corresponding person 
c) Selection of target compound classes and individual compounds 
d) Passive samplers provided by participants for analysis of selected target 
compounds 
e) Statement of ability to analyse their selected analytes in NORMAN provided 
samplers 
f) Statement on level of expertise in analysis of selected analytes in passive 
samplers (Table 8): 
Altogether, 30 laboratories registered for the study, with the following numbers of 
participants registered to analyse individual contaminant classes:  
Polar pesticides   – 19 participants 
Pharmaceuticals  – 17 participants 
Steroid hormones  – 15 participants 
Triclosan   –  8 participants 
Bisphenol A   –  11 participants 
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PFOA, PFOS   –  8 participants 
PBDE    – 16 participants 
Note that despite registration, not all laboratories delivered results for all registered 
compound classes and several laboratories did not report any data. 
 
7.2 Participating laboratories 
For the result presentation anonymous codes from Lab16 to Lab51 were attributed to 
the participants. 
 
Table 9  List of participating laboratories 
Institute  Institute address Country Participant name 
Aix Marseille 
University 
Institut des 
Sceinces 
Moleculaires de 
Marseille (ISM2) 
Equipe AD2EM 
Europole Environnement 
Petit Arbois - Bat Villemin 
- BP80 
Aix en Provence 
13545 
France Laure Malleret 
laure.malleret@univ-
cezanne.fr  
BRGM 3 avenue Claude 
Guillemin 
Orleans 
45060 
France Catherine Berho 
c.berho@brgm.fr  
Irstea 3 bis quai Chauveau, CP 
220 
Lyon 
69336 
France Cecile Miege 
cecile.miege@irstea.fr  
Cemagref 
UR REBX 
50 avenue de Verdun 
Cestas 
33612 
France Nicolas Mazzella 
nicolas.mazzella@irstea.fr  
Deltares/TNO PO Box 85467 
Utrecht 
3508 AL 
The 
Netherlands 
Foppe Smedes 
Henry Beeltje 
foppe.smedes@deltares.nl  
Eawag 
Swiss Federal 
Institute of 
Aquatic Science 
and Technology,  
Überlandstr. 133 
Dübendorf 
8600 
Switzerland Juliane Hollender 
Etienne Vermeirssen 
juliane.hollender@eawag.ch  
etienne.vermeirssen@eawag.c
h  
Oekotoxzentru
m Eawag-EPFL 
Überlandstr. 133 
Dübendorf 
8600 
Switzerland Nadzeya Homazava 
nadzeya.homazava@eawag.c
h  
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Institute  Institute address Country Participant name 
Environment 
Agency, 
National 
Laboratory 
Service 
19 Penyfai Lane, Furnace, 
Llanelli 
Carmarthenshire 
SA15 4EL 
Wales Anthony Gravell 
anthony.gravell@environment
-agency.gov.uk  
European 
Commission, 
DG Joint 
Research Centre 
(JRC) 
Unit H01 - Water 
Resources Unit, Via Enrico 
Fermi, I-21020 Ispra 
Italy Robert Loos 
robert.loos@jrc.ec.europa.eu  
Institute for 
Environmental 
Studies 
De Boelelaan 1085 
Amsterdam 
1081HV 
The 
Netherlands 
Petra Booij 
petra.booij@ivm.vu.nl  
Institute of 
Public Health 
Ostrava 
Partyzánské nám. 7 
Ostrava 
70200 
Czech 
Republic 
Samuel Mach 
samuel.mach@zu.cz  
LABAQUA C/ Dracma 16-18 
Alicante 
03114 
Spain Julio Llorca 
julio.llorca@labaqua.com  
Marine 
Scotland 
Science 
Marine Laboratory, PO 
Box 101, 375 Victoria 
Road, 
Aberdeen 
AB11 9DB 
UK Craig Robinson 
craig.robinson@scotland.gsi.g
ov.uk  
Masaryk 
University 
RECETOX,  
Kamenice 126/3 
Brno 
62500 
Czech 
Republic 
Jiří Kohoutek 
jiri.kohoutek@recetox.muni.cz  
NIVA Norwegian 
Institute for 
Water Research  
Gaustadalleen 21 
Oslo 
NO-0349 
Norway Ian Allan 
ian.allan@niva.no  
Omegam 
Laboratoria 
HJE Wenckebachweg 120 
Amsterdam 
1096 AR 
The 
Netherlands 
Linda Landwehr 
L.Landwehr@omegam.nl  
Ontario 
Ministry of 
Environment - 
Laboratory 
Services Branch 
125 Resources Road  
Etobicoke 
M9P 3V6 
Canada Rita Dawood 
rita.dawood@ontario.ca  
SLU, Dep of 
Aquatic Sciences 
and Assessment 
P.O Box 7050 
Uppsala 
SE-750 07 
Sweden Christer Jansson 
Christer.Jansson@slu.se  
T. G. Masaryk 
Water 
Research 
Institute 
Podbabská 30/2582 
Prague 
160 00 
Czech 
Republic 
Magdalena Kvíčalová 
magdalena_kvicalova@vuv.cz  
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Institute  Institute address Country Participant name 
UFZ- Helmholtz 
Centre for 
Environmental 
Research 
Department of 
Ecological 
Chemistry,   
Permoserstrasse 15 
Leipzig 
04318 
Germany Albrecht Paschke 
albrecht.paschke@ufz.de  
Universita 
degli Studi di 
Genova 
Dipartimento di 
Chimica e 
Chimica 
Industriale  
Via Dodecaneso, 31 
Genoa 
16146 
Italy Emanuele Magi 
magie@chimica.unige.it  
Universitá di 
Cagliari 
Dipartimento di 
Igiene e Sanita 
pubblica 
Via Porcell, 4 
Cagliari 
9124 
Italy Marco Schintu 
schintu@unica.it  
University 
Bordeaux 1, 
EPOC-LPTC, UMR 
5255 CNRS 
351 crs de la Liberation 
Talence 
33405 
France Helene Budzinski 
h.budzinski@epoc.u-
bordeaux1.fr  
University of 
Connecticut, 
Department of 
Marine Sciences 
1080 Shennecossett Rd. 
Groton, CT 
6340 
USA Penny Vlahos 
penny.vlahos@uconn.edu  
University of 
Portsmouth, 
School of 
Biological 
Sciences 
King Henry I Building, 
King Henry I Street 
Portsmouth 
PO1 2DY 
United 
Kingdom 
Janine Bruemmer 
janine.bruemmer@port.ac.uk  
University of 
Queensland 
Entox 
39 Kessels Road 
Coopers Plains 
4108 
Australia Karen Kennedy 
k.kennedy@uq.edu.au  
University of 
Rhode Island 
Graduate School 
of Oceanography  
South Ferry Road 
Narragansett 
RI 02882 
USA Rainer Lohmann 
lohmann@gso.uri.edu  
University of 
Winnipeg 
515 Portage Ave. 
Winnipeg, Manitoba 
R3B2E9 
Canada Charles Wong 
wong.charles.shiu@alum.mit.
edu  
Veolia 
Environnement 
Recherche et 
Innovation (site 
de St Maurice) 
Immeuble &quot;Le 
Dufy&quot; - 1 place de 
Turenne 
Saint Maurice Cedex 
94417 
France Perrine Wund 
p.wund@epoc.u-bordeaux1.fr  
Waterproef 
Foundation 
Dijkgraaf Poschlaan 6 
Edam 
1135 ZG 
The 
Netherlands 
Mai Thao Nguyen 
m.nguyen@waterproef.nl  
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8. Sampling station 
8.1 Site description 
The exercise was performed at a single sampling site – the discharge of treated 
wastewater from a large municipal WWTP in Brno-Modřice (capacity cca. 500 000 
equivalent inhabitants). The sampling was performed in an effluent basin that is used for 
measurement of flow and volume of discharged treated wastewater. The basin is cube-
shaped with vertical concrete walls. The basin is situated at the end of a straight 
horizontal wastewater discharge pipeline that feeds into the basin at a depth of 3 m 
below ground level. The minimum water depth in the basin is 2.35 m. Standard 
parameters of the discharged treated wastewater that were sampled/measured during 
the exercise are shown in Section 8.5. The basin is equipped with side walkways which 
were used for suspension of PS devices during the exercise.  
The site was secure so that expensive onsite equipment such as the continuous 
automatic water sampler could be used. Also, WWTP kindly provided some of the 
necessary supporting measurements (continuous temperature, discharge, pH). Access to 
the sampling site was permitted by the WWTP operator. Details of the WWTP facility are 
given at the website [25]. 
 
 
Figure 5.  Layout of the WWTP in Brno-Modřice. The sampling site is located at the discharge of 
treated wastewater and is marked with the red circle.  
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Figure 6.  Views of the sampling site; discharge of treated wastewater from the WWTP in Brno-
Modřice. A suspended sidewalk above the basin with the discharge pipe allowed a 
convenient deployment of passive samplers. The yellow rectangles in the middle right 
picture describe horizontal coordinates of possible positions for sampler deployment. The 
bottom picture illustrates vertical profile of the basin. Samplers were suspended from the 
sidewalk on ropes and exposed at water depth 0.5-2 m. 
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8.2 Initial sampling site characterisation 
Preliminary information on emerging organic contaminants present in the treated 
wastewater at the outflow of the WWTP was available from a study “New procedures for 
monitoring the impact of urban agglomerations on qualitative parameters of fluvial 
environment with emphasis on the identification of endocrine substances” (funded by the 
Czech The Ministry of Education, Youth and Sports)1 that was performed also at this 
sampling site, allowed preliminary identification of relevant substances Data from the 
study was kindly provided by Institute of Public Health Ostrava. 
An initial screening campaign at the sampling site was performed from 18th June to 2nd 
July 2010. Several types of passive samplers were deployed (POCIS, Chemcatcher fitted 
with SDB/RPS, SDB/XC with and without polyethersulphone membrane, silicone sheets) 
and analysed in several laboratories. Results from the screening survey are available 
[26].  
 
Table 10 Compound classes analysed in passive samplers from an initial screening of the 
sampling site. 
Compound class Sampler Laboratory 
Polar pesticides POCIS Irstea Lyon 
Polar pesticides, pharmaceuticals SDB/RPS 
Empore disk 
Eawag 
Steroid hormones POCIS, 
SDB-XC 
Empore disk 
RECETOX  
PBDE Silicone sheets RECETOX 
Pharmaceuticals POCIS University 
Bordeaux 
PFOA, PFOS POCIS RECETOX 
Triclosan SPMD IPH Ostrava 
Bisphenol A Water sample/SBSE VUVH 
Photos of the sampling site, collected during the initial screening campaign, are available 
(Vrana, 2010a,b). 
8.3 Passive sampling homogeneity test 
One of the critical issues in preparation of the interlaboratory study was the suitability of 
the selected sampling site in terms of (1) the presence of target analytes in time, (2) 
homogeneity of their aqueous concentrations and (3) homogeneity of sampler exposure 
conditions in the basin (i.e. flow conditions and temperatures). 
                                           
1 New procedures for monitoring the impact of urban areas on qualitative parameters of 
fluvial environment with emphasis on the identification of endocrine substances. Project 
MŠMT 2B06093, funded by the Czech The Ministry of Education, Youth and Sports. 
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The issue of homogeneity of exposure conditions, especially the possible effect of flow 
velocity/turbulence on passive sampler performance has been raised at the steering 
group meeting on 24th November in Bratislava. To assess this aspect, a test of exposure 
homogeneity was performed before the actual study. 
From 20th December 2010 till 3rd January 2011 (14 days), 5 standard POCIS sampler 
deployment cages containing 3 POCIS (with Oasis HLB adsorbent and fitted with 
polyethersulphone membrane) were deployed each at various positions (2 positions and 
3 water depths). The aim of the study was to investigate whether the position of cages 
within the basin had a significant effect on the sampler uptake. Following exposure, 
sorbent from individual samplers was transferred to SPE cartridges, dried, weighted, 
eluted and the extracts were analysed for a suite of polar pesticides by LC/MS.  
 
Figure 7 Sampling homogeneity test using POCIS samplers. Five standard POCIS sampler 
deployment cages containing 3 POCIS (with Oasis HLB adsorbent) each were deployed at 
various positions (2 positions and 3 depths) in the outflow object of the WWTP in Brno 
Modřice. 
Data for compounds are reported where levels were higher than limit of quantification 
(LOQ). Blank samplers contained concentrations below method LOQ for all analysed 
compounds. Graphs in Figure 8 are comparing individual cages for different compounds 
(ng/sampler). 
  
 
cages 
cages 
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Figure 8  Mean amounts [ng/sampler] (± 1 standard deviation) of pesticides accumulated in triplicate 
POCIS samplers placed in 5 deployment cages at various positions (2 positions and 3 
depths) in the outflow object of the WWTP in Brno Modřice. The various sampling 
coordinates are outlined in Figure 7 (e.g. AD means horizontal position A and vertical 
position D). 
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The results of the homogeneity test were following: 
 
1. Data were normally distributed, with equal variance, with exception of isoproturon. 
There was a high variability of isproturon even in parallel samples from the same 
cage which we cannot explain. 
2. The coefficient of variation for the complete dataset for most compounds was less 
than 20%, with exception of simazine (33%) and isoproturon (>100%). The total 
coefficient of variation in the final result (CV2total) is made up of 2 contributions. One 
is from variation in the composition of the laboratory samples due to the nature of 
the sorbent material and the sampling procedures used (CV2sample). The other 
(CV2analysis) is from the analysis of the samples carried out in the laboratory: 
2 2 2
total sample analysisCV CV CV        (Equation 1) 
The CV of the instrumental analysis of standard solutions of pesticides was ca 5%. 
The  CV of triplicate samples exposed within an individual cage (excluding simazine 
and isoproturon) was less than 18%. This is a reasonable precision when considering 
that it includes variability originating from both sampling (within the same cage) and 
sample analysis. 
3. The variability of the amount of analytes in POCIS within individual deployment 
cages was mostly comparable or even higher than the variability of calculated from 
the means in the five cages (Table 11).  
4. . The test results indicate that if samplers are deployed in the same type of 
deployment cage, location in the outflow tank within the tested zone did not have an 
effect on their performance higher than the variance of the analysis of sample 
replicates in the laboratory. At least not for the compounds under investigation. 
Table 11 Comparison of the variability of measured pesitcide amount in POCIS within 
individual deployment cages with the variability of the mean analyte amount 
determined in the five deployment cages. 
Compound 
Mean CV 
within 
cages  
Mean CV 
between 
cages  
Atrazine 13% 4% 
Chlorsulfuron 6% 6% 
Diazinon 14% 6% 
Simazine 24% 18% 
Dimethachlor 8% 10% 
Metolachlor 12% 2% 
Isoproturon 51% 56% 
Metazachlor 21% 6% 
Terbuthylazine 14% 6% 
Chlortoluron 17% 7% 
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8.4 Sampler exposure 
Samplers were exposed in 3 subsequent sampling campaigns. The timeline of the 
sampler field exposures for the 7 investigated compound groups is shown in Figure 9. 
 
Figure 9 Exposure of samplers for different compound classes. 
8.5 Field parameters 
Data on several parameters of sampled water were provided by the WWTP operator. 
Those included water discharge, temperature, suspended solids, pH, conductivity and 
TOC (Figure 10-15)  
 
Figure 10 Water discharge. 
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Figure 11 Water temperature. 
 
 
Figure 12 Suspended solids in water samples. 
 
 
Figure 13 pH in water samples. 
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Figure 14 Conductivity in water samples.  
 
 
Figure 15 Total organic carbon in water samples. 
8.5.1 Current velocities 
On 1.6.2011 measurement of local current velocities was performed using a hand held 
Flow Tracker P3661. Current velocities were measured at several places in the discharge 
basin at 3 depths (0.1, 0.5 and 1 m) below the water surface. Flow velocities ranged 
from 2×10-4 to 0.36m/s and differences in flow condition were observed in different parts 
of the system. These may have fluctuated during the sampler exposure, depending on 
discharge conditions and other effects such as the observed massive growth of green 
filamentous algae that adhered close to water surface to the ropes with deployed 
samplers. Samplers were deployed in a way that extreme flow conditions were avoided 
(e.g. positioning of samplers directly in front of the discharge pipe was avoided). Algae 
were regularly removed from the ropes and deployment cages. Participants were 
informed about the coordinates of their sampler in the exposure system and the 
approximate local flow velocities were provided together with other supporting field 
parameters. In most cases participants used special deployment devices to buffer 
potential effects of water currents. Uniform deployment devices were applied for 
deployment of provided passive samplers. Some participants applied various approaches 
to quantify the potential effect of flow velocity on sampler performance. These included 
the active pumping of water at a desired flow velocity (CFIS sampler; lab 30); 
application of passive flow monitors (PFM; labs 19 and 36) [29] or application of 
performance reference compounds (PRCs). Details can be found in Annexes. 
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8.6 Water sampling 
An automatic water sampler (Bühler 1029, Hach Lange, Germany) collected water 
samples at the sampling site during entire 14 day passive sampler deployment period (in 
the first and second sampler deployment period). The sampling was time-proportional, 
not flow-proportional and followed the schemes in Figure 16 and Figure 17. Every 24 h, 
the sampler was programmed to collect a total of 2.5 L of water (100 ml water every 
hour). During collection, the 24-h water sample was evenly distributed to glass cylinders 
(1 L) inside the apparatus and they were kept at 4°C in the autosampler storage 
container. 
Every 24h the collected water samples from 12x1 L autosampler cylinders were 
transferred to a single clean 2.5 L amber glass bottle, and this 24-h composite sample 
was transported on ice to the laboratory. 
 
8.6.1 Preparation of a 7-day composite sample 
Immediately after collection of a 24-h composite field sample, the glass bottle containing 
the 24-h composite sample was transported to laboratory, homogenized (by shaking) 
and filtered through a Whatman GF/F filter. Aliquots were distributed to storage bottles 
and stored at 4°C (pesticides, triclosan, bisphenol A, PFOA/PFOS) or frozen to -20°C 
(pharmaceuticals and steroids). 
Every day of a 7-day sampling period, a prescribed aliquot was added to the storage 
bottles. Seven-day composite samples were obtained every week by applying this 
procedure. Extra backup field samples were stored at RECETOX until the laboratory 
analysis was completed. Water samples and blank samples were once per week shipped 
by a fast courier service from RECETOX to central laboratories for analysis. 
8.6.2 Preparation of 7-day composite blank samples 
In addition to field samples, blank samples were prepared using aliquots of Milli-Q water 
filtered daily through Whatman GF/F filter to check for potential contamination during 
sample treatment. Seven-day composite blank samples were obtained by applying this 
procedure. 
 
  
40 
 
Figure 16 Water sampling scheme for obtaining 7-day composite water samples for analysis of 
pesticides and pharmaceuticals 
Collect 100 mL/h x 24h = 2400 ml/day
Transfer 24h composite water sample every day from 12x1 L autosampler cylinders to 
a clean 2.5 L amber glass bottle, homogenise and transport on ice to the laboratory
Automatic sampler (on site):
Transport to
RECETOX:
Pharmaceuticals Pesticides
1000 mL/day
Filter through Whatman GF/F
500 mL/day 300 mL/day
bottle A
2L; Nalgene
bottle B
2L; Nalgene
bottle E
2L; Nalgene
250 ml/day 250 ml/day
Filter through Whatman GF/F
500 mL Milliq water/day
bottle F
1L; glass bottle
250
ml/day
140
ml/day
Store @ -20°C Store @ 4°C
Store @ -20°C Store @ -20°C
BLANK SAMPLES
FIELD SAMPLES
bottle D
1L; glass bottle
bottle C
1L; glass bottle
Store @ 4°C Store @ 4°C
140
ml/day
140
ml/day
980 ml / 7-day 
composite BACKUP 
store at RECETOX
1750 ml / 7-day 
composite BACKUP, 
store at RECETOX
1750 ml / 7-day 
composite sample
Send weekly to ISM-
LPTC Bordeaux
1750 ml / 7-day 
composite BLANK 
Send weekly to
ISM-LPTC
Bordeaux
980 ml / 7-day 
composite BLANK 
Send weekly to
Cemagref
Bordeaux
980 ml / 7-day 
composite sample
Send weekly to
Cemagref  Bordeaux
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Figure 17 Water sampling scheme for obtaining 7-day composite water samples for analysis of 
triclosan, bisphenol A, PFOS, PFOA and steroid hormones. 
9. Tested materials 
9.1 Standard solutions 
The standard solution of analytes was prepared by the central laboratories (Table 7), 
which also performed sample homogeneity tests before distribution to participants. 
Participants were asked to perform recommended dilution with the appropriate solvents 
of injection. Participants were asked not to evaporate the standard solutions. A minimum 
Collect 100 mL/h x 24h = 2400 ml/day
Transfer 24h composite water sample every day from 12x1 L autosampler cylinders to 
a clean 2.5 L amber glass bottle, homogenise and transport on ice to the laboratory
Automatic sampler (on site):
Transport to
RECETOX:
min. 2000 mL/day
Filter through Whatman GF/F
FIELD SAMPLES
1200 ml / 7-day 
composite sample
Send weekly to
Cemagref  Lyon
2000 ml / 7-day 
composite sample 
Send weekly to 
UK EA
Steroid 
hormones
340 mL/day
Store @ 4°C
bottle F
2x 1L; glass 
bottle
bottle E
2x 1L; glass 
bottle
Store @ -20°C
Store @ -20°C
170
ml/day
170
ml/day
1200 ml / 7-day 
composite BACKUP 
store at RECETOX
2000 ml / 7-day 
composite BACKUP, 
store at RECETOX
PFOA/PFOS
570 mL/day
bottle C
2L; Nalgene
bottle D
2L; Nalgene
285 ml/day 285 ml/day
Store @ 4°C
2000 ml / 7-day 
composite sample
Send weekly to 
DG JRC IES
Triclosan AND 
Bishpenol A
570 mL/day
bottle A
2x1 L; glass 
bottle
bottle B
2x1 L; glass 
bottle
285 ml/day 285 ml/day
Store @ 4°C Store @ 4°C
2000 ml / 7-day 
composite sample 
Send weekly to 
UK EA
bottle Blank B
2L; Nalgene
Filter through Whatman GF/F
1000 mL Milliq water/day
bottle Blank C
1L; glass bottle
285
ml/day
170
ml/day
Store @ 4°C Store @ -20°C
BLANK SAMPLES
2000 ml / 7-day 
composite BLANK 
PFOS/PFOA
Send weekly to
DG JRC IES
1200 ml / 7-day 
composite BLANK 
Steroids
Send weekly to
Cemagref Lyon
bottle Blank A
2L; glass bottle
285
ml/day
2000 ml / 7-day 
composite BLANK 
triclosan and bisphenol A
Send weekly to
UK EA
Store @ 4°C
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volume of standard solution was recommended for use for each sample injection. 
Implementation of gravimetric controls was encouraged. Laboratories were asked to 
perform 4 replicates of sample injection to the instrumental system. Organisers 
recommend that the injections of the calibration solution is spread over the analysis 
sequences so that at least 4 other sample injections are made between individual 
injections of this solution. Distribution of standard solution to participating laboratories 
was performed in cooled polystyrene containers together with provided samplers by a 
fast courier service. 
9.1.1 Polar pesticides 
1 ml of standard solution mixture in amber glass vials with a screw cap, containing 2 
µg/mL in acetone of each individual compound, was distributed to participants. 
Reference concentration of each analyte with associated expanded uncertainty is show in 
Table 12. 
Table 12 Reference concentration of polar pesticides in distributed standard solution, stated 
by the central laboratory. 
CAS Compound Standard 
solution 
units Expanded 
uncertainty 
(k=2) 
% CV 
1912-24-9 Atrazine 1.37 ug/mL 0.29 21% 
10605-21-7 Carbendazim 1.85 ug/mL 0.34 18% 
6190-65-4 Desethylatrazine 1.88 ug/mL 0.29 15% 
30125-63-4 Desethylterbutylazine 2.00 ug/mL 0.22 11% 
330-54-1 Diuron 2.76 ug/mL 0.43 16% 
87392-12-9 S-metolachlor 1.91 ug/mL 0.17 9% 
5915-41-3 Terbutylazine 1.76 ug/mL 0.23 13% 
 
Table 13 Reference concentration of pharmaceuticals in distributed standard solution, stated 
by the central laboratory. 
CAS Compound Standard 
solution 
units Expanded 
uncertainty 
(k=2) 
% CV 
29122-68-7 Atenolol 2.65 ug/mL 0.14 5% 
298-46-4 Carbamazepine 2.14 ug/mL 0.13 6% 
15307-86-5 Diclofenac 2.79 ug/mL 0.13 5% 
15687-27-1 Ibuprofen 3.61 ug/mL 0.12 3% 
22204-53-1 Naproxen 2.40 ug/mL 0.13 5% 
439-14-5 Diazepam 2.41 ug/mL 0.21 9% 
28981-97-7 Alprazolam 3.75 ug/mL 0.62 17% 
29122-68-7 Ketoprofen 7.13 ug/mL 0.22 3% 
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9.1.2 Pharmaceuticals 
1 ml of standard solution mixture in amber glass vials with a screw cap, containing 2 
µg/mL in acetone of each individual compound, was distributed to participants The 
reference concentration of each analyte with associated expanded uncertainty is shown 
in Table 13. 
9.1.3 Steroid hormones 
1 ml of standard solution mixture in amber glass vials with a screw cap, containing 20 
ng/mL in acetone of each individual compound, was distributed to participants. The 
reference concentration of each analyte with associated expanded uncertainty is shown 
in Table 14. 
 
Table 14 Reference concentration of steroid hormones in distributed standard solution, stated 
by the central laboratory. 
CAS Compound Standard 
solution 
units Expanded 
uncertain
ty (k=2) 
% CV 
57-91-0 17-alpha-Estradiol 0.0214 ug/mL 0.0024 11% 
57-63-6 17-alpha-
Ethinylestradiol 
0.0158 ug/mL 0.0012 8% 
50-28-2 17-beta-Estradiol 0.0205 ug/mL 0.0029 14% 
82115-62-6 Estriol 0.0214 ug/mL 0.0032 15% 
50-27-1 Estrone 0.0206 ug/mL 0.0016 8% 
9.1.4 Brominated diphenyl ethers - PBDEs 
2 mL amber glass ampoules were used for the standard dissolved in cyclohexane. The 
reference concentration of each analyte with associated expanded uncertainty is shown 
in Table 15.  
 
Table 15 Reference concentration of PBDEs in distributed standard solution. 
CAS Compound Standard 
solution 
units CVCertified by 
supplier 
41318-75-6 BDE 28 20 ng/mL ±10% 
5436-43-1 BDE 47 71 ng/mL ±10% 
60348-60-9 BDE 99 100 ng/mL ±10% 
189084-64-8 BDE 100 20 ng/mL +10% 
68631-49-2 BDE 153 16 ng/mL ±10% 
207122-15-4 BDE 154 15 ng/mL ±10% 
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9.1.5 Fluorinated surfactants 
1 ml of standard solution mixture in 2 mL amber glass vials with a screw cap, containing 
50 ng/mL in methanol of each individual compound, was distributed to participants. The 
reference concentration of each analyte with associated expanded uncertainty is shown 
in Table 16. 
 
Table 16 Reference concentration of fluorinated surfactants in distributed standard solution, 
stated by the central laboratory. 
CAS Compound Standard 
solution 
units Certified by 
supplier  
335-67-1 PFOA 0.048 ug/mL ±10% 
1763-23-1 PFOS 0.050 ug/mL ±10% 
 
9.1.6 Bisphenol A and Triclosan 
1 ml of standard solution of each compound in amber glass vials with a screw cap, 
containing cca. 100 ng/mL in acetone was distributed to participants. The reference 
concentration of each analyte with associated expanded uncertainty is shown in Table 
17. 
 
Table 17 Reference concentration of bisphenol A and triclosan in distributed standard 
solutions, stated by the central laboratory. 
CAS Compound Standard 
solution 
units Expanded 
uncertainty 
(k=2) 
% CV 
80-05-7 Bisphenol A 0.110 ug/mL 0.0035 3% 
3380-34-5 Triclosan 0.108 ug/mL 0.0030 3% 
9.2 Provided samplers 
Variability in analytical results increases when samples contain natural matrix, such as 
co-extracted organic macromolecular material. The analysis of the provided samplers (3 
replicates + field blank) by participating laboratories allowed an inter-calibration of the 
analysis of passive samplers and an estimate to be made of the contribution of the 
analytical (sampler extraction + analysis) component to total variability of PS process.  
The samplers to be ”provided samplers”, were exposed to water at the sampling site 
together with participant samplers. Following exposure, each sampler was labelled with a 
number that enabled to identify exposure conditions including location in the exposure 
system.  
9.2.1 POCIS  - provided samplers for polar compounds 
The provided sampler applied for pesticides, pharmaceuticals, steroid hormones, 
fluorinated surfactants, bisphenol A and triclosan was a POCIS sampler with a standard 
configuration (200 mg of OASIS HLB sorbent fitted with polyethersulphone membrane 
with 0.1 µm pore size and 45.8 cm2 surface area), prepared by the central laboratory ( 
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Table 7). For the study with pesticides the adsorbent was spiked with app. 4 µg/g of D5-
desisopropylatrazine (D5-DIA) before sampler assembly.  
Following exposure, adsorbent material was separated from each sampler by the study 
organiser in the laboratory, filled into an empty SPE cartridge, dried and the sorbent 
mass was recorded. Samplers were randomised before distribution to participants and 
each individual POCIS from the triplicate analysed by each laboratory originated from a 
different location in the sampled object. Each participant laboratory received sorbent 
material from 3 replicate samplers + 1 field blank. SPE cartridges with adsorbent were 
distributed to study participants by courier in cooled containers.  
Participants were asked to report results in ng/g of sorbent. For calculation of this 
concentration the mass of sorbent written on the SPE cartridge was applicable. In case of 
pesticide analysis, participants were also asked to report PRC data (DIA-d5) in ng/g. In 
this case the true concentration of DIA-d5 was not considered important but the ratio 
between the amount in exposed and unexposed sampler, i.e. sample and field blank. 
Participants were also asked to report an estimation of the freely dissolved concentration 
in the water phase (Cw) in ng/L. The procedure to calculate this concentration was not 
prescribed and participants were asked to use methods that they routinely apply for 
evaluation of data from POCIS or use relevant up-to-date information from scientific 
literature. For the calculation of procedure applied, participants were asked to give 
details including references to calibration data (sampling rates and distribution 
coefficients) in the reporting form. The reported information is given in Annex I. 
9.2.2 Silicone rubbers - provided samplers for PBDEs 
The provided sampler applied for PBDEs was made of Altesil® silicone rubber. Each 
sampler consisted of 3 sheets (90 x 55 x 0.5 mm) with approximate mass of 8.91 g. The 
exact dry weight of each sampler was determined by participants after extraction. The 
samplers were spiked with PRCs (D10-biphenyl, PCBs: CB001, CB002, CB003, CB010, 
CB014, CB021, CB030, CB050, CB055, CB078, CB104, CB145, CB204) during 
preparation. ”Provided samplers” were exposed to water at the sampling site for 42 days 
from 11.7.-22.8., together with participant samplers. Samplers were randomised before 
distribution to participants and each sampler consisted of 3 sheets randomly taken from 
a different location in the sampled object. 
Each participant laboratory received from the organiser provided samplers; 3 replicate 
field exposed samplers + 1 field blank + 1 field blank spiked by a uniform concentration 
of BDEs. 
Participants were asked to report results in absolute ng/sampler. Participants were also 
asked to report PRC data. The true concentration of PRCs was not relevant but the ratio 
between the amount in exposed and unexposed sampler, i.e. sample and field blank. A 
qualitative standard was supplied to help participants setting up the instrumental 
method. PRC data were reported in amount/sampler 
Participants were also asked to report an estimation of the freely dissolved concentration 
in the water phase pg/L. The procedure to calculate this concentration was not 
prescribed and participants were asked to use methods that they routinely apply for 
evaluation of data from silicone rubber samplers or use relevant up-to-date information 
from scientific literature. For the calculation procedure applied, participants were asked 
to give details including references to calibration data (sampling rates and distribution 
coefficients) in the reporting form. 
9.3 Participant samplers 
Participants were encouraged to deploy passive samplers (3 replicates and one field 
blank) that they usually apply in sampling of target compounds. Participant samplers 
were exposed to water at the sampling site together with provided samplers according to 
time schedule given in 8.4. Following exposure, each sampler was handled and stored 
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according to participant instructions and sent to participant laboratory by courier in 
cooled containers. 
In the reporting form participants described sampler specification, transport and storage, 
field deployment and recovery, and aspects of analytical and data evaluation (especially 
calculation of water concentration). Laboratories were asked to use their validated 
routine methods and procedures to analyse samplers. They were asked not to correct 
data for blanks except for the calculation of freely dissolved concentrations. For 
estimation of the freely dissolved concentration in the water phase, laboratories were 
asked to give details including references to applied procedures and calibration data 
(sampling rates and partition coefficients) in the report form. Analytes were reported as 
ng/sampler; ng/cm2 of sampler surface area; ng/g of sampler sorbent phase; and finally 
an estimation of the freely dissolved concentration in the water phase (ng/L or pg/L). 
9.4 Spot samples  
Despite the lack of an external reference value, water concentrations derived from 
passive samplers can be compared to an alternative method, which is based on analysis 
of weekly composite water samples, with exception of PBDEs. In contrast to passive 
samplers, water samples were analysed only by a single expert laboratory (Table 7). The 
procedure of collection and preparation of composite water samples is described in 8.6 
10. Data evaluation approach 
Participant data were log2 transformed for statistical treatment, assuming a log-normal 
distribution. For data presentation in graphs, results were back-transformed to original 
values. Box-and-whisker plots, bar graphs and biplot graphs were used to display 
participant data. The graphs have equal design for all compound classes and are 
described just once this chapter not to repeat unnecessary text. 
10.1 Box-and-whisker plots 
Each of the following chapters discussing the results of the individual analyte groups 
starts with a general view on the overall variability of all data (no outliers rejected) in 
the form of box-and-whisker plots. The box in the plot comprises the data between the 
25th and the 75th  percentile with the median of the data shown by the horizontal line 
inside the box. The ends of the whiskers represent the 10th and the 90th percentile. The 
plots have a logarithmic scale to show upward and downward variation with equal 
weight. For all compounds, groups of four graphs were made showing: 
1. The results obtained from the analyses of standard solution with the crosses 
showing the concentration declared as reference value by the central laboratory. 
The uncertainty (k=2) is superimposed on the graph as a blue line error bar. 
2. The data obtained from analyses of the provided sampler (NPS) expressed as 
uptake per unit of surface. For NPS uptake is assumed to be integrative and thus 
proportional to the surface area. 
3. Aqueous phase concentrations derived from the participant`s samplers. The 
results from spot samples are drawn as blue crosses and the limit of 
quantification as a red cross. 
4. Ratios between aqueous concentrations derived from provided sampler and 
participant’s sampler. 
10.2 Bar graphs 
Bar graphs were used for comparison of results obtained by individual participating 
laboratories. Three bar charts that compare results obtained by individual laboratories 
are shown for every compound. These represent 3 matrices analysed: the standard 
solution, the provided sampler (NPS, expressed as uptake per unit of sampler surface 
  
47 
area) and the participant Sampler (PPS, expressed as calculated water concentration), 
respectively. Since results of the latter two sample types could be linked neither to a 
standard nor to and an externally assigned value, a comparison was only made among 
the participating laboratories, showing the deviation of their own result from the median 
of all reported data. 
The number on the x-axis identifies the laboratory. In contrast to a traditional proficiency 
testing scheme approach, results obtained by laboratories are not ranked from the 
lowest to the highest value, but the position of data by a particular laboratory on the x-
axis of the bar graph is kept fixed. This allows an easy comparison of results obtained by 
the laboratory for a particular compound across different matrices (standard solution, 
provided sampler, participant sampler). 
Before plotting, identifying outliers, and calculation of the standard deviations the data 
were log transformed (base 2). Log base of 2 was selected since such scale allows a 
good orientation in the data – one tick increase on the y-axis represents a factor 2 
increase in the displayed value that was back transformed to a regular number. Data on 
the y-axis is always centred to the median of all participant’s data. The bars represent 
the mean values of the replicate (4 for the analysis of standards and 3 for the analysis of 
samplers) determinations in a particular matrix by an individual laboratory. 
Consequently, the length of the bar represents the deviation of the laboratory’s mean 
result from the median. The median is selected is because a standard or externally 
assigned “reference” value was not available and a comparison was only made between 
the participating laboratories. 
The repeatability (within laboratory variability) of participant data is indicated by error 
bars. The error bars are calculated from replicate determinations and represent ± 2 
times the standard deviation. 
High outliers were identified as values larger than the sum of the 75% percentile and 1.5 
times the inner quartile range (the inner quartile range is the 75th minus the 25th 
percentile). Values lower than the 25th percentile subtracted by 1.5 times the inner 
quartile range are also marked as outliers. Outliers are coloured orange in the bar charts. 
The reproducibility (between laboratory variability) of data is displayed as horizontal 
dashed lines above and below the median line, which represent ±2 times the standard 
deviation, after excluding outlier values. 
In the graph showing results of the standard solution analysis, reference values of 
concentrations (determined by central laboratories) are shown in the bar chart as a blue 
horizontal line. The dotted blue horizontal lines cover the interval of reference value ± 
declared expanded uncertainty with the coverage factor k=2. 
With exception of PBDEs, central laboratories measured concentration of analytes in 2 
weekly composite samples of water (water samples). The mean of the 2 composite 
samples is displayed as a blue dotted horizontal line. In addition, the limit of detection in 
water samples is displayed as a red horizontal line. 
Statistical data are displayed left of the bar graphs. These include the median (Median), 
standard deviation (s)2, geometric mean (Geomean), number of data points (n) of all 
participant data and the number of outlier values (Outliers), and a standard deviation of 
data excluding those outlier values (s excl. outl), respectively. For the standard solution, 
the reference value of the concentration (Refvalue) and associated expanded combined 
uncertainty with coverage factor 2 (Exp. unc.) are displayed. Next to the participant 
                                           
2 Errata: In statistical data that are displayed left of the bar graphs showing results for 
the analysis of the standard solution, (s) values shown below the lines (Median) show 
the  relative standard deviation. The value of standard deviation can be obtained by 
multiplying this value with the value of (Median). 
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sampler bar graph (showing calculated water concentration), analysis results are shown 
of the two 7-day composite water samples (water samples; Period 1 and Period 2) and 
the spot sample detection limit (LOD), respectively. 
Meaning of various objects and symbols in the graph is shown in Figure 18.  
 
 
 
Figure 18 Explanation of objects and symbols in bar graphs that display results of analysis of standard 
solution, provided and participant sampler by participating laboratories. 
10.3 Biplot graphs 
A scatter biplot graphical method (sometimes referred to as “Youden plot”) was applied 
for analysis of inter-laboratory data, where laboratories have analysed the compounds of 
interest in 2 samples (the participant sampler and the provided sampler). The plot 
visualises the between-laboratory variability along the diagonal line and deviations from 
the line indicate differences within laboratory or, only for the left plot, differences in 
uptake rate between provided and participant sampler (possible if types were different) . 
In other words, points that lie near the equality line (the 45 degrees line), but far from 
each other, indicate systematic error. Points that lie far from the equality line indicate 
random error or differences between provided and participant sampler (only left biplot). 
Most of the laboratories that participated in the exercise analysed the target compounds 
in 2 types of samplers: the participant sampler and the provided sampler. Data obtained 
by these two methods can be directly compared, assuming that certain simplifying 
criteria are fulfilled. 
1. The samplers differed in the surface area and the mass of sorbent material 
applied. In most cases the sampler uptake capacity was high and an integrative 
uptake over the 2 weeks of exposure can be assumed. This implies that the mass 
of analyte found in the sampler depends solely on the sampling rate and not on 
the sampler uptake capacity. In other words, sampling is considered to be 
integrative and the samplers far from the thermodynamic equilibrium with the 
sampled water. 
2. The sampling rate is a product of mass transfer coefficient and the active sampler 
surface area. In most samplers applied the main barrier to mass transfer is the 
water boundary layer and similar mass transfer coefficients are expected. 
Thus, it is reasonable to directly compare surface specific uptake (ng/cm2) in two 
different samplers analysed by the same laboratory. Furthermore, water concentration 
calculated from analyte uptake in different samplers should ideally result in the same 
value. 
The axes in the biplot are drawn on the same log 2 scale: one unit on the x-axis (ng/cm2 
or ng/L) has the same length as one unit on the y-axis. Each point in the biplot 
corresponds to the results of one laboratory and is defined by the provided sampler data 
on the horizontal axis and the participant sampler data on the vertical axis, respectively. 
In addition, analyte concentrations determined in 2 weekly composite water samples by 
central laboratories are shown on the biplot as blue triangles and the limit of 
quantification in spot water samples is plotted as a red square. A one to one reference 
 
+ 2 × stand. dev. of log2 transf. data
median
- 2 × stand. dev. of log2 transf. data
+ expanded uncertainty with k = 2
reference value  
- expanded uncertainty with k = 2
outlier colour
sampler type
S
P
M
D
repeatability (± 2 × SD)
composite water 
sample
(2 per exposure)
water sample 
mean
mean value
LOD of
a water sample
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line (the 45 degrees line) is drawn to show the equality of the 2 values. Labels of points 
identify the type of participant passive sampler according to Table 18 unless the 
participant sampler had the same design as the sampler provided by the organiser 
(POCIS for polar compounds or silicone rubber for PBDEs, respectively). In such case the 
points are not labelled. 
10.4 Expression of data variability as coefficient of variation 
Variability of participant data at different procedural levels is expressed as coefficient of 
variation (CV). CV was estimated from standard deviations of log2 transformed data 
according to the properties of the log-normal distribution [30]. 
2logs2lnCV           (Equation 2) 
Where slog 2 is the standard deviation of log 2 transformed data without outliers.  
Within laboratory variability (repeatability) was determined from replicate determinations 
of analytes in different matrices analysed: standard solution (n = 4), participant sampler 
(n = 3), provided sampler (n = 3) and associated water concentration estimates (n = 3). 
Between laboratory variability was determined from standard deviations of the mean of 
replicate values reported by laboratories. Outlier values were identified according to the 
procedure described in 10.2 and were excluded from the calculation of reported 
coefficients of variation. 
Variability (CVs) of reported results for individual compounds at different procedure 
levels is presented in bar graphs (see e.g. Figure 27). The procedure levels include the 
analysis of standard solution, the “participant sampler” (PPS) and the provided sampler 
(NPS), respectively. For passive sampler results the variability is shown as that of the 
surface specific uptake (ng/cm2) as well as that of the reported water concentration 
(ng/L), respectively.  
Note that the calculated CV of surface specific uptake results (ng/cm2) from participant 
sampler (PPS) may be an overestimation since the uptake per surface unit may differ 
between sampler types and the reported CV has not been corrected for those systematic 
differences. 
Summary tables that report the variability range at different procedure levels for the 
compound groups (i.e. polar pesticides, pharmaceuticals etc.) are also provided (see e.g. 
Table 19). 
10.5 Contribution of the calculation procedure to data variability 
Besides sampling and analytical variability, the calculation of water concentration Cw 
from PS data contributes to the result uncertainty. In general, passive samplers for 
compounds under investigation in this study are considered to be integrative during the 
entire sampling period and linear uptake of compounds is assumed. In most cases 
participants applied a simple linear uptake model to calculate Cw: 
 
PS
w
S
N
C
R t
           Equation 3 
Where NPS is the amount analysed on the sampler, RS is the sampling rate and t the 
deployment time. For this model, neglecting the error in t, the combined coefficient of 
variation can be expressed from the law of error propagation as: 
2 2
w PS SC N R
CV CV CV          Equation 4 
where individual terms express coefficients of variation of the water concentration 
estimate (CVCw), of the analyte amount accumulated by the provided sampler (CVNps) 
and of the sampling rate applied in calculation (CVRs), respectively. The rearranged 
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equation provides a formula to calculate the coefficient of variation of the sampling rates 
applied in calculation: 
2 2
s w PSR C N
CV CV CV          Equation 5 
10.6 Sampler designs employed by participating laboratories 
A wide range of passive sampler designs has been applied by the participants. Table 18 
lists the main categories of sampler design which were applied and their abbreviations 
that are used to label them in the graphs. The details of sampling methods applied and 
associated aspect of sample storage, transport, extraction and instrumental analysis can 
be found in Annexes II, IV, VI, VIII, X, XII, XIV. 
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Table 18. A brief desription and abbreviations of various passive sampler designs applied in 
the interlaboratory study 
Sampler Abbreviation 
POCIS pharmaceutical version POCIS 
Empore Disk ED 
POCIS, pesticide version POCIP 
Chemcatcher (3rd generation) polar configuration CCPOL 
silicone rubber material SR 
Empore SDB-RPS with PES-Membrane (0.1um) EDPES 
CFIS (Continuous Flow Integrative Sampler) CFIS 
BAKERBOND® Speedisk SPEED 
Polyoxymethylene sheet POM 
Modified POCIS POCIM 
standard SPMD (length 1m) SPMD 
Low density polyethylene LDPE 
membrane enclosed silicone collector (MESCO) MESCO 
non-polar Chemcatcher (3rd generation)  CCNP 
11. Results 
11.1 Polar pesticides 
Up to 19 laboratories participated in the exercise, but the numbers varied depending on 
target analytes and matrices analysed. One of the laboratories (Lab 50) did not provide 
own samplers for the exercise and only reported results for the standard solution and the 
provided sampler using 2 different analytical methods.  
Overall data variability is shown in box-and-whisker plots in Figure 19. Results for 
individual compounds and laboratories are displayed in bar graphs in Figure 20-26. The 
explanation of data projection applied is described in chapter 10. 
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11.1.1 Overall data variability 
 
 
Figure 19 Concentrations of polar pesticides in various analysed matrixes: standard solution (top left), 
provided sampler (top right), water concentration estimated from the participant sampler 
(bottom left) and the ratio of water concentrations determined in provided and participant 
passive sampler (bottom right), respectively. Further graph explanation is given in 10.1. 
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11.1.2  Results by laboratories – polar pesticides 
 
Figure 20 Results of analysis of atrazine Graph explanation is given in 10.2.and 10.3 
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Figure 21 Results of analysis of carbendazime. Graph explanation is given in 10.2.and 10.3 
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Figure 22 Results of analysis of desethylatrazine. Graph explanation is given in 10.2.and 10.3 
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Figure 23 Results of analysis of desethylterbutylazine. Graph explanation is given in 10.2.and 10.3 
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Figure 24 Results of analysis of diuron. Graph explanation is given in 10.2.and 10.3 
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Figure 25 Results of analysis of S-metolachlor. Graph explanation is given in 10.2.and 10.3 
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Figure 26. Results of analysis of terbutylazine. Graph explanation is given in 10.2.and 10.3 
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11.1.3 Sample variability 
 
 
Figure 27 Variability of reported pesticide results at different procedure levels. Coefficients of variation 
for individual compounds are shown. NPS – provided passive sampler; PPS – participant 
passive sampler. (N) –amount; (Cw) – water concentration. See also 10.4. 
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Table 19. Variability range at different procedure levels Polar pesticides. 
 
  Coefficient of variation (%) 
Variability:  Within laboratory Between laboratory 
Matrix analysed: Min. Max. Min. Max. 
Standard 
solution 
 4% 6% 6% 18% 
Provided 
sampler 
NPS amount (ng/cm2) 9% 12% 16% 101% 
 NPS water concentration 8% 13% 89% 161% 
Participant 
sampler 
PPS amount (ng/cm2) 12% 18% 51% 179% 
 PPS water concentration 11% 16% 39% 236% 
See 10.4 for further explanation 
11.1.4 Standard solution 
A good within laboratory variability of analysis of individual compounds in pesticide 
standard solution was observed with the mean CV from 4 to 6% (Figure 24-26, Table 
19). The between laboratory variability was satisfactory, too, ranging between 6 and 
18%. With exception of atrazine and diuron the reference concentration of pesticides was 
within the range comprised by the participant results (median ± 2 standard deviations 
excluding outliers) and vice versa, the median and geometric mean of participant results 
were within the uncertainty range stated by the central laboratory. For atrazine and 
diuron in standard solution there was a significant difference between median of 
participant results and the reference value stated by the central laboratory. An error in 
preparation of standard solution or a stability issue are 2 possible reasons of the 
observed bias. 
Also for these two compounds, (atrazine, terbutylazine,) participants with outlier results 
showed also the highest within laboratory variability, which indicates that the 
instrumental methods were not under control. 
11.1.5 Provided sampler 
11.1.6 Field blanks 
Concentrations of polar pesticides in field blank samplers was low, always <10% of the 
concentration found in exposed samplers and in most cases close to method detection 
limits (Table 20). 
11.1.7 Sampling variability 
An excellent within laboratory variability of analysis of polar pesticides in provided 
sampler (ng/cm2) was observed with the mean CV between 9 and 12% for sampler 
uptake and between 8 and 13% for the water concentration estimate, respectively (Table 
19).  
The between laboratory variability (excluding outliers) for sampler uptake (ng/cm2) was 
higher, ranging from 16 to 101% for different compounds. A higher (81 to 161%) 
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variability (1.3-5.6 times higher) was observed for the derived water concentration 
estimate. 
The between laboratory variation of the analysis of individual compounds was 2-7 times 
larger for the provided samplers than the standard solution. 
11.1.8 Contribution of the calculation procedure to data variability 
Contribution of the applied calculation procedure of CW from the amount on the sampler, 
to the overall coefficient of variation in CW was estimated using the approach described in 
10.5. Table 21 shows that for atrazine, desethylterbutylazine and terbutylazine, the 
variability of applied calculation procedure and sampler calibration procedure is the main 
factor causing the elevated between laboratory variability in CW estimates from provided 
sampler data. For the remaining compounds the analytical variability was too high to 
distinguish the contribution of the applied calculation procedure from the overall 
variability of CW estimates. 
Table 20. Concentrations of polar pesticides in field blank sampler (ng/sampler) provided by 
the organizer
*
. 
Labora-
tory 
Terbu-
tylazine 
Des-
ethyl-
atrazine 
Desethyl
terbutyl-
azine 
Atrazine Carben-
dazim 
S-Meto-
lachlor 
Diuron 
17 <2.80 <2.80 <2.80 <2.80 <2.80 <2.80 <2.8 
18        
19        
21        
23        
23a        
30 <0.12 <0.12  <0.12   <0.12 
32        
36 1.09 0.57 0.03 1.57 0.07 0.21 0.96 
37        
39 0.92     0.42  
40 0.54     0.07  
42 <0.20 <0.20 <0.20 <0.20 <0.20 <0.20 <0.20 
43 <2.00 <2.00 <2.00 <2.00 <2.00 <2.00 <2.00 
43a <2.00 <2.00 <2.00 <2.00 <2.00 <2.00 <2.00 
44  0.11 0.02 0.04 0.37 0.05 0.05 
47    0.01 0.02  0.70 
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Table 20 (continued) Concentrations of polar pesticides in field blank sampler (ng/sampler) 
provided by the organizer
*
. 
Labora-
tory 
Terbu-
tylazine 
Des-
ethyl-
atrazine 
Desethyl
terbutyl-
azine 
Atrazine Carben-
dazim 
S-Meto-
lachlor 
Diuron 
48 <4.00 <4.00  <3.00 <1.00 <1.60  
49    0.00 0.00  3.62 
50        
50a 0.05 0.40  0.02  0.05  
*Empty fields indicate cases where participants did not report a value. 
 
 
Table 21. Estimated CV(Rs) for Cw calculation for provided sampler; Polar Pesticides 
Compound CV(NNPS) 
(%) 
CV(Cw;NPS) 
(%) 
CV(Rs) (%) 
Atrazine 16 90 88 
Carbendazim 68 96 67 
Desethylatrazine 82 138 111 
Desethylterbutylazine 23 110 108 
Diuron 94 125 82 
S-metolachlor 59 93 72 
Terbutylazine 40 124 118 
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Figure 28 Various categories of participant passive samplers applied in analysis of polar pesticides. 
Sampler was counted only when a particular compound was measured above the method 
LOQ. A brief description of sampler category (shown as abbreviation in the legend) is given 
in Table 18. 
11.1.9 Participant samplers 
Figure 28 shows the different types of samplers successfully employed (above method 
LOQ) for polar pesticide sampling. The most frequent design of sampler applied in the 
study corresponded with the standard configuration of the POCIS with OASIS HLB 
adsorbent and fitted with polyethersulphone membrane. The same design was also 
applied in the provided  passive sampler. Other types of samplers applied included 
Empore disks, the “pesticide” version of POCIS, the polar version of Chemcatcher, 
silicone rubber sheets, Empore disks fitted with a polyethersulphone membrane and 
Speeddisks. Details on samplers applied by participants and their processing are also 
given in Annex II. 
11.1.10 Field blanks 
Concentrations of polar pesticides in field blank samplers was low, always <10% of the 
concentration found in field exposed samplers (with exception of desethylatrazine in lab 
36 and lab 43; desethylterbutylazine, atrazine and carbendazime in lab 43; S-
metolachlor in labs 17, 36, 43 and 48) and close to method detection limits. 
11.1.11 Sampling variability 
Also in participant samplers a good within laboratory variability of analysis of polar 
pesticides (ng/cm2) was observed with the mean CV between 12 and 18% for sampler 
uptake and between 11 and 16% for the related water concentration estimate, 
respectively (Table 19). 
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The between laboratory variability (excluding outliers) for sampler uptake (ng/cm2) was 
higher, ranging from 51 to 179% for different compounds3. Even higher (39 to 236%) 
variability was observed for the water concentration estimate. 
With exception of carbendazim, the between laboratory variability of water concentration 
estimate derived from participant passive samplers was lower than that derived from 
provided sampler. This may reflect that participating laboratories had more experience in 
use and data interpretation of samplers they normally apply in their research. 
Table 22. Concentrations of polar pesticides in field blank participant sampler (ng/sampler)
*
. 
Labora
tory 
Sampl
er type 
Terbut
ylazine 
Deseth
ylatraz
ine 
Deseth
ylterbu
tylazin
e 
Atrazi
ne 
Carben
dazim 
S-
Metola
chlor 
Diuron 
17 POCIS <3.0 <3.0 <3.0 <3.0 <3.0 <3.0 <3.0 
18 POCIS        
19 ED      0.12  
21 POCIS        
23 POCIP        
23a POCIS        
30 CFIS <1.0   1.0   <1.0 
36 CCPOL 0.05 0.19 0.04 0.14 0.15 4.7 0.07 
37 POCIS        
39 POCIS 1.0     0.37  
40 POCIS 0.36    0.24 0.13  
43 SPEED <2.0 <2.0 <2.0 <2.0 <2.0 <2.0 <2.0 
43a SR <2.0 <2.0 <2.0 <2.0 <2.0 <2.0 <2.0 
44 POCIS  0.06 0.07 0.06 0.28 0.03 0.19 
47 POCIS    0.20 0.77  0.74 
48 EDPES <4.0 <4.0  <3.0 <1.0 <1.6  
49 POCIS       <0.02 
*Empty fields indicate cases where participants did not report any value. 
Individual laboratories found in most cases well comparable results (close to equality) for 
participant and provided sampler (when both were POCIS) for uptake per surface area 
                                           
3 Note that uptake per surface unit may differ between sampler types and the CV is not 
corrected for that systematic differences. 
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(left-hand biplots), as well as the resulting water concentration (Cw, right-hand biplot) 
(Figure 20-26). In several cases points far from the equality line for uptake (left biplot) 
can be explained from a significantly different working principle in comparison to the 
provided samplers, e.g. silicone rubber that often attained equilibrium during exposure. 
After transferring to CW the data are much closer (right biplot). 
11.1.12 Water samples 
Results of water sample analysis are given in Table 23. Pesticide concentrations in water, 
reported from spot samples, were above the method limit of quantification, with 
exception of S-metolachlor. A comparison of these concentrations with water 
concentration estimates from passive samplers is displayed in bottom bar charts and 
right hand biplot charts in Figure 20-26. The concentration of pesticides in composite 
spot samples was always within the range comprised by the water concentration 
estimates from passive sampler results (median ± 2 standard deviations excluding 
outliers). 
 
Table 23 Concentrations of polar pesticides in weekly composite water samples 
Sample/Compo
und 
Filtration 
blank  
(30.5.-
5.6.) 
Filtration 
blank 
 (6.6.-
13.6.) 
Weekly 
composite 
(30.5.-5.6.) 
Weekly 
composite 
(6.6.-13.6.) 
Uni
ts 
Atrazine <10 <10 25 17 ng/L 
Carbendazim <10 <10 90 100 ng/L 
Desethylatrazine <10 <10 37 38 ng/L 
Desethylterbutyla
zine 
<10 <10 39 33 ng/L 
Diuron <20 <20 220 170 ng/L 
S-metolachlor <20 <20 21 <20 ng/L 
Terbutylazine <10 <10 30 24 ng/L 
11.1.13 Conclusions for polar pesticides 
1. An acceptable within laboratory variability was observed for standard solution of 
polar pesticides showing that calibration of instrumental methods was not expected 
to cause excessive variability in reported data. 
2. A very low (<12%) within laboratory variability was observed for the provided 
samplers which basically evidenced that the sampling process and samplers position 
caused little variation; i.e. confirming the investigations reported in section 8.3 . 
3. Consequently, the high between laboratory variability is dominantly connected to 
laboratory born analytical differences.  
4. Both the analysis and the procedure for calculation of Cw are a large source of 
between laboratory variability and both need improvement..  
5. Within laboratory differences between provided and participant samplers were small 
when that was expected based on similarity of the sampler design. 
6. The water concentrations obtained by PS and spot sampling do not disagree, 
however, the variability of reported results is high.  
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11.2 Pharmaceuticals 
Up to 17 laboratories participated in the exercise, but the numbers varied depending on 
target analytes and matrices analysed. Results for individual compounds are displayed in 
Figure 30-37. The explanation of data projection applied is described in chapter 10. 
11.2.1 Overall data variability 
 
 
Figure 29 Concentrations of pharmaceuticals in various analysed matrixes: standard solution (top left), 
provided sampler (top right), water concentration estimated from the participant sampler 
(bottom left) and the ratio of water concentrations determined in provided and participant 
passive sampler (bottom right), respectively. For explanation of symbols see legend to 
Figure 19. 
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11.2.2 Results by laboratories - pharmaceuticals 
 
Figure 30 Results of analysis of alprazolam. Graph explanation is given in 10.2.and 10.3 
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Figure 31 Results of analysis of atenolol. Graph explanation is given in 10.2.and 10.3 
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Figure 32 Results of analysis of carbamazepine. Graph explanation is given in 10.2.and 10.3 
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Figure 33 Results of analysis of diazepam. Graph explanation is given in 10.2.and 10.3 
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Figure 34 Results of analysis of diclofenac. Graph explanation is given in 10.2.and 10.3 
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Figure 35 Results of analysis of ibuprofen. Graph explanation is given in 10.2.and 10.3. 
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Figure 36 Results of analysis of ketoprofen. Graph explanation is given in 10.2.and 10.3. 
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Figure 37 Results of analysis of naproxen. Graph explanation is given in 10.2.and 10.3. 
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11.2.3 Sample variability 
 
 
 
Figure 38 Variability of reported pharmaceutical results at different procedure levels. Results are the 
coefficients of variation for individual compounds. NPS – provided passive sampler; PPS – 
participant passive sampler. (N) –amount; (Cw) – water concentration. 
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Table 24 Variability range at different procedure levels for pharmaceuticals. 
Pharmaceuticals 
  Coefficient of variation (%) 
Variability:  Within laboratory Between laboratory 
Matrix analysed: Min. Max. Min. Max. 
Standard 
solution 
 3% 8% 6% 35% 
Provided 
sampler 
NPS amount (ng/cm2) 11% 14% 35% 133% 
 NPS water concentration 8% 13% 70% 333% 
Participant 
sampler 
PPS amount (ng/cm2) 10% 33% 13% 117% 
 PPS water concentration 9% 21% 68% 205% 
11.2.4 Standard solution 
Results provided by participating laboratories for the standard solution are shown in the 
top bar charts in Figure 30-37. The range of variability of reported results is given in 
Table 24. Variability observed for individual compounds is also shown in Figure 38. 
A good within laboratory variability of analysis of individual compounds in pharmaceutical 
standard solution was observed with the mean CV from 3 to 8% (Table 24). The between 
laboratory variability (excluding outliers) ranged between 6 and 35% and averaging 
around 20%. Also because this rather high variability the reference concentration of 
pharmaceuticals was in all cases within the range comprised by the participant results 
(median ± 2 standard deviations excluding outliers). For diclofenac, ibuprofen, naproxen 
and ketoprofen, the median and geometric mean of participant results were outside the 
uncertainty range stated by the central laboratory. Laboratory 31 reported outlier results 
for all analysed compounds, which indicates a systematic error, possibly related to 
sample dilution or calculation. 
11.2.5 Provided sampler 
The results provided by participating laboratories compared to the median are shown in 
the middle bar charts in Figure 30-37.  
11.2.6 Field blanks 
Concentrations of polar pesticides in field blank samplers was low, in most cases less 
than 10% of the concentration found in field exposed samplers (exceptions are 
alprazolam in lab 17, atenolol in lab 43, diazepam in lab 17 and ibuprofen in lab 47) and 
close to method detection limits (Table 25). 
11.2.7 Sampling variability 
An excellent within laboratory variability of analysis of pharmaceuticals in provided 
sampler (ng/cm2) was observed with the mean CV between 11 and 14% for sampler 
uptake and between 8 and 13% for the water concentration estimate, respectively (Table 
24). 
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The between laboratory variability (excluding outliers) for sampler uptake (ng/cm2) was 
higher, ranging from 35 to 133% for different compounds. Even higher (70 to 333%) 
variability (up to 4.3 times higher) was observed for the water concentration estimate. 
Analysis of individual compounds in provided sampler was affected by between 
laboratory variation 1.3 to 9 times larger than the analysis of standard solution. 
Participants can check whether results reported by their laboratory are comparable 
(within the study variability) with results provided by the other laboratories (Figure 30-
Figure 37). Participants also may check whether a bias in instrument calibration (outlier 
result in analysis of standard solution) may have contributed to the bias of provided 
sampler data reported by this laboratory. For example, for atenolol, carbamazepine and 
diclofenac results by laboratory 32 were evaluated as outliers for analysis of standard 
solution and the provided sampler, respectively. 
11.2.8 Contribution of the calculation procedure to data variability 
Coefficient of variation of the applied calculation procedure was estimated using the 
approach described in 10.5. For atenolol and carbamazepine the contribution of 
uncertainty in calculation procedure to the overall uncertainty of water concentration 
procedure was minor. For the remaining compounds the variability of the applied 
calculation procedure and the sampler calibration procedure were the main factors 
causing the elevated between laboratory variability of water concentration estimate from 
provided sampler data. 
 
Table 25 Concentrations of pharmaceuticals in field blank sampler (ng/sampler) provided by 
the organizer
1
. 
Labo-
ratory 
Alpra-
zolam 
Ateno-
lol 
Carba-
mazepi
ne 
Diaze-
pam 
Diclo-
fenac 
Ibu-
profen 
Keto-
profen 
Napro-
xen  
17 <5.2 <5.2 <5.2 <5.2 <5.2 <5.2 <5.2 <5.2 
19         
23   0.80 <0.17 2.4  1.8 15 
23a   0.80 <0.17 2.4  1.8 15 
29  <1.2 <3.2  <3.2  <1.2 <3.2 
31  4.8 5.2  2.9   3.0 
32         
36  0.86 1.3 0.03 0.09  2.8  
39  0.08 2.9  2.2   0.68 
40         
43  <4.0 <4.0  <4.0 <4.0 <4.0 <4.0 
43a  <4.0 <4.0  <4.0 <4.0 <4.0 <4.0 
44   0.10  2.7 0.62   
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Table 25 (continued) Concentrations of pharmaceuticals in field blank sampler (ng/sampler) 
provided by the organizer
1
. 
Labo-
ratory 
Alpra-
zolam 
Ateno-
lol 
Carba-
mazepine 
Diaze-
pam 
Diclo-
fenac 
Ibu-
profen 
Keto-
profen 
Napro-
xen  
47  1.1 <0.02  <0.02 <2.0   
48   <1.6  <3.0    
49  <2.5 <0.002  19  <0.01 <0.04 
50   0.75  1.9 0.48 1.5 1.4 
50a  0.04 0.21    0.43  
51         
1Empty fields indicate cases where participants did not report any value. 
 
Table 26. Estimated CV(Rs) for Cw calculation for provided sampler; pharmaceuticals. 
Compound CV(NNPS) 
(%) 
CV(Cw;NPS) 
(%) 
CV(Rs) (%) 
Alprazolam 38 not estimated not estimated 
Atenolol 76 73 not estimated 
Carbamazepine 93 100 37 
Diazepam 58 88 66 
Diclofenac 74 256 245 
Ibuprofen 119 171 123 
Ketoprofen 35 73 64 
Naproxen 55 112 97 
11.2.9 Participant sampler 
Figure 39 shows the different sampler types successfully (above method LOQ) applied by 
participants in sampling of pharmaceuticals. As for pesticides, the most frequently 
applied design of sampler applied in the study corresponded with the standard 
configuration of the POCIS with OASIS HLB adsorbent and fitted with polyethersulphone 
membranes. The same design was also applied in the provided passive sampler. Other 
types of samplers applied included Empore disks, the “pesticide” version of POCIS, the 
polar version of Chemcatcher, silicone rubber sheets, Empore disks fitted with a 
polyethersulphone membrane and Speeddisks. Details on samplers applied by 
participants and their processing are given also in Annex IV. 
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Figure 39 Various categories of participant passive samplers applied in analysis of pharmaceuticals. A 
sampler was counted only when a particular compound was measured above method LOQ. 
A brief description of sampler category (shown as abbreviation in the legend) is given in 
Table 18. 
 
The results provided by participating laboratories compared to the median are shown in 
the bottom bar charts in Figure 30-37.  
11.2.10 Field blanks 
Concentrations of pharmaceuticals in field blank samplers were low, always <10% of the 
concentration found in field exposed samplers and close to method detection limits 
(Table 27). 
11.2.11 Sample variability 
A good within laboratory variability of analysis of pharmaceuticals in participant samplers 
(ng/cm2) was observed with the mean CV between 10 and 33% for sampler uptake and 
between 9 and 21% for the related water concentration estimate, respectively (Table 
24). 
The between laboratory variability (excluding outliers) for sampler uptake (ng/cm2) was 
higher, ranging from 13 to 117% for different compounds. Even higher (68 to 205%) 
variability was observed for the water concentration estimate. 
In most cases the between laboratory variability of water concentration estimate derived 
from participant passive samplers was comparable to that derived from provided 
samplers. 
Individual laboratories found in most cases well comparable results (close to equality) for 
participant and provided sampler for uptake per surface area (left-hand biplots), as well 
as the resulting water concentration (Cw, right-hand biplot) (Figure 30-Figure 37). Points 
that lie near the equality line but far from the median values indicate a large systematic 
error introduced by the laboratory. Points far from the equality line for uptake are mostly 
data from samplers that significantly differ from provided samplers in terms of their 
working principle (e.g. silicone rubber).  
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Table 27. Concentrations of polar pharmaceuticals in field blank participant sampler 
(ng/sampler)
*
. 
Labo-
ratory 
Samp
-ler 
Alpra-
zolam 
Ateno
-lol 
Carba
-
maze
pine 
Diaze
-pam 
Diclo-
fenac 
Ibupr
o-fen 
Keto-
profe
n 
Napro
-xen  
17 POCIS <6 <6 <6 <6 <6 <6 <6 <6 
19 ED         
23 POCIP         
23a POCIS         
29 POCIS  <1 <3  <3  <1 <3 
31 POCIS  4.6 1.9  1.9   1.0 
36 CCPOL  0.2 0.7 0.01 1.0  10.1  
39 POCIS         
40 POCIS   0.2  0.3  3.1 0.1 
43 SPEED <5 <5 <5 <5 <5 <5 <5 <5 
43a SR   <5    5.0  
44 POCIS   0.6  4.2 4.4   
47 POCIS  1.8 <0.1  0.2 <10   
48 EDPES   <1.6  <3    
49 POCIS  <2.5     <0.01 <0.04 
11.2.12 Water samples 
Results of water sample analysis are given in Table 28. Pharmaceutical concentrations in 
water, reported from spot samples by the expert laboratory, were above the method 
limit of quantification. However, concentrations of diazepam and alprazolam were close 
to the limit of quantification. A comparison of these concentrations with water 
concentration estimates from passive samplers is displayed in the bottom bar charts and 
right hand biplot charts in Figure 30-37. The concentration of pharmaceuticals in 
composite spot samples was always within the range comprised by the water 
concentration estimates from passive sampler results (median ± 2 standard deviations 
excluding outliers). 
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Table 28 Concentrations of pharmaceuticals in weekly composite water samples, analysed by 
a central laboratory 
Sample/Co
mpound 
Filtration 
blank 
(30.5.-5.6.) 
Filtration 
blank 
 (6.6.-
13.6.) 
Weekly 
composite 
(30.5.-5.6.) 
Weekly 
composite 
(6.6.-13.6.) 
units 
Alprazolam <0.3 <0.3 3.5 3.4 ng/L 
Atenolol <0.6 <0.6 160 140 ng/L 
Carbamaze-
pine 
<0.3 <0.3 760 800 ng/L 
Diazepam <1.6 <1.6 3.2 4.0 ng/L 
Diclofenac <1.0 <1.0 780 720 ng/L 
Ibuprofen <2.0 <2.0 90 100 ng/L 
Ketoprofen <2.4 <2.4 340 340 ng/L 
Naproxen <0.2 <0.2 290 300 ng/L 
11.2.13 Conclusions for pharmaceuticals 
1. An acceptable within laboratory variability was observed for standard solution of 
pharmaceuticals but the 20% average between laboratory variability is considered 
high for the analysis of a standard  
2. Sampling with provided samplers was homogeneous as can be conluded from the very 
low within laboratory variability of analysis of provided samplers.  
3. The higher between laboratory variability in water concentration estimates in 
comparison to sampler uptake per surface area can be attributed to errors introduced 
by different approaches in the translation of uptake data to water concentrations. For 
atenolol and carbamazepine the contribution of uncertainty in calculation procedure to 
the overall uncertainty of water concentration procedure was minor. For the remaining 
pharmaceutical compounds the variability of applied calculation procedure and/or 
calibration parameters was the main factor causing the elevated between laboratory 
variability of water concentration estimate from provided sampler data. 
4. Similar results for different passive samplers analysed within individual laboratories 
indicate that the PS process is not causing excessive variability. 
5. There was no significant difference between the water concentrations measured by PS 
and the spot sampling method, however, the PS method precision is low and needs to 
be improved. 
6. The much (up to 13x) higher between laboratory variability of water concentration 
estimate in comparison to within laboratory precision is likely related to systematic 
error in results of individual laboratories, which in turn can be related to difficulties 
with analysis in the complex matrix of the field exposed passive sampler. 
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11.3 Steroid hormones 
Up to 13 laboratories participated in the exercise, but the numbers varied depending on 
target analytes and matrices analysed. Results for individual compounds are displayed in 
Figure 41-45. The explanation of data projection applied is described in chapter 10. 
11.3.1 Overall data variability 
 
 
Figure 40 Concentrations of steroids in various analysed matrixes: standard solution (top left), 
provided sampler (top right), water concentration estimated from the participant sampler 
(bottom left) and the ratio of water concentrations determined in provided and participant 
passive sampler (bottom right), respectively. For explanation of symbols see legend to 
Figure 19. 
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11.3.2 Results by laboratories – steroid hormones 
 
Figure 41 Results of analysis of 17-alpha-estradiol. Graph explanation is given in 10.2.and 10.3. 
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Figure 42 Results of analysis of 17-alpha-ethinylestradiol. Graph explanation is given in 10.2.and 
10.3. 
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Figure 43 Results of analysis of 17-beta-estradiol. Graph explanation is given in 10.2.and 10.3. 
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Figure 44 Results of analysis of estriol. Graph explanation is given in 10.2.and 10.3. 
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Figure 45 Results of analysis of estrone. Graph explanation is given in 10.2.and 10.3. 
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11.3.3 Sample variability 
 
 
 
Figure 46 Variability of reported steroid hormone results at different procedure levels. Results are the 
coefficients of variation for individual compounds. NPS – provided passive sampler; PPS – 
participant passive sampler. (N) –amount; (Cw) – water concentration. 
11.3.4 Standard solution 
Results provided by participating laboratories for the standard solution are shown in the 
top bar charts in Figure 41-45. The range of variability of reported results is given in 
Table 29. Variability observed for individual compounds is also shown in Figure 46. 
A good within laboratory variability of analysis of individual compounds in steroid 
standard solution was observed with the mean CV from 11 to 22% (Table 29). The 
between laboratory variability (excluding outliers) was satisfactory, too, ranging between 
8 and 53%. In all cases the reference concentration of steroids was within the range 
comprised by the participant results (median ± 2 standard deviations excluding outliers) 
and with exception of 17-alpha-Ethinylestradiol the median and geometric mean of 
participant results were within the uncertainty range stated by the central laboratory. 
Outlier results were reported by laboratories 20, 23 and 36. 
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Table 29 Variability range at different procedure levels for steroid hormones. 
Steroid hormones 
    Coefficient of variation (%)   
Variability:   Within laboratory Between laboratory 
Matrix analysed: Min. Max. Min. Max. 
  Standard solution 11% 22% 8% 53% 
Provided 
sampler 
NPS amount (ng/cm2) 53% >300% 208% >300% 
NPS water concentration 48% 101% 251% >300% 
Participant 
sampler 
PPS amount (ng/cm2) 3% 60% 154% >300% 
PPS water concentration 3% 163% 65% >300% 
 
11.3.5 Provided sampler 
The results provided by participating laboratories are shown in the middle bar charts in 
Figure 41-45. 
The analysis of steroid hormones in provided passive samplers proved challenging since 
the exposure concentrations of target compounds in water were very low (Table 33). 
This is reflected by the fact that from 13 laboratories that provided results for standard 
solution, less than a half was able to measure steroids (with exception of estrone) above 
their method limits of quantification in provided samplers. 
11.3.6 Field blanks 
Concentrations of steroids in field blank samplers was low, in most cases less than 10% 
of the concentration found in field exposed samplers and close to method detection limits 
(Table 30). 
11.3.7 Sample variability 
An elevated within laboratory variability of analysis of steroid hormones in provided 
samplers (ng/cm2) was observed with the mean CV higher than 53% for sampler uptake 
and between 48 and 101% for the water concentration estimate, respectively (Table 29). 
This reflects well the fact that measurement uncertainty increases when concentrations 
are close to the method detection limit. 
The between laboratory variability (excluding outliers) for sampler uptake (ng/cm2) as 
well as related water concentration estimate (ng/L) was very high (higher than 200%). 
The high variability is likely because the concentrations in provided samplers were close 
to participant method LOQs. Method precision dramatically decreases as the 
concentration approaches LOQ. Furthermore, analysis of steroids in complex 
environmental matrixes seems to be challenging for the participating laboratories [31]. 
11.3.8 Contribution of the calculation procedure to data variability 
For steroids the contribution of uncertainty in calculation procedure to the overall 
uncertainty of water concentration was minor in comparison to the uncertainty of 
sampling and analysis. 
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Table 30. Concentrations of steroids in field blank sampler (ng/sampler) provided by the 
organiser. *Empty fields indicate cases where participants did not report any value. 
11.3.9  
 
Table 31. Estimated CV(Rs) for Cw calculation for provided sampler; steroids. 
Compound CV(NNPS) (%) CV(Cw;NPS) (%) CV(Rs) (%) 
17-alpha-Estradiol 1428 1043 not estimated 
17-alpha-Ethinylestradiol 413 289 not estimated 
17-beta-Estradiol  830 387 not estimated 
Estriol not estimated not estimated not estimated 
Estrone 169 170 23 
 
Laboratory 17-alpha-
Estradiol 
17-alpha-
Ethinylestrad
iol 
17-beta-
Estradiol 
Estriol Estrone 
19      
20  1.35 0.98  0.37 
23 <0.10 <0.08 <0.10 <0.08 <0.08 
26      
33      
36      
37      
39      
43 9.17  5.12  8.37 
43a 9.17  5.12  8.37 
44  0.03 0.03  0.03 
45  <0.05 0.008   
49 <0.25 <2.5 <0.13 <0.5 <0.13 
51      
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11.3.10 Participant sampler 
Figure 47 shows the different types of samplers that were successfully (above method 
LOQ) applied by participants in sampling of steroids. The most frequently applied design 
of sampler applied in the study corresponded with the standard configurations of the 
POCIS (pharmaceutical or pesticide version). Other types of samplers applied included 
silicone rubber and polyoxymethylene. Details on other samplers applied by participants 
and their processing are given in Annex VI. The results provided by participating 
laboratories are shown in the bottom bar charts in Figure 41-45.  
 
 
Figure 47 Various categories of participant passive samplers successfully applied in analysis of 
steroid hormones. Sampler was counted only when a particular compound was measured 
above method LOQ. A brief description of sampler category (shown as abbreviation in the 
legend) is given in Table 18. 
 
11.3.11 Field blanks 
Concentrations of steroid hormones in field blank samplers were low, always <10% of 
the concentration found in field exposed samplers and close to method detection limits 
(Table 32). 
11.3.12 Sample variability 
The within laboratory variability of analysis of steroids in participant samplers (ng/cm2) 
was observed with the mean CV between 3 and 60% for sampler uptake and between 3 
and 163% for the related water concentration estimate, respectively (Table 29). 
The between laboratory variability (excluding outliers) was high for all compounds, 
higher than 154% for sampler uptake (ng/cm2) and higher than 65% for the water 
concentration estimate (ng/L), respectively. 
As was stated for provided samplers, this reflects well the fact that measurement 
uncertainty increases when concentrations are close to method detection limit. 
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Individual laboratories found in most cases well comparable results (close to equality) for 
participant and provided sampler for uptake per surface area (left-hand biplots), as well 
as the resulting water concentration (Cw, right-hand biplot) (Figure 41-Figure 45). Points 
that lie near the equality line but far from the median values indicate a large systematic 
error introduced by the laboratory. Points far from the equality line for uptake are mostly 
data from samplers that significantly differ from provided sampler working principle (e.g. 
POM).  
 
Table 32. Concentrations of steroid hormones reported in field blank participant sampler 
(ng/sampler)
*
. 
Laboratory 17-alpha-
Estradiol 
17-alpha-
Ethinylestr
adiol 
17-beta-
Estradiol 
Estriol Estrone 
19      
20  1.71 1.02  1.55 
23      
26      
33      
36      
37      
39      
43 <5  <5  <5 
43a <5  <5  <5 
44      
45      
49 <0.25 <2.5 <0.13 <0.5 <0.13 
51      
11.3.13 Spot samples 
Results of water sample analysis are given in Table 33. Steroid hormone concentrations 
in water, reported from spot samples, were in most cased below method LOQ. The only 
exception was 17-beta-estradiol, however, also this value was very close to method LOQ. 
A comparison of these concentrations with water concentration estimates from passive 
samplers is displayed in bottom bar charts and right hand biplot charts in Figure 41-45. 
The reported data (< LOQ) of composite spot samples was always within the range 
comprised by the water concentration estimates from passive sampler results (median ± 
2 standard deviations excluding outliers). 
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Table 33 Concentrations of steroids in weekly composite water samples. 
Sample/Compou
nd 
Filtration 
blank 
(20.6.-
26.6.) 
Filtration 
blank 
 (27.6.-
4.7.) 
Weekly 
composite 
(20.6.-26.6.) 
Weekly 
composite 
(27.6.-4.7.) 
uni
ts 
17-alpha-Estradiol <1.3 <0.9 <1.1 <0.9 ng/
L 
17-alpha-
Ethinylestradiol 
<17 <14 <10 <12 ng/
L 
17-beta-Estradiol  0.7 <0.5 0.5 0.6 ng/
L 
Estriol <2.9 <2.8 <7.5 <8.3 ng/
L 
Estrone <1.1 <0.9 <0.9 <0.7 ng/
L 
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11.3.14 Conclusions for steroids 
1. An acceptable within laboratory variability was observed for standard solution of 
steroids and only in a few cases laboratories reported results outside the between 
laboratory variability range. In all cases the reference concentration of steroids was 
within the range comprised by the participant results (median ± 2 standard deviations 
excluding outliers). The between laboratory variability of was acceptable, with 
exception of 17-alpha-ethinylestradiol (CV of 53%). With these few exceptions, 
calibration of instrumental methods applied for steroids was not expected to cause 
excessive variability in reported data. However, it has to be admitted that the selected 
test concentration (20 ng/mL) was in most cases higher than concentration levels in 
real samples analysed by laboratories and uncertainty of instrumental measurement is 
expected to increase with decreasing concentration. 
2. Analysis of steroids in passive samplers was much more challenging than the analysis 
of polar pesticides or pharmaceuticals. There was a high within laboratory variability 
of analysis of provided as well as participant samplers. This is not surprising since 
concentrations found in provided samplers were in most cases close to participant 
method LOQs, where variability is elevated by definition. The lower concentrations 
than those analysed in standard solution, combined with a more complex sample 
matrix, can explain the observed increased variability. 
3. Similar results for estrone (a compound analysed above LOQ by the highest number of 
laboratories in both types of samplers) analysed by individual laboratories by different 
passive samplers indicate that the PS process itself is not causing excessive 
variability. For other compounds the results were close to the LOQ not allowing such 
evaluation. 
4. Considering the high between laboratory variability in sampler uptake no realistic 
estimation is possible of the contribution to the overall variability of different 
approaches in translation from passive sampler uptake to water concentration. 
5. A direct comparison of PS data with spot sampling was precluded since spot sample 
data were below LOQ. However, there is no contradiction between PS and spot 
sampling method.  
6. Although results from individual laboratories indicate that PS method allows 
measurement of concentrations lower than spot sampling method LOQs, the 
interlaboratory method precision needs a significant improvement. 
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11.4 Brominated diphenyl ethers – PBDEs 
Up to 14 laboratories participated in the exercise, but the numbers varied depending on 
target analytes and matrices analysed. Results for individual compounds are displayed in 
Figure 49 -54. The explanation of data projection applied is described in chapter 10. 
11.4.1 Overall data variability 
  
Figure 48 Concentrations of brominated diphenyl ethers in various analysed matrixes: standard 
solution (top left), provided sampler (top right), water concentration estimated from the 
participant sampler (bottom left) and the ratio of water concentrations determined in 
provided and participant passive sampler (bottom right), respectively. For explanation of 
symbols see legend to Figure 19. 
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11.4.2 Results by laboratories - PBDEs 
 
Figure 49 Results of analysis of BDE 28. Graph explanation is given in 10.2.and 10.3. 
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Figure 50 Results of analysis of BDE 47. Graph explanation is given in 10.2.and 10.3. 
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Figure 51 Results of analysis of BDE 99. Graph explanation is given in 10.2.and 10.3. 
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Figure 52 Results of analysis of BDE 100. Graph explanation is given in 10.2.and 10.3. 
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Figure 53 Results of analysis of BDE 153. Graph explanation is given in 10.2.and 10.3. 
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Figure 54 Results of analysis of BDE 154. Graph explanation is given in 10.2.and 10.3. 
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11.4.3 Sample variability 
  
  
  
Figure 55 Variability of reported PBDE results at different procedure levels. Results are the 
coefficients of variation for individual compounds. NPS – provided passive sampler; PPS – 
participant passive sampler. (N) –amount; (Cw) – water concentration 
 
Table 34 Variability range at different procedure levels for PBDEs. 
PBDEs 
    Coefficient of variation (%)   
Variability:   Within laboratory Between laboratory 
Matrix analysed: Min. Max. Min. Max. 
 Standard solution  4% 11% 25% 45% 
Provided sampler NPS amount (ng/cm2) 9% 20% 13% 77% 
NPS water concentration 11% 137% 68% >200% 
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Participant 
sampler 
PPS amount (ng/cm2) 12% 68% 41% >200% 
PPS water concentration 14% 79% 112% >200% 
 
11.4.4 Standard solution 
Results provided by participating laboratories for the standard solution are shown in the 
top bar charts in Figure 49-54. The range of variability of reported results is given in 
Table 34. Variability observed for individual compounds is also shown in Figure 55. 
A good within laboratory variability of analysis of individual compounds in PBDE standard 
solution was observed with the mean CV from 4 to 11% (Table 34). The between 
laboratory variability (excluding outliers) was satisfactory, too, ranging between 25 and 
45%. In all cases the reference concentration of PBDEs was within the range comprised 
by the participant results (median ± 2 standard deviations excluding outliers) and with 
exception of BDE 99, the median and geometric mean of participant results were within 
the uncertainty range stated by the central laboratory. Several outlier results were 
observed, but this bias was not systematic (not occurring for all compounds reported by 
one laboratory). 
11.4.5 Provided sampler 
The results provided by participating laboratories are shown in the middle bar charts in 
Figure 49-54.  
11.4.6 Field blank 
Concentrations of PBDEs in field blank samplers were low, in most cases less than 10% 
of the concentration found in field exposed samplers (with exception of BDE 99,BDE 100, 
BDE 153 in lab 36) and close to method detection limits (Table 35). 
11.4.7 Spiked field blank 
Results of analysis of PBDEs in spiked field blanks are shown in Figure 56. Relatively high 
between laboratory variability was observed in analysis of spiked field blanks. 
Coefficients of variation for BDE47, BDE 99, BDE 100 and BDE 153 were 44%, 72%, 
59% and 68%, respectively. The high variability indicates that some laboratories had 
difficulties in analysis of PBDEs in the silicone rubber matrix. 
11.4.8 Sampling variability 
An excellent within laboratory variability of analysis of PBDEs in provided samplers was 
observed with the mean CV between 9 and 20% for sampler uptake. The between 
laboratory variability of for the water concentration estimate was higher, ranging from 11 
to 137% (Table 34). 
The between laboratory variability (excluding outliers) for sampler uptake was higher, 
ranging from 13 to 77% for different compounds. Even higher (higher than 68%) 
variability was observed for the water concentration estimate. 
Analysis of individual compounds in provided samplers was affected by between 
laboratory variation up to 2.5 times larger than the analysis of standard solution. This 
can be explained by lower concentrations and potential interferences originating from a 
more complex matrix analysed. 
Participants can check whether results reported by their laboratory are comparable 
(within the study variability) with results provided by the other laboratories (Figure 49-
54). Participants also may check whether a bias in instrument calibration (outlier result 
in analysis of standard solution) may have contributed to the bias of provided sampler 
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data reported by this laboratory. For example, for BDE 99 results by laboratory 21 were 
evaluated as outliers for both analysis of standard solution and the provided sampler, 
respectively. 
11.4.9 Contribution of the calculation procedure to data variability 
Coefficient of variation of the applied calculation procedure was estimated using the 
approach described in 10.5. For PBDEs, the variability of applied calculation procedure 
and sampler calibration procedure is the main factor causing the elevated between 
laboratory variability of water concentration estimates from provided sampler data. This 
is somewhat surprising since the procedures to reduce uncertainty of estimation of free 
dissolved concentrations from accumulation in silicon rubbers have been described in the 
literature (see chapter 1.7 for details) and are routinely used in monitoring programmes. 
Besides difficulties in proper application of the sampler uptake models, difficulties with 
the analysis of PRC compounds may have contributed to the high variability of reported 
water concentration. Accurate measurement of the % of PRCs remained in the sampler 
after exposure are an absolute requirement for obtaining unbiased estimates of PBDE 
sampling rates in the field. 
Table 35 Concentrations of PBDEs in field blank sampler (ng/sampler) provided by the 
organizer.. 
Laboratory BDE 28 BDE 47 BDE 99 BDE 100 BDE 153 BDE 154 
19 <0.1 0.16 0.06 0.04 <0.10 <0.10 
20       
21       
23 <0.01 0.05 0.02 <0.01 0.02 <0.01 
25 <0.04    0.25 0.15 
26       
29 <0.05 <0.05 <0.05 <0.05 <0.05 0.05 
30 <5 <5 <5 <5 <5 <5 
36 1.03 2.26 20.15 7.05 0.53 1.03 
36a 1.03 2.26 20.15 7.05 0.53 1.03 
36b 1.03 2.26 20.15 7.05 0.53 1.03 
36c 1.03 2.26 20.15 7.05 0.53 1.03 
36d 1.03 2.26 20.15 7.05 0.53 1.03 
37  0.02 0.01 0.002 0.01 0.00 
38       
43       
44       
50 0.27 0.39 <0.05 <0.05 <0.05 <0.05 
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Figure 56 Concentrations of PBDEs in spiked field blank sampler provided by the organizer 
(ng/sampler). The central line shows the median value and the dashed lines ± 2 standard 
deviations of log 2 transformed values without outliers. Outlier values are labelled in darker 
colour. 
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Table 36 Estimated CV(Rs) for Cw calculation for provided sampler;  PBDEs. 
Compound CV(NNPS) 
(%) 
CV(Cw;NPS) 
(%) 
CV(Rs) (%) 
BDE 28 62 187 176 
BDE 47 14 231 230 
BDE 99 19 549 548 
BDE 100 74 572 569 
BDE 153 53 665 663 
BDE 154 13 66 65 
11.4.10 Participant sampler 
Figure 57 shows the different sampler types (above method LOQ) applied by participants 
in sampling of BDEs. The most frequently applied design of sampler applied in the study 
was based on the use of silicone rubber. The same design as the provided passive 
sampler. Other types of samplers applied included SPMD, LDPE, CFIS, MESCO, and the 
non-polar version of Chemcatcher. Laboratory 36 applied several designs of passive 
samplers. Details on other samplers applied by participants and their processing are 
given in Annex VIII. 
 
 
 
Figure 57 Various categories of participant passive samplers applied in analysis of PBDEs. A sampler 
was counted only when a particular compound was measured above method LOQ. A brief 
description of sampler category (shown as abbreviation in the legend) is given in Table 18. 
The results provided by participating laboratories are shown in the bottom bar charts in 
Figure 49-54.  
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11.4.11 Field blank 
Concentrations of PBDEs in field blank samplers were low, in most cases less than 10% 
of the concentration found in field exposed samplers (with exception of BDE28, BDE 99, 
BDE 100, BDE 153 in CFSIS sampler; lab 30; BDE 99, BDE 100, BDE 153 and BDE 154 in 
lab 36) and close to method detection limits (Table 37). 
11.4.12 Sample variability 
A good within laboratory variability of analysis of PBDEs in participant samplers was 
observed with the mean CV between 10 and 33% for sampler uptake and between 9 and 
21% for the related water concentration estimate, respectively (Table 24). 
The between laboratory variability (excluding outliers) for sampler uptake (ng/cm2) was 
higher, ranging from 13 to 117% for different compounds. Even higher (68 to 205%) 
variability was observed for the water concentration estimate. 
In most cases the between laboratory variability of water concentration estimates 
derived from participant passive samplers was comparable to that derived from provided 
samplers. 
Individual laboratories found in most cases well comparable results (close to equality) for 
participant and provided sampler for uptake per surface area (left-hand biplots), as well 
as the resulting water concentration (Cw, right-hand biplot) (Figure 49-Figure 54). Points 
that lie near the equality line but far from the median values indicate a large systematic 
error introduced by the laboratory. 
Table 37. Concentrations of PBDEs in field blank participant sampler (ng/sampler)
*
. 
Laboratory Sampler BDE 28 BDE 47 BDE 99 BDE 100 BDE 153 BDE 154 
19 SR <0.10 0.2 0.1 0.02 <0.10 <0.10 
20 LDPE 0.01 0.01 0.02 0.03 0.04 0.02 
21 SR       
23 SPMD 0.02 0.1 0.1 0.01 0.01 <0.01 
26 SPMD  1.0 0.9    
29 SR <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 
30 CFIS <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 
36 LDPE 0.02 3.9 4.7 11 9.1 5.0 
36a MESCO 0.7 0.9 1.1 1.4  0.3 
36b SR   0.02 0.01 0.03  
36c CCNP    0.02   
36d SR       
38 MESCO       
43 SR  0.2 0.4    
*Empty fields indicate cases where participants did not report any value. 
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11.4.13 Water samples 
This step was not performed for brominated diphenylethers since alternative methods 
(other than PS) for measurement of their dissolved concentrations in water are not 
available. Furthermore, because of very low PBDE concentrations large volumes of water 
would be required for analysis of concentrations at pg/L level. 
11.4.14 Conclusions for PBDEs 
1. An acceptable within laboratory variability was observed for standard solution of 
PBDEs and only in a few cases laboratories reported results outside the between 
laboratory variability range. The between laboratory variability of the analysis of the 
standard solution was satisfactory, too. Thus, calibration of instrumental methods 
applied for PBDEs was not expected to cause excessive variability in reported data. 
2. Sampling with provided samplers was homogeneous. This is supported by a very low 
within laboratory variability of analysis of provided samplers. Thus, the contribution to 
total result variability that may have been introduced by non-homogeneity of the 
distributed samples can be considered minor. 
3. Analysis of individual compounds in provided samplers was affected by between 
laboratory variability up to 2.5 times larger than the analysis of standard solution. A 
similar observation was made also when results of analysis of homogeneously spiked 
field blanks were compared between laboratories. The elevated variability can be 
explained by much lower concentrations and higher potential interferences originating 
from a more complex matrix analysed. 
4. The increase of the between laboratory variability in water concentration estimates in 
comparison to sampler uptake per surface area can be attributed to errors introduced 
by different approaches in data translation from uptake to water concentration. For 
PBDEs, the variability of applied calculation procedure and sampler calibration 
procedure is the main factor causing the elevated between laboratory variability of 
water concentration estimate from provided sampler data. Besides difficulties the 
laboratories experienced in proper application of the sampler uptake models, 
difficulties with the analysis of PRC compounds may have contributed to the variability 
of reported water concentration. Training of laboratories in proper analysis of PRCs 
and application of published uptake models may in future help to significantly reduce 
this source of variability. 
5. Similar results for different passive samplers analysed by individual laboratories 
indicate that the PS process is not causing excessive variability. 
6. The higher between laboratory variability of water concentration estimates in 
comparison to within laboratory precision is likely related to systematic error in results 
of individual laboratories, which in turn can be related to both difficulties with analysis 
in the complex matrix of the field exposed passive sampler as well as application of 
biased uptake models and/or calibration data. 
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11.5 Fluorinated surfactants 
Up to 9 laboratories participated in the exercise, but the numbers varied depending on 
target analytes and matrices analysed. Results for individual compounds are displayed in 
Figure 59-60. The explanation of data projection applied is described in chapter 7.5. 
11.5.1 Overall data variability 
 
 
 
Figure 58 Concentrations of PFOA and PFOS in various analysed matrixes: standard solution (top 
left), provided sampler (top right), water concentration estimated from the participant 
sampler (bottom left) and the ratio of water concentrations determined in provided and 
participant passive sampler (bottom right), respectively. For explanation of symbols see 
legend to Figure 19. 
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11.5.2 Results by laboratories – fluorinated surfactants 
 
Figure 59. Results of analysis of PFOS. Graph explanation is given in 10.2.and 10.3. 
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Figure 60. Results of analysis of PFOA. Graph explanation is given in 10.2.and 10.3. 
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11.5.3 Sample variability 
  
Figure 61 Variability of reported results for fluorinated surfactants at different procedure levels. Results 
are the coefficients of variation for individual compounds. NPS – provided passive sampler; 
PPS – participant passive sampler. (N) –amount; (Cw) – water concentration. 
 
Table 38. Variability range at different procedure levels for fluorinated surfactants.  
Fluorinated surfactants 
    Coefficient of variation (%)   
Variability:   Within laboratory Between laboratory 
Matrix analysed: Min. Max. Min. Max. 
  Standard solution 2% 2% 28% 37% 
Provided 
sampler 
NPS amount (ng/cm2) 15% 25% 36% 51% 
NPS water concentration 5% 9% n.d. n.d. 
Participant 
sampler 
PPS amount (ng/cm2) 18% 25% 64% 67% 
PPS water concentration 20% 21% n.d. n.d. 
11.5.4 Standard solution 
Results provided by participating laboratories for the standard solution are shown in the 
top bar charts in Figure 59-60. The range of variability of reported results is given in 
Table 38. Variability observed for individual compounds is also shown in Figure 61 . 
An excellent within laboratory variability of analysis of individual compounds in standard 
solution of PFOA and PFOS was observed with the mean CV not higher than 2% (Table 
38). The between laboratory variability (excluding outliers) was satisfactory, too, ranging 
between 28 and 37%. For both compounds the reference concentration was within the 
range comprised by the participant results (median ± 2 standard deviations excluding 
outliers), but only in case of PFOA the median and geometric mean of participant results 
were within the uncertainty range stated by the central laboratory. 
11.5.5 Provided sampler 
The results provided by participating laboratories are shown in the middle bar charts in 
Figure 59-60.  
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11.5.6 Field blanks 
Concentrations of fluorinated surfactants in field blank samplers were low, in most cases 
less than 10% of the concentration found in field exposed samplers and close to method 
detection limits (Table 39). 
11.5.7 Sample variability 
A good within laboratory variability of analysis of fluorinated surfactant in provided 
samplers was observed with the mean CV between 15 and 25% for sampler uptake 
(Table 38). The between laboratory variability (excluding outliers) for sampler uptake 
(ng/cm2) was higher, ranging from 36 to 51%.  
The evaluation of between laboratory variability for water concentration estimate cannot 
be made because only 2 laboratories reported results for water concentration. This is 
because passive sampler calibration data for fluorinated surfactants were scarce at the 
time when the study was performed. 
Comparison of results for participant and provided sampler for uptake per surface area 
(left-hand biplots), as well as the resulting water concentration (Cw, right-hand biplot) 
can be seen in Figure 60. Points that lie near the equality line but far from the median 
values indicate a large systematic error introduced by the laboratory. 
 
11.5.8 Contribution of the calculation procedure to data variability 
Since very few participants estimated water concentration from PS data, the estimation 
of sampling rate uncertainty was not performed. 
 
Table 39. Concentrations of PFOA and PFOS in field blank sampler (ng/sampler) provided by 
the organizer.  
Laboratory PFOA PFOS 
19 0.2  
21 0.1 0.003 
23 0.4 0.1 
29   
37   
39 1.2  
43 <0.5 <0.5 
44 0.3 0.1 
52 3.7 0.5 
 
11.5.9 Participant sampler 
Figure 62 shows the different types of samplers that were (above method LOQ) applied 
by participants in sampling of fluorinated surfactants. The most frequently applied design 
of sampler applied in the study corresponded with the standard configuration of the 
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POCIS with OASIS HLB adsorbent and fitted with polyethersulphone membrane. Other 
types of samplers applied included POCIS modifications with different adsorbent 
materials and Speeddisks. Details on other samplers applied by participants and their 
processing are given in Annex XIV. The results provided by participating laboratories are 
shown in the bottom bar charts in Figure 59-60. 
 
Figure 62 Various categories of participant passive samplers applied in analysis of fluorinated 
surfactants. A sampler was counted only when a particular compound was measured above 
method LOQ. A brief description of sampler category (shown as abbreviation in the legend) 
is given in Table 18. 
 
11.5.10 Field blank 
Concentrations of fluorinated surfactants in field blank samplers were low, in most cases 
less than 10% of the concentration found in field exposed samplers and close to method 
detection limits (Table 40). 
11.5.11 Sample variability 
The within laboratory variability of analysis of fluorinated surfactants in participant 
samplers (ng/cm2) was observed with the mean CV between 18 and 25% for sampler 
uptake. The between laboratory variability (ng/cm2; excluding outliers) was higher, 
between 64 and 67% for sampler uptake. 
The evaluation of between laboratory variability for water concentration estimates cannot 
be made because only 2 laboratories reported results for water concentration. This is 
because passive sampler calibration data for fluorinated surfactants are scarce. 
Table 40. Concentrations of PFOA and PFOS in field blank participant sampler (ng/sampler). 
Laboratory Sampler PFOA PFOS 
19 POCIM 0.29  
21 POCIS 0.04 0.003 
23 POCIP   
29 POCIS <3 <3 
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37 POCIS 0.3  
39 POCIS   
43 SPEED <0.5 <0.5 
44 (blank)   
52 (blank)   
11.5.12 Water samples 
Results of water sample analysis are given in Table 41. Concentrations in water, reported 
from analysis of weekly composite water samples, were above the method limit of 
quantification. A comparison of these concentrations with water concentration estimates 
from passive samplers is displayed in the bottom bar charts and right hand biplot charts 
in Figure 60. The concentration of compounds in composite spot samples was always 
within the range comprised by the water concentration estimates from passive sampler 
results (median ± 2 standard deviations excluding outliers). 
 
Table 41 Concentrations of fluorinated in weekly composite water samples, analysed by a 
central laboratory 
Sample/Co
mpound 
Filtration 
blank  
(20.6.-
26.6.) 
Filtration 
blank 
 (27.6.-
4.7.) 
Weekly 
composite 
 (20.6.-
26.6.) 
Weekly 
composite 
 (27.6.-
4.7.) 
units 
PFOA 1.4 1.0 27.5 36.0 ng/L 
PFOS 1.1 0.9 5.7 8.5 ng/L 
11.5.13 Conclusions for fluorinated surfactants 
1. An excellent within laboratory variability of analysis of individual compounds in 
standard solution of PFOA and PFOS was observed and the between laboratory 
variability was satisfactory, too. Thus, calibration of instrumental methods applied 
for pharmaceuticals was not expected to cause excessive variability in reported 
data. 
2. Sampling with provided samplers was homogeneous. This is supported by a very 
low within laboratory variability of analysis of provided samplers. Thus, the 
contribution to total result variability that may have been introduced by non-
homogeneity of the distributed samples can be considered minor. 
3. As for pesticides and pharmaceuticals, the low within laboratory variability of data 
from provided samplers was likely facilitated by the use of a uniform deployment 
system (deployment cages). 
4. The between laboratory variability of analysis was 2-3 x higher than the within 
laboratory variability. 
5. Since passive sampler calibration data for fluorinated surfactants were scarce at 
the time when the study was performed, effect of the water concentration 
estimation procedure on data variability was not evaluated. 
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11.6 Bisphenol A and Triclosan 
Up to 6 laboratories participated in the exercise for bisphenol A. Triclosan was measured 
only by 3 laboratories. Although the number of registered participants in this part of 
exercise was small, the data illustrate the applicability of PS for monitoring of these 
compounds. Results for bishpenol A and triclosan are displayed in Figure 64-65. The 
explanation of data projection applied is described in chapter 10. 
11.6.1 Overall data variability 
  
Figure 63 Concentrations of bisphenol A and triclosan in various analysed matrixes: standard solution 
(top left), provided sampler (top right), water concentration estimated from the participant 
sampler (bottom left) and the ratio of water concentrations determined in provided and 
participant passive sampler (bottom right), respectively. For explanation of symbols see 
legend to Figure 19. 
 
Standard solution, µg/mL
B
is
ph
en
ol
 A
Tr
ic
lo
sa
n
µ
g
/m
L
0.05
0.06
0.07
0.08
0.09
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
2
0.1
1
Provided sampler, ng/cm
2
B
is
ph
en
ol
 A
Tr
ic
lo
sa
n
n
g
/c
m
2
0.1
1
10
Participant sampler, Cw in ng/L
B
is
ph
en
ol
 A
Tr
ic
lo
sa
n
n
g
/L
0.1
1
10
100
1000
Ratio of water concentrations provided/participant sampler 
B
is
ph
en
ol
 A
Tr
ic
lo
sa
n
C
w
(N
P
S
)/
C
w
(P
P
S
)
0.1
1
10
100
1000
  
118 
11.6.2 Results by laboratories – bisphenol A and triclosan 
 
Figure 64 Results of analysis of bisphenol A. Graph explanation is given in 10.2.and 10.3. 
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Figure 65 Results of analysis of triclosan. Graph explanation is given in 10.2.and 10.3. 
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11.6.3 Sample variability 
  
Figure 66 Variability of reported results for bisphenol A and triclosan at different procedure levels. 
Results are the coefficients of variation for individual compounds. NPS – provided passive 
sampler; PPS – participant passive sampler. (N) –amount; (Cw) – water concentration. 
 
Table 42 Variability range at different procedure levels for bisphenol. 
Compound:  Bisphenol A 
    Coefficient of variation (%) 
Variability:   Within laboratory Between laboratory 
Matrix analysed: Mean Min. Max.   
  Standard solution 8% 1% 20% 162% 
Provided 
sampler 
NPS amount (ng/cm2) 19% 5% 36% 183% 
NPS water concentration 14% 5% 30% >200% 
Participant 
sampler 
PPS amount (ng/cm2) 31% 10% 60% >200% 
PPS water concentration 33% 6% 60% >200% 
 
Table 43 Variability of triclosan results at different procedure levels. 
Compound:  Triclosan 
    Coefficient of variation (%) 
Variability:   Within laboratory Between laboratory 
Matrix analysed: Mean Min. Max.   
  Standard solution 3% 0% 8% 82% 
Provided 
sampler 
NPS amount (ng/cm2) 15% 7% 23% 98% 
NPS water concentration 16% 7% 20% 45% 
Participant 
sampler 
PPS amount (ng/cm2) 13% 11% 14% >200% 
PPS water concentration 11% 10% 11% >200% 
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11.6.4 Standard solution 
Results provided by participating laboratories for the standard solution are shown in the top 
bar charts in Figure 64-65. The range of variability of reported results is given in  
Table 42 and  
Table 43. Variability observed for individual compounds is also shown in Figure 66. 
A good within laboratory variability of analysis of individual compounds in standard 
solution was observed with the mean CV from 8 and 3% for bisphenol A and triclosan, 
respectively. The between laboratory variability was much higher, 162% for bisphenol A 
and 82% for triclosan, respectively. For bisphenol A, 3 of 6 participating laboratories 
(labs 20, 23 and 45 provided positively biased results. For triclosan, only 1 of the 3 
laboratories provided unbiased result. This means that laboratories experienced difficulty 
already with the analysis of the standard solution, which is the simplest step in the 
analytical process.  
11.6.5 Provided sampler 
The results provided by participating laboratories are shown in the middle bar charts in 
Figure 64-65.  
11.6.6 Field blanks 
Concentrations of bisphenol A and triclosan in field blank samplers was low, in most 
cases less than 10% of the concentration found in field exposed samplers (with 
exception of bisphenol A in laboratory 19) and close to method detection limits (Table 
44). 
11.6.7 Sample variability 
A good within laboratory variability of analysis of in for uptake to provided samplers was 
observed with mean CV 19% and 15% for bisphenol A and triclosan, respectively. The 
between laboratory variability for sampler uptake (ng/cm2) was higher, 183% and 98% 
for bisphenol A and triclosan, respectively. 
A reasonable evaluation of between laboratory variability for water concentration 
estimate cannot be made because in both cases maximum 3 laboratories reported results 
for water concentration. This is because passive sampler calibration data for these 
compounds are scarce. 
Comparison of results for participant and provided samplers for uptake per surface area 
(left-hand biplots), as well as the resulting water concentration (Cw, right-hand biplot) 
can be seen in Figure 64 and Figure 65. Points that lie near the equality line but far from 
the median values indicate a large systematic error introduced by the laboratory. 
11.6.8 Contribution of the calculation procedure to data variability 
Coefficient of variation of the applied calculation procedure was estimated only for 
bisphenol A using the approach described in 10.5. Both the analytical variability 
(CV=153%) and the variability of calibration data (CV=181%) contributed equally or 
similarly to the overall variability of water concentration estimates. 
11.6.9 Participant sampler 
Figure 67 shows the different types of samplers that were (above method LOQ) applied 
by participants in sampling of target compounds. The most frequently applied design of 
sampler applied for bisphenol A corresponded with the standard configuration of the 
POCIS with OASIS HLB adsorbent and fitted with polyethersulphone membranes. The 
same design was also applied in the provided passive sampler. Other types of samplers 
applied included polyoxymethylene (POM) and Empore disks. For triclosan, Empore disks, 
SPMDs and LDPE sheets were applied. Details on other samplers applied by participants 
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and their processing are given in Annex XII. The results provided by participating 
laboratories are shown in the bottom bar charts in Figure 64-65. 
 
Figure 67 Various categories of participant passive samplers applied in analysis of bisphenol A and 
triclosan. A sampler was counted only when a particular compound was measured above 
method LOQ. A brief description of sampler category (shown as abbreviation in the legend) 
is given in Table 18. 
 
Table 44 Concentrations of PFOA and PFOS in field blank sampler (ng/sampler) provided by 
the organizer
*
. 
Laboratory Bisphenol A Triclosan 
19 130 8.5 
20 6.6 1.8 
23 <14 0.82 
26 1.1  
39 0.80  
45 6.1  
 
11.6.10 Field blanks 
Concentrations of bisphenol A and triclosan in field blank samplers were low, in most 
cases less than 10% of the concentration found in field exposed samplers (with 
exception of triclosan samplers from laboratory 19 and 20) and close to method 
detection limits (Table 39). 
11.6.11 Sample variability 
The within laboratory variability of analysis in participant samplers (ng/cm) was observed 
with the mean CV 31% and 13% for sampler uptake of bishpenol A and triclosan, 
respectively. The between laboratory variability for sampler uptake was higher than 
200%. 
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The evaluation of between laboratory variability for water concentration estimate cannot 
be made because maximum 3 laboratories reported results for water concentration. 
11.6.12 Water samples 
Results of water sample analysis are given in Table 46. Concentration of triclosan was 
lower than the spot sampling method LOQ. A comparison of these concentrations with 
water concentration estimates from passive samplers is displayed in bottom bar charts 
and right hand biplot charts in Figure 64-65. 
Table 45. Concentrations of bisphenol A and triclosan in field blank participant sampler 
(ng/sampler). 
Laboratory Sampler Bisphenol A Triclosan 
19 ED  21 
20 POM 14 60 
23 SPMD <18 3.2 
26 POCIS 3.3  
39 POCIS 2.9  
 
The concentration of compounds in composite spot samples for bisphenol A was within 
the range comprised by the water concentration estimates from passive sampler results 
(median ± 2 standard deviations). For triclosan, concentration estimates from passive 
sampler results were lower than the LOQ of the spot sampling method. 
 
Table 46 Concentrations of bisphenol A and triclosan in weekly composite water samples, 
analysed by a central laboratory 
Sample/Co
mpound 
Filtration 
blank 
(20.6.-
26.6.) 
Filtration 
blank 
 (27.6.-
4.7.) 
Weekly 
composite 
 (20.6.-
26.6.) 
Weekly 
composite 
 (27.6.-
4.7.) 
units 
Triclosan <50 <50 <50 <50 ng/L 
Bisphenol A <75 <75 210 120 ng/L 
11.6.13 Conclusions for bisphenol A and triclosan 
1. An acceptable within laboratory variability was observed for standard solution 
showing that calibration of instrumental methods was not expected to cause 
excessive variability in reported data. Some laboratories experienced difficulty 
already with the analysis of the standard solution, which is the simplest step in 
the analytical process. 
2. Sampling with provided samplers was homogeneous based on the acceptable 
within laboratory variability in analysis of provided samplers. 
3. Considering the high between laboratory variability in sampler uptake it is difficult 
to make statements about the contribution to the overall variability of different 
approaches in the translation of passive sampler uptake data to water 
concentration. For bisphenol A and triclosan it seems that the contribution of 
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uncertainty in calculation procedure to the overall uncertainty of water 
concentration was of the same level as the uncertainty of sampling and analysis. 
4. For bisphenol A comparable results for different passive sampler designs analysed 
by individual laboratories indicate that the PS process is causing less variability 
than the analysis. 
5. Although results from individual laboratories indicate that PS method allows 
measurement of concentrations lower than spot sampling method LOQs, the 
interlaboratory method precision needs a significant improvement. 
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12. Variability of DIA-D5 dissipation from Provided samplers 
The analysis of the provided samplers for polar pesticides also included the analysis of 
deuterated desisopropylatrazine (DIA-D5). Mazzella et al., (2010) suggested applicability 
of DIA-D5 as a suitable PRC for compensation of effects of environmental conditions 
(especially flow velocity) on performance of POCIS fitted with OASIS HLB sorbent. The 
applicability of this approach was tested in this study from the results of provided 
exposed and blank samplers supplied by the organiser that allowed to assess the DIA-D5 
concentration in samplers before and after exposure. 
The % of DIA-D5 (PRC) retained in the sampler after exposure was calculated as: 
NPSB
NPSPS
N
N
PRC%           Equation 6 
where NPS NPS  and NB NPS is the mean amount of DIA-D5 in triplicate exposed and blank 
provided passive samplers, respectively. The associated coefficient of variation was 
calculated from error propagation law. 
Fifteen laboratories reported data for DIA-D5 concentrations in provided samplers. The 
within laboratory variability of retained DIA-D5 fraction was acceptable, less than 22% 
(median 15%). Two exceptions were laboratories 43 and 44 with much higher variability 
of 44 and 103%, respectively. Surprisingly, the high variability in these 2 cases was 
caused not only by difficulties with analysis of the matrix-affected exposed samplers, but 
also by high variability in reported initial DIA-D5 levels reported in not exposed 
samplers.  
The between laboratory variability of reported %PRC was 69%. The low within laboratory 
and high between laboratory variability indicates difficulties with accuracy of DIA-D5 
determination in samplers. Attention has to be paid to a reliable analysis of the 
compound in the passive samplers before further application as a PRC can be evaluated. 
It is difficult to find a suitable labelled surrogate to check the procedural recovery of DIA-
D5, since the compound is already isotopically labelled. A compound labelled with 13C 
carbon atoms would be required that would allow correction for ion suppresion, which is 
expected to differ between field exposed and the blank sample.   
 
 
Figure 68 Percentage of DIA-D5 retained in exposed provided samplers 
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13. Correlation between result deviation from median and 
level of expertise of participating laboratories 
Individual laboratories seem to have introduced a systematic bias to their results by 
chemical analysis and also by the following estimation of water concentration. A poor 
between laboratory precision was observed especially for compounds with environmental 
concentrations approaching method detection limit (e.g. steroids). This observation 
points at difficulties that some laboratories experienced with the analysis of complex 
environmental matrices. The study organiser did not restrict the participation only to 
expert laboratories that routinely analyse the target compounds in passive samplers and 
have a fully operational QA/QC system. Thus, the observed between laboratory 
variability may be partially attributed to the limited experience among laboratories with 
the analysis of emerging substances in the complex analysed matrix. 
During registration process, most of the participating laboratories provided a statement 
on level of expertise in analysis of selected compounds in passive samplers (Table 8). 
This information enabled to investigate whether there is a correlation between the stated 
level of expertise of participating laboratory and deviations of reported results. For the 
purpose of assessment, nummeric levels 1, 2, and 3 were used for the higher to lower 
expertise levels A, B and C respectively. Then the absolute differences of the 2log 
transformed results reported by the laboratory and the median were correlated with the 
nummeric expertise level. This was done seprately for the results obtained for the 
standard solution (ng/mL), the provided sampler (ng/cm2) and the water concentration 
estimated by the participant from participant samplers (ng/L).  
Results of the correlation are shown in Figure 69-73. Positive as wel as negative 
correlations with the level of experience were observed, which were in most cases weak 
and not significant. Figure 74 shows the few correlations between expertise level and 
deviations that were found significant. These were observed only for water 
concentrations estimated from the participant samplers.  
Several conclusions can be drawn from the results.  
1. Deviations of laboratory’s results for the standard solution from the median were 
not related to their indicated level of expertise on passive sampling. 
2. For the analysis of the provided sampler, where the difference from the median 
were much larger, also no relation with the experties level was observed, i.e. both 
the inexperienced laboratories and those that claimed to be skilled in the analysis 
of passive samplers equally contributed to the observed high between laboratory 
variability. 
3. Only for Cw data reported from participant samplers showed deviations from the 
median a significant positive correlation with the self assessed level of expertise 
was observed, but only for a limited number of compounds (terbutylazine, S-
metolachlor, BDE 99 and PFOA).We could assume that experienced labs have a 
better estimates of the sampling rate. 
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Figure 69 Correlation between absolute deviations from median (log transformed data) and laboratory 
level of expertise for polar pesticides. Analysed matrices included standard solution, 
provided sampler (ng/cm2) and water concentration estimated from the participant sampler 
(ng/L ). The numbers next to bars indicate number of laboratories that analysed the sample. 
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Figure 70 Correlation between absolute deviations from median (log transformed data) and laboratory 
level of expertise for pharmaceuticals. Explanation is given in Figure 69. 
 
 
Figure 71 Correlation between absolute deviations from median (log transformed data) and laboratory 
level of expertise for steroids. Explanation is given in Figure 69. 
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Figure 72 Correlation between absolute deviations from median (log transformed data) and laboratory 
level of expertise for BDEs. Explanation is given in Figure 69. 
 
 
Figure 73 Correlation between absolute deviations from median (log transformed data) and laboratory 
level of expertise for PFOA, PFOS, bisphenol A and triclosan. Explanation is given in Figure 
69. 
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Figure 74 Relation between result deviations from median (log transformed data) and laboratory level 
of expertise expertise for compounds where the correlation was statistically significant 
(α=0.05). Analysed matrix was the water concentration estimated from the participant 
sampler (ng/L). 
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 Conclusions 
Conclusions made for individual compound groups investigated in the interlaboratory 
study can be generalised: 
1. With a few exceptions an acceptable within laboratory precision and also between 
laboratory variability was observed for analysis of target compounds in standard 
solution. For most compounds the reference concentration of analytes was within 
the range comprised by the participant results. Thus, in most cases calibration of 
instrumental methods did not cause excessive variability or bias in reported data. 
2. For most classes of polar compounds sampling with provided samplers (POCIS) 
was homogeneous, which was confirmed by the low within laboratory variability in 
their analysis. This implies that the compound uptake by these samplers was not 
depending on the position of samplers in the sampled system. Use of uniform 
deployment cages seems to help buffering differences in local water 
velocity/turbulence and thus facilitate uniform sampler uptake. Lower within 
laboratory precision of steroids in provided samplers can be explained by the very 
low concentrations that were close to the method limit of detection. 
3. In cases where provided and participant sampler uptake mechanisms were 
expected to be similar, the obtained within laboratory results for surface specific 
uptake (ng/cm2) by the different passive samplers were well comparable. This 
indicates that the PS process is causing less variability than the between 
laboratory chemical analysis and subsequent data translation to water 
concentration. 
4. In most cases the between laboratory variability of results from passive samplers 
was roughly a factor 5 larger than the within laboratory variability.  
5. The higher between laboratory variability of water concentration estimates in 
comparison to sampler uptake in provided samplers indicates that there is no 
agreement on approaches in translation of sampler uptake data to water 
concentrations. This observation reflects the limited agreement of sampler 
calibration data published for adsorption PS devices as has been reviewed 
recently by Harman et al., 2011, 2012). For most polar compounds both the 
analytical variability and the variability of applied calibration data contribute 
similarly to the overall variability of water concentration estimates. 
6. Only for a limited number of compounds there has been a significant positive 
correlation between the accuracy of results reported from participant samplers 
and the self assessed level of expertise. 
7. For PBDEs, which were sampled by partitioning-based passive samplers (silicone 
rubber), the variability of applied calculation procedures is the main factor 
causing the elevated between laboratory variability of water concentration 
estimates from provided sampler data. Besides difficulties the laboratories 
experienced in application of the sampler uptake models available in the literature 
(see chapter 1.7), difficulties with the analysis of PRC compounds also 
significantly contributed to the total variability of reported water concentration. 
Training of laboratories in proper analysis of PRCs and application of published 
uptake models will help to significantly reduce this source of variability. 
8. In most cases, discrepancies between water concentrations obtained by PS and 
spot sampling were not observed, however, the precision of the PS method needs 
improving. In several cases (e.g. S-metolachlor, triclosan) it has been 
demonstrated that PS is able to detect contaminant concentrations that are below 
method detection limits of conventional spot sampling methods. 
The overall conclusion of this exercise is that the passive sampling process works as 
expected, but participating laboratories experienced difficulties in accurately determining 
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the analyte amount sorbed by the sampler as well as in deriving aqueous concentrations 
from the amount in passive sampler. 
 Recommendations 
The exercise revealed several weak points of the methods currently applied in analysis 
and passive sampler data evaluation. In this last chapter we provide some 
recommendations to tackle these problems in future. 
Accuracy of analysis of complex samples using LC/MS 
methods 
The study revealed that many laboratories experience difficulties with the accuracy of 
analysis in passive sampler extracts, when LC/MS methods were applied. The analysis of 
compounds using LC/MS with electro-spray ionisation (ESI) in the presence of co 
extracted matrix is and continues to be very susceptible to ion suppression or also ion 
enhancement. Such problem is not specific for analysis of extracts from adsorption-based 
passive samplers, but occurs as well in other sample preparation techniques, such as 
solid phase extraction. Several recommendations can be to make improvements to 
accuracy and reproducibility of sampler analysis in future: 
1. Laboratories should validate their LC/MS methods specifically also for extracts 
from passive samplers exposed in wastewater or similarly complex environment. 
2. Mass labelled standards should be applied whenever possible to control and 
correct the LC/MS results for the effects of ion suppression. However, it has to be 
acknowledged that even use of isotopically labelled internal standards does not 
always solve the problem. In case it is not possible to apply labelled standards for 
each compound under investigation, the analytical method performance should be 
verified using analyte standard addition to tested samples. 
3. Despite the broadly spread believe that LC/MS/MS techniques are selective and 
thus, sample cleanup is generally not required, we strongly recommend sample 
dilution and/or cleanup to reduce the potential matrix effects in the sample 
analysis. 
4. Use of alternative ionisation techniques such as atmospheric pressure chemical 
ionisation (APCI) instead of ESI may help to reduce problems with ion 
suppression. 
Availability of accurate calibration data for adsorption based 
PS 
Besides the accuracy of applied analytical methods, in most cases the variability of 
available and applied calibration data contributed similarly to the overall variability of 
water concentration estimates. The recently organised NORMAN/AQUAREF workshop on 
passive sampling techniques for monitoring of contaminants in the aquatic environment 
(Lyon, 27-28 November 2014) concluded that currently, the mechanisms of uptake to 
adsorption based PS are neither completely understood, nor fully under control. The 
calibration data that are available from literature are often variable and (unlike in 
partitioning PS) very substance specific [22]. The exchange of polar compounds between 
sampler and the aqueous phase was often observed to be anisotropic. In consequence, it 
is generally not possible to use release of PRC (performance reference compounds) to 
calibrate the uptake rate for calculation of TWA (time weighted average) water 
concentrations for a wider range of compounds. In general, simple linear uptake models 
are applied and are considered sufficient for translation of passive sampler uptake into 
water concentration, providing the sampler uptake capacity is high enough to allow 
integrative contaminant uptake during the whole sampler exposure. 
1. The understanding and monitoring (or control) of the contaminant uptake to 
adsorption based samplers is the prerequisite for further decrease of variability 
from calibration data applied in conversion from sampler-based data to water 
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concentrations. This issue remains open for further research of adsorption based 
PS. 
2. PRCs still could be used as surrogates to monitor exposure conditions in time and 
space or link to calibration data (quality controls). 
3. Whenever water concentrations are calculated from passive sampler data, 
existing variability of available calibration data should also be taken into account, 
besides analytical variability. Ideally, water concentration estimate should be 
reported as a confidence interval. The upper confidence limit of estimated water 
concentration (taking into account the minimum assumed sampling rate) can be 
used as a “worst case” concentration, which may often be sufficient to check 
compliance with environmental quality standards.  
Experience with state-of-the art approaches to evaluate data 
from partition-based PS of hydrophobic compounds 
The study identified that for partitioning based PS many participants had a limited 
experience with the analysis of PRC compounds in provided passive samplers, and also 
with the application of published procedures and models to estimate water concentration 
from passive partition PS data. Several general recommendations can be made for a 
correct application of partitioning PS: 
1. In case samplers reach equilibrium with sampled water sampler-water partition 
coefficient (Ksw) are required to derive the concentration of a chemical in the 
water phase from the amount accumulated in the sampler. Accurate values of 
PS/water partition coefficients should be available for both target analytes and 
PRCs applied. 
2. In case no equilibrium is attained aqueous concentration can be estimated by 
sampler/water exchange kinetics models that can be in situ calibrated from the 
release of performance reference compounds (PRCs) dosed to the sampler prior to 
exposure [33]. Booij and Smedes (2010) recommend that efforts to reduce the 
bias and variability in water concentration estimates should primarily focus on 
reducing the uncertainties in the Ksw values of the PRCs. Increasing the number 
of PRCs that are used is also relevant, however, it is expected to have a smaller 
effect. 
3. The applied uptake kinetics models often consider that uptake is controlled by the 
water boundary layer (WBL) at the surface of the sampler. This requires that 
internal transport resistance is sufficiently low, i.e. does not limit the uptake rate. 
This can be confirmed by measuring the diffusion coefficients inside the sampler 
material. Thus, it is necessary to know also diffusion coefficients of analytes and 
PRCs in the polymer used in partitioning PS.  
We refer users of partition PS to use freely available guidelines for passive sampling of 
hydrophobic contaminants in water using silicone rubber samplers [34]. Dissemination of 
the existing knowledge on the best practice in evaluation of data from partitioning PS by 
organisation of training courses or workshops is recommended as well. 
Organisation of future interlaboratory studies  
In future interlaboratory studies, it will be necessary to clearly separate the issue of 
laboratory analysis from the passive sampling testing. 
We propose a two stage interlaboratory study: 
1. In preparation of the interlaboratory study, a (certified) reference material 
should be prepared centrally by expert laboratories, e.g. a homogenised extract of 
passive samplers exposed in a real environment that contains environmentally 
relevant concentrations of analytes of interest. 
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2. The first stage of the study would be a Proficiency Testing (PT) scheme, 
where laboratories would analyse the reference material prepared in step 1. Only 
laboratories that demonstrate acceptable performance in the PT scheme would be 
admitted to participate in the main interlaboratory study addressing the passive 
sampling intercomparison. Alternatively, If the PT scheme is performed in parallel 
with the interlaboratory sampler comparison, passive sampling results of 
laboratories that failed in the PT scheme would be excluded from evaluation (or, 
depending on the achieved z-score, their result will have a lower weight). This 
approach would minimise the effect of laboratory analysis on the variability of 
passive sampling results. 
3. The second stage of the study would be an interlaboratory passive sampler 
comparison, with a similar design to the one demonstrated in this study. 
Provided and participant samplers would again be deployed in parallel at a single 
sampling site. Variability of sampled analyte amount and water 
concentrations derived from various passive samplers selected by the individual 
participating laboratories would be assessed and compared to the criteria set for 
routine monitoring methods e.g. under the Water Framework Directive. 
4. Assessment of trueness of water concentrations calculated from the passive 
sampling data is the most important objective of future interlaboratory studies. 
Such assessment can be practically performed in real environment only for those 
compounds, where water concentration measurements obtained by an alternative 
sampling method (giving comparable results to PS) can be accepted as a “true” or 
reference value. For polar compounds, an acceptable alternative method is 
based on continuous active sampling of water e.g. using automatic water sampler, 
followed by preparation of a composite water sample in an approach similar to the 
one described in this study (8.6). In order to obtain an acceptable reference 
value of water concentration, several expert laboratories must perform 
independent representative collection and analysis of water at the test site during 
the time period of passive sampler exposure. Providing the variability of results 
obtained from active sampling by expert laboratories is acceptable, the assigned 
reference value for water concentration can be calculated e.g. as the mean of 
these results. 
5. For hydrophobic compounds, there is currently no alternative method to PS for 
measurement of free dissolved concentration. Therefore, at the moment the only 
way to provide a reference value for the assessment of trueness is to set a 
consensus value measured by passive sampling, and agreed upon by a group of 
expert laboratories. 
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Annex I  Provided passive samplers of polar pesticides: method information 
 
Table AI- 1 Provided passive samplers of polar pesticides: method information 
LAB No. 17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
PS type : POCIS, pharmaceutical version 
Receiving phase material: sorbent Oasis HLB, 60 μm  
Receiving phase mass (g): 0.200 g; mass of sorbent separated from samplers after exposure is given on each SPE cartridge 
Receiving phase volume (cm3)  
Membrane material : Polyethersulphone; SUPOR 100 Membrane Disc Filters (0.1 μm, 90 mm diameter) 
Active sampler surface area (or membrane area) 
(cm2): 
45.8 cm2 
 
Performance and Reference Compound (PRC) * 
Passive samplers with PRC : Deisopropylatrazine (DIA) d5 
 concentration cca. 4ug/g sorbent 
Transport and storage 
Storage conditions before deployment (°C)**: Fridge (4 degrees C) 
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Table AI -2 Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
Storag
e 
conditi
ons 
after 
sampl
er 
recove
ry 
(°C)**
: 
  Fridge 
(4 
degree
s C)  
- 20 
degree
s 
celsius 
     -20 -20°C -20ºC   freezer   Storag
e in 
freezer 
at -
20°C 
  
Date 
of 
return 
shipm
ent 
from 
the 
organi
ser to 
the 
partici
pant 
labora
tory:*
* 
 26.07.
2011 
21/07/
2011 
13/07/
2011 
     18.07.
2011 
18/07/
2011 
4 July 
2011 
~31/8/
2011 
~31/8/
2011 
   07/07/
2011 
  
Date 
of 
receip
t by 
the 
partici
pant 
labora
tory 
** : 
29/07/
2011 
28.07.
2011 
26/07/
2011 
15/07/
2011 
21/06/
2011 
    19.07.
2011 
19/07/
2011 
6 July 
2011 
~2/9/2
011 
~2/9/2
011 
10/25/
11 
03/08/
2011 
22/07/
2011 
08/07/
2011 
August
, 5th 
August
, 5th 
REMA
RKS: 
         - -  Dates 
are 
approxi
mate 
Dates 
are 
approxi
mate 
   /   
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(continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 3
2 
3
6 
3
7 
39 40 42 43a 43 44 4
7 
48 49 50
a 
5
0 
Sampler deployment and recovery 
Date and 
hour of 
the 
deployme
nt ** : 
30/05/
2011 
 30/05/20
11; 
10:35am, 
11:50am, 
12:25pm 
5/30/20
11  
between 
10:35 
and 
12:40 
30.5.2011, 
10:35 
5/30/
11 
11:50 
   30.05.201
1 11:30 
samplers 
3, 9 : 
30/05/20
11  
10:35:00 
; sampler 
101 : 
30/05/20
11 12:40 
2011-
05-30 
20/06/20
11 
20/06/20
11 
(16)  
5/30/1
1, 
10:35   
(20)  
5/30/1
1, 
10:35         
(59) 
5/30/1
1, 
11:50 
 Sampler 
43: 
30.05.20
11 11:10 
Sampler 
54: 
30.05.20
11 11:50 
Sampler 
75: 
30.05.20
11 12:25 
Sample 
70: 
30/05/20
11 at 
11:50; 
sample 
74: 
30/05/20
11 at 
12:25; 
sample 
87: 
30/05/20
11 at 
12:25 
  
Air Temp 
on 
deployme
nt (°C)** 
  Average 
temp 
between 
10am and 
12 pm = 
21 
21 21 14    22 samplers 
3, 9 : 20 
; sampler 
101 : 23 
20-
23ºC 
  (16) 
20°C                  
(20) 
20°C                        
(59) 
21°C 
 Sampler 
43: 21; 
Sampler 
54, 75: 
22 
Sample 
70: 
22°C; 
sample 
74: 
22,5°C; 
sample 
87: 
22,5°C 
  
Duration 
of the 
deployme
nt 
(exposur
e to air 
for field 
control)*
* 
  45mins, 
40 mins, 
35 mins 
+/- 30 
minutes 
0.03125 40 
min  
   30 min samplers  
3, 9 : 
00:45 ; 
sampler 
101 : 
00:15 
13.96
2 
  (16) 
45 min               
(20) 
45 min                      
(59) 
40 min 
 Sampler 
43: 
35min 
Sampler 
54: 
30min 
Sampler 
75: 
35min 
Sample 
70: 40 
min; 
sample 
74: 35 
min; 
sample 
87: 35 
min 
  
Air Temp 
on 
recovery 
(°C)** 
  Average 
temp 
between 
10am and 
12 pm = 
20.25 
21 19 15    20 samplers 
3, 9 : 20 
; sampler 
101 : 22 
18-
22ºC 
  (16) 
18°C                  
(20) 
18°C                         
(59)  
20°C 
 Sampler 
43, 54: 
21; 
Sampler 
75: 22 
Sample 
70: 
21°C; 
sample 
74: 
21,5°C; 
sample 
87: 
21,5°C 
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Table AI -2 (continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 3
2 
3
6 
3
7 
39 40 42 43a 43 44 4
7 
48 49 50
a 
5
0 
Duration 
of the 
recovery 
(exposur
e to air 
for field 
control)*
* 
  39  mins, 
16 mins, 
30 mins 
+/- 30 
minutes 
0.0277777
78 
17 
min  
   30 min samplers 
3, 9 : 
00:39 ; 
sampler 
101 : 
00:18 
   (16) 
39 min               
(20) 
39 min                      
(59) 
17 min 
 Sampler 
43: 9min 
Sampler 
54: 
17min 
Sampler 
75: 
30min 
Sample 
70: 17 
min; 
sample 
74: 30 
min; 
sample 
87: 30 
min 
  
Date and 
hour of 
the 
recovery 
** : 
13/06/
2011 
 13/6/201
1; 
9:16am, 
10:43am, 
11:30pm 
6/13/20
11  
between 
9:16 
and 
12:00 
13.6.2011, 
9:16 
6/13/
11 
10:43 
   13.06.201
1 10:00 
samplers 
3, 9 : 
13/06/20
11  09:16 
; sampler 
101 : 
13/06/20
11 12:00 
2011-
06-13 
04/07/20
11 
04/07/20
11 
(16) 
6/13/1
1,  
9:16     
(20) 
6/13/1
1,  
9:16           
(59) 
6/13/1
1, 
10:43 
 Sampler 
43: 
13.06.20
11 10:34 
Sampler 
54: 
13.06.20
11 10:43 
Sampler 
75: 
13.06.20
11 11:30 
Sample 
70: 
13/06/20
11 at 
10:43; 
sample 
74: 
13/06/20
11 at 
11:30; 
sample 
87: 
13/06/20
11 at 
11:30 
  
Comment 
on 
fouling**
: 
   no 
fouling 
     Exposed 
membran
es were 
spotted 
and 
darker 
than 
unexpose
d ones 
-       Not much   
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Table AI -2 (continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
Field deployment device used: standard POCIS deployment cage for 6 samplers 
Analytical aspects 
Extrac
tion 
techni
que: 
elution 
MeOH 
SPE, 3 
mL of 
MeOH 
and 3 
mL 
MeOH:
ethyl 
acetate
, 75:25 
Elution 
of 
cartrid
ges 
under 
gentle 
vacuu
m with 
3mL 
methan
ol, 2mL 
acetoni
trile, 
2mL 
aceton
e 
sorbent 
rinsed 
with 
+/- 10 
ml milli 
Q into 
empty 
glass 
column 
with 
PTFE 
frit, 
drying 
10 
minute
s (-50 
kPa), 
elution 
with 3x 
4ml 
methan
ol 
liquid 
extracti
on 
Solvent 
extracti
on 
methan
ol 
SPE 3 x 15 
min 
ultraso
nic 
extracti
on with 
toluene
:MeOH
:DCM 
(1:1:8) 
accordi
ng to 
Alvarez 
2004 
5 mL 
MeOH - 
5 mL 
MeOH/
DCM 
(50/50
) - 5 
mL 
DCM 
elution 
with 
Methan
ol and 
dichlor
ometha
ne 
3 ml 
Methan
ol + 3 
mL 
75/25 
Methan
ol/Ethy
lacetat
e 
Elution 
with 4 
ml 
methyl
tertiary
butylet
her 
followe
d by 8 
ml 
methan
ol 
Elution 
with 4 
ml 
methyl
tertiary
butylet
her 
followe
d by 8 
ml 
methan
ol 
3x 5ml 
100% 
MeOH 
In 
column 
extracti
on with 
80/20 
Dichlor
ometha
ne/IPA 
5 mL 
Methan
ol 
SPE SPE SPE 
Date 
of 
extrac
tion: 
08/08/
2011 
 29/08/
2011 
29/09/
2011 
 12/20/
11 
17/08/
2011 
15/11/
2011 
20/10/
2011 
12.09.
2011 
12/09/
2011 
08/12/
2011 
20/10/
2011 
20/10/
2011 
13/12/
2011 
12/12/
2011 
19/08/
2011 
25/07/
2011 
october
, 13th 
october
, 13th 
Date 
of 
instru
menta
l 
analys
is: 
23/08/
2011 
 05/09/
2011 
18/10/
2011 
 12/20/
11 
09/06/
2011 
 21/10/
2011 
15.09.
2011 
24/09/
2011 
08/12/
2011 
27/10/
2011 
27/10/
2011 
05/01/
2012 
10/01/
2012 
22/08/
2011 
23/09/
2011 
novem
ber, 
11th 
novem
ber, 
11th 
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Table AI -2 (continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
Cleanu
p 
metho
d: 
no none   no The 
extract 
obtaine
d by 
extracc
tion 
techniq
ue 
describ
ed is 
filtered 
with 
0.2 μm 
PVDF 
membr
ane  
no 
cleanu
p 
NaSO4, 
0.45 
µm 
cellulos
e 
acetate 
membr
ane 
no No 
cleanu
p 
no OnLine 
SPE 
No No  No 
clean 
up 
 / - - 
Instru
menta
l 
metho
d: 
UPLC/
MS/MS 
HPLC-
MS/MS 
LCMS LC-MS LC/MS/
MS 
HPLC-
MS/MS  
HPLC-
MS/MS 
LC-
MS/MS 
LC-
MS/MS 
LC-MS-
MS 
LC-
MS/MS 
LC-
MS/MS 
LC-
MSMS 
LC-
MSMS 
LC/MS/
MS, 
ESI+, 
column
: 
Betasil 
C18, 
Mobile 
phase: 
gradien
t water 
5mM 
NH4CO
OH, 
MeOH 
5mM 
NH4CO
OH 
LCMS 
QQQ 
and 
GCMS 
(for 
Atrazin
e) 
online 
SPE 
(Oasis 
HLB) 
HPLC-
MS/MS 
LC-
MS/MS 
HPLC-
MS/MS 
GCMS 
Injecti
on 
solven
t: 
MEOH Water:
MeCN, 
90:10 
50% 
methan
ol/ 
water 
milli Q MeOH/
water 
Methan
ol  
MeOH:
H2O 
MeOH 75% 
methan
ol/25% 
5mM 
ammon
ium 
acetate 
MeOH Methan
ol 
50/50 
methan
ol/Milli
Q 
Acetoni
trile-
water 
Acetoni
trile-
water 
methan
ol:wate
r 5mM 
NH4CO
OH 
(1:1) 
In 
mobile 
phase 
HPLC 
grade 
Water, 
Methan
ol 
Water methan
ol 
dichlor
ometha
ne 
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Table AI -2 (continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
Recov
ery 
and 
intern
al 
standa
rds 
used: 
Simazi
ne d10 
No 
correcti
on with 
recover
ies, 
use of 
deuter
ated 
compo
unds 
as 
internal 
standar
ds 
IS: 
25ng 
d-
simazin
e, RS: 
12ng 
d-
atrazin
e 
 IS = 
C13 
labelle
d 
Simazi
n, RS 
not 
used 
Atrazin
e-D5 
none  yes Simazi
ne d10, 
Hexazi
none 
d6, 
Diuron 
d6, 
Atrazin
e d5, 
Terbut
ylazine 
d5, 
Irgarol 
d9 
alachlo
r-d13, 
atrazin
e-d5, 
hydrox
yatrazi
ne-d5, 
carbofu
ran-d3, 
cyanazi
ne-d5, 
dea-
d7, 
diuron-
d6, 
hexazi
none-
d6, 
irgarol-
d9, 
isoprot
uron-
d6, 
simazin
e-d10, 
terbuty
lazine-
d5 
No 
recover
y test, 
IS: 
Atrazin
-d5, 
Isoprot
uron-
d6, 
Terbut
ylazin-
d5 
Several 
standar
ds 
used 
but 
genera
aly not 
the 
target 
compo
unds, 
Therefo
re no 
correcti
ons 
were 
made. 
Several 
standar
ds 
used 
but 
genera
aly not 
the 
target 
compo
unds, 
Therefo
re no 
correcti
ons 
were 
made. 
internal 
standar
ds: 
Atrazin
e D5, 
Isoprot
uron 
D6, 
Simazi
ne D5, 
Terbutr
yn D5 
Deuter
ated 
(D5) 
Atrazin
e, (D6) 
Diuron 
and 
(D3)Ca
rbenda
zim 
Labele
d IS 
used 
for 
every 
compo
und 
analyse
d 
/ only 
check 
on 
internal 
standar
ds 
only 
check 
on 
internal 
standar
ds 
REMA
RKS: 
         - -  No 
correcti
ons for 
suppre
ssion 
made 
No 
correcti
ons for 
suppre
ssion 
made 
 Matrix 
interfer
ence 
made 
quantifi
cation 
of 
Atrazin
e and 
Atenolo
l 
proble
matic. 
Ibuprof
en was 
not 
present 
above 
our 
detecti
on 
limits 
 / DIA-d5 
is not 
used 
for 
quantifi
cation 
DIA-d5 
is not 
used 
for 
quantifi
cation 
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Table AI -2 (continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
Data evaluation aspects 
Metho
d for 
estima
tion of 
water 
conce
ntratio
n from 
passiv
e 
sampl
er: 
m/Rst Data in 
ng/g, 
determ
ination 
of TWA 
concen
tration
s with 
applica
tion of 
ku 
(Lissald
e et al. 
2011) 
and 
PRC 
(Mazzel
la et al. 
2010) 
data 
Cw = 
Ns/(Rs
*t) 
accordi
ng to 
Mazzell
a et al. 
ES&T, 
vol. 44, 
no5, 
2010 
eq 2 
and 6, 
DIAd5 
PRC 
Log 
Ksw 
3.85 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
To 
determ
ine the 
averag
e 
concen
tration 
of 
differe
nt 
analyte
s in 
water  
sampli
ng rate 
values 
for 
POCIS 
have 
been 
search 
in 
bibliogr
aphy. 
Knowin
g the 
sampli
ng 
rate, 
the 
mass 
adsorb
ed and 
the 
exposu
re time 
the 
value 
of the 
averag
e 
concen
tration 
of 
water 
has  
The 
rough 
estimat
ion of 
4,2 L is 
based 
upon a 
report 
by 
Robert
s & 
Balaam 
·       
Robert
s, P.H., 
Balaam
, J.L, 
2006. 
Offline 
extracti
on and 
passive 
sampli
ng. 
Modelk
ey 
progres
s 
report 
SSPI-
CT-
2003-
511237
-2. 
 
They 
found 
water 
extracti
ons 
betwee
n 50 
and 
300 ml 
Rs 
from 
Literat
ure 
TWA 
calculat
ed 
accordi
ng to 
Alvarez 
2004 
Calcula
tion 
with 
followin
g 
formul
a : Cs 
x 0,2 = 
Cw Rs t 
(Vrana 
et al., 
2005) 
PRC 
aproac
h using 
Salbuta
mol-
d3, 
Caffein
-C13 
and 
DIA-d5 
Analysi
s of 
DIA-d5 
Uptake 
of 
Clotrim
aziole, 
Carba
mezapi
ne, 
Thiabe
ndazol, 
transfe
red to 
sample
d 
volume 
using 
Cw 
from 
SR 
sampli
ng 
Uptake 
of 
Clotrim
aziole, 
Carba
mezapi
ne, 
Thiabe
ndazol, 
transfe
red to 
sample
d 
volume 
using 
Cw 
from 
SR 
sampli
ng 
N.Mazz
ella, S. 
Lissald
e, S. 
Moreira
, F. 
Delmas
, P. 
Mazelli
er, J.N. 
Huckin
s: 
Environ
. Sci. 
Techno
l. 
2010, 
44, 
1713–
1719. 
For 
Diuron: 
N. 
Mazzell
a, J.-F. 
Dubern
et, F. 
Delmas
: 
Journal 
of 
Chrom
atogra
phy A 
2007, 
1154,) 
42–51 
Estimat
ion of 
water 
calculat
ion not 
used 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
To 
obtain 
laborat
ory Rs: 
Plot of 
the 
concen
tration 
factor 
as a 
functio
n of 
the 
time 
until 
the 
t1/2: 
CF=Cs/
Cw=(R
s*t)/(M
s). Use 
of this 
lab Rs 
in 
order 
to 
obtain 
in situ 
TWA 
concen
tration
s using 
the 
equatio
n 
Cw=(C
s*Ms)/
(Rs*t) 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
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Table AI -2 (continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
Sampli
ng 
rates 
used 
(litera
ture 
value/
own 
calibra
tion): 
littérat
ure 
Lissald
e et al. 
2011 
Literat
ure 
(DA 
Alvarez 
et al, 
Tool for 
monito
ring 
hydrop
hilic 
contam
inants 
in 
water: 
polar 
organic 
chemic
al 
integra
tive 
sample
r 
(POCIS
), In 
Compr
ehensi
ve 
Analyti
cal 
Chemis
try, D. 
Barcelo
, 
Elsevie
r. 
2007. 
p. 171-
197 ). 
Atrazin
e=0.24
0, 
deseth
ylatrazi
ne=0.2
6 
literatu
re 
value 
Mazzell
a 
2007, 
Mazzell
a 2008 
  literatu
re 
values 
for 
pesticid
es and 
pharm
aceutic
als 
Mazzell
a 
2007, 
Lissald
e 2011 
Sampli
ng 
rates 
from 
Lissald
e et 
al., 
2011 
were 
used 
own 
calibrat
ion 
0.253 
(Mozzel
la and 
DIA-
d5) 
From 
calibrat
ion 
with 
SR 
results, 
Sample
d 
volume 
= 3.0, 
3.6, 
3.4  L 
From 
calibrat
ion 
with 
SR 
results, 
Sample
d 
volume 
= 3.0, 
3.6, 
3.4  L 
Rs[L/d]
- 
literatu
re 
values: 
Environ
.Sci. 
Techno
l.- Rs 
(DEA)=
0,167, 
Rs 
(DET)=
0,205, 
Rs(Atra
zine)=
0,239, 
Rs(S-
Metolal
chlor)=
0,225. 
J.Chro
matogr
aphy 
A: Rs 
(Diuron
)=0.24
7. Rs 
for 
carben
dazim 
not 
found. 
N/A  Own 
calibrat
ion: 
ATRA=
0,1891 
L/d; 
CARB=
0,2949 
L/d; 
DIU=0,
1976 
L/d 
Journal 
of 
Chrom
atogra
phy A, 
1218 
(2011) 
1492-
1502 
and 
Water 
Resear
ch 43 
(2009) 
903-
914 
Journal 
of 
Chrom
atogra
phy A, 
1218 
(2011) 
1492-
1502 
Ksw 
applie
d 
 No No log 
Ksw 
3.85 
No no  NO - - -  none none  N/A  /   
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Table AI -2 (continued) Provided passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23 30 32 36 37 39 40 42 43a 43 44 47 48 49 50a 50 
Perfor
mance 
refere
nce 
compo
unds 
applie
d 
(YES/
NO):  
YES YES NO YES NO NO  NO NO NO YES NO NO NO NO NO  NO NO NO 
Were 
the 
calibra
tion 
data 
adjust
ed to 
reflect 
expos
ure 
conditi
ons 
(temp
eratur
e, 
flow, 
pH...?) 
no Yes No no No No  averag
e flow 
was 
estimat
ed with 
PFM: 
O'Brien 
et al., 
Chemo
sphere 
83 (9), 
2011 
no NO PRC No Only 
an 
attemp
t to 
correct 
for flow 
Only 
an 
attemp
t to 
correct 
for flow 
No N/A  No 
(labora
tory 
calibrat
ion: 
temper
ature=
20,7°C
; 
pH=7,6
; 
conduc
tivity=
429 
µS/cm; 
DOC=1
3,3 
mg/L; 
flow=1
1 
cm/s) 
  
REMA
RKS: 
       PRC 
not 
used 
for 
Ctwa-
calculat
ion 
Amoun
t of 
DIA-d5 
(cell 
M12-
P12) 
present
ed as 
% of 
initial 
concen
tration 
(G12-
I12). 
- -  Not 
very 
confide
nt on 
sampli
ngrate 
applied 
Not 
very 
confide
nt on 
sampli
ngrate 
applied 
  No 
estimat
ion of 
water 
concen
tration. 
Sampli
ng 
rates 
were 
only 
availabl
e for 
triphasi
c 
POCIS. 
/   
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Annex II. Participant passive samplers of polar pesticides: method information 
 
Table AII- 1 Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23a 23 30 36 37 39 40 43a 43 44 47 48 49 
PS type : POCIS 
pharmaceut
ical version 
POCIS, 
pharmaceut
ical version 
Empore 
Disk  
POC
IS 
POCIS, 
pharmaceut
ical version 
POCIS, 
pesticide 
version 
CFIS 
(Continu
ous Flow 
Integrati
ve 
Sampler) 
Chemcatc
her (3rd 
generatio
n) polar 
configurat
ion 
POC
IS 
POCIS, 
pharmaceut
ical version 
POC
IS 
Altesil 
translucen
t silicone 
rubber (4 
sheets of 
100cm2 
each) 
Speedis
ks (2 
disks 
form 
one 
sampler
) 
POCIS, 
pharmaceut
ical version 
POC
IS 
Empore 
SDB-
RPS with 
PES-
Membra
ne 
(0.1um) 
POCIS, 
pharmaceut
ical version 
Home 
made or 
commer
cial PS : 
Commercial  Home 
made 
Commerc
ial 
hom
e 
mad
e 
commercial commer
cial 
Home 
made 
homemad
e 
hom
e 
mad
e 
Home 
made 
Hom
e 
mad
e 
Home 
made 
J.T. 
Baker, 
Bakerbo
nd 
Speedis
k, H2O 
Philic 
DVB, 
Art.nr.: 
8072-
07 
commercial Hom
e 
mad
e 
 Home 
made 
       Home 
made 
Chemcatc
her 
bodies: 
University 
of 
Portsmou
th (UK) 
 - Hom
e 
mad
e 
     Home 
made 
Supplier 
: 
Exposmeter  Phenome
nex 
 EST EST LABAQU
A S.A.  
Empore 
disk: 
VWR, 
Dresden 
(D); 
LDPE: 
University 
of 
Portsmou
th 
 - - Altecweb.c
om 
JT 
Baker 
ExposMeter 
AB, 
Sweden 
 Infochro
ma 
/ 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23
a 
23 30 36 37 39 40 43a 4
3 
44 47 48 49 
Receivin
g phase 
material: 
OASIS HLB sorbent 
Oasis 
HLB, 60 
μm  
SDB-RPS 
Reverse 
Phase 
Sulfonate
d 
Sepra ZT, 
Phenomenex
, 30 um, 85A 
Oasis 
HLB 
Biobeads, 
Ambersor
b and 
Isolute 
ENV+ 
Sorbent 
Oasis 
HLB 60 
μm 
Varian 
Empore 
SDB-RPS 
extractio
n disk 47 
mm 
Oasi
s 
HLB 
Oasis 
HLB 
sorbent
, 60 µm 
Oasis HLB 
60µm 
custom 
Bulk 
WAT10606
8 
AlteSilTM 
translucen
t material, 
0.5±0.05 
mm 
thickness 
DVB  OASIS 
HLB 
Styrene
-
divenyl-
benzene 
modified 
with 
sulfonic 
acid 
groups 
(SDB-
RPS) 
sorben
t Oasis 
HLB, 
60 μm  
Receivin
g phase 
mass 
(g): 
0,2 g 
approximativel
y 
0.200 g; 
mass of 
sorbent 
separate
d from 
samplers 
after 
exposure 
is given 
on each 
SPE 
cartridge 
0.398 300 0.22 0.22 0.2458 0.327 0.1 0.2 200 mg 14 0.95 0,200
g 
227m
g 
0.331 0.2 
Receivin
g phase 
volume 
(cm3) 
  1.73494    unknow
n  
0.344   - 12     / 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
1
7 
18 19 21 23a 23 30 36 37 39 40 43a 43 44 47 48 49 
Membr
ane 
materi
al : 
PE
S 
Polyethersu
lphone; 
SUPOR 100 
Membrane 
Disc Filters 
(0.1 μm, 90 
mm 
diameter) 
Polyether
sulfone 
(0.45um) 
SUPOR 
450 filters 
PALL Life 
Sciences 
polyethersul
fone, Pall 
corporation 
Polyethers
ulphone 
Polyethers
ulphone 
no 
memb
rane 
Pall Supor 
200 
polyether
sulfone 
polyethers
ulphone 
STERLITEC
H 0.45um 
Polyethersu
lphone; 
SUPOR 100 
Membrane 
Disc Filters 
(0.1 μm, 
90 mm 
diameter) 
PES 
Supor-
100, 0,1 
µm, 
90mm, 
100/PK 
Product#
60311 
Silicon 
rubber 
Glass
fibre 
Filter 
±0.5 
mm 
 Pall 
Polyether
sulfone 
Supor 
100, 
0.10um 
Polyether
sulfone 
(PES) 
Polyethersu
lphone; 
SUPOR 100 
Membrane 
Disc Filters 
(0,1 μm, 
90 mm 
diameter) 
Active 
sample
r 
surfac
e area 
(or 
membr
ane 
area) 
(cm2): 
45
.8 
41 cm2 16 45.8044208
9 
47.5 47.5 not 
apply 
15.9 14-Jan 42.47 45,78 
cm² 
400 35 45,8
cm2 
45.8cm2 12.6 45.8 
Performance Reference Compounds (PRC) 
Comm
ercial 
passiv
e 
sample
rs with 
PRC: 
no Deisopropyl
atrazine 
(DIA) d5 
  No No    NO no  No 
PRCs 
No   No 
or 
home 
made 
PS 
spiked 
with 
PRC:  
no concentrati
on cca. 
4ug/g 
sorbent 
 desisopropyl
atrazine d5 
  The 
receivi
ng 
phase 
materi
al 
does 
not 
contai
n PRC 
Pirimicarb
-D6; 
Diuron-
D6, 
Alachlor-
D13, 
Atrazine-
D5 (each 
500 
ng/disk) 
no NO Home 
made 
PRC : 
DIA-d3, 
Salbuta
mol-d3, 
Caffein-
C13 
(10µg/g) 
Home 
spiked,
D10-
biphen
yl, 
PCBs: 
CB001, 
CB002, 
CB003, 
CB010, 
CB014, 
CB021, 
CB030, 
CB050, 
CB055, 
CB078, 
CB104, 
CB145, 
CB204 
No 
PRCs 
 None 
used 
 No 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23a 23 30 3
6 
3
7 
39 40 43a 43 44 47 48 49 
Transport and storage 
Date of 
receipt by 
the study 
organiser
: 
26,04,20
11 
 14 May 
2011 
(Handove
r at 
conferenc
e) 
16-
May-
11 
  13/05/20
11 
  16.05.201
1 
16/05/20
11 
~13/05/20
11 
~13/05/20
11 
5/26/1
1 
 11/05/20
11 
19/05/20
11 
Storage 
condition
s before 
deployme
nt (°C): 
_ 20 °C  Fridge (4 
degrees 
C)  
- 20 
degre
es 
celsius 
  4ºC   room 
temperatu
re 
-20°C 4°C 
immersed 
in water 
4°C 
immersed 
in water 
freeze
r 
 4 Storage 
in fridge 
at 4°C 
Storage 
condition
s after 
sampler 
recovery 
(°C): 
_ 20 °C  Fridge (4 
degrees 
C)  
- 20 
degre
es 
celsius 
  4ºC   -20 -20°C minus 
20°C 
minus 
20°C 
freeze
r 
  Storage 
in freezer 
at -20°C 
Date of 
return 
shipment 
from the 
organiser 
to the 
participan
t 
laborator
y: 
 26.07.20
11 
21/07/20
11 
13-
Jul-11 
  15/06/20
11 
  15.06.201
1 
15/06/20
11 
~31/8/201
1 
~31/8/201
1 
6/23/1
1 
 15/06/20
11 
07/07/20
11 
Date of 
receipt by 
the 
participan
t 
laborator
y: 
24/06/20
11 
28.07.20
11 
26/07/20
11 
15-
Jul-11 
21/06/20
11 
21/06/20
11 
16/06/20
11 
  16.06.201
1 
16/06/20
11 
~2/9/2011 ~2/9/2011 6/23/1
1 
03/08/20
11 
16/06/20
11 
08/07/20
11 
REMARKS
: 
         - - Dates are 
approximat
e 
Dates are 
approximat
e 
   / 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 1
8 
19 21 23a 23 30 3
6 
3
7 
39 40 43a 43 44 4
7 
48 49 
Sampler deployment and recovery 
Date and 
hour of the 
deploymen
t: 
30/05/11 
15h55 
 30/05/2011
; 19:50 
30/05/201
1 17:40 
30.5.2011
, 16:15 
30.5.2011
, 16:15 
5/30/1
1 
11:50 
  30.05.201
1 15:10 
30/05/201
1 15:10 
30/05/201
1 
30/05/201
1 
5/30/11
, 14:30 
 30/05/201
1 20:20 
30/05/201
1 at 16:28 
Air Temp 
on 
deploymen
t (°C) 
23  21 21 23 23 14   23 23   23°C  20 23.5 
Duration of 
the 
deploymen
t (exposure 
to air for 
field 
control) 
25 
minutes 
 27 min 30  
minutes 
00:15 00:15 50 min   20 min 00:35   25 min  30 min 29 min 
Air Temp 
on 
recovery 
(°C) 
23  23 23 22 22 15   22 23   23°C  23 22 
Duration of 
the 
recovery 
(exposure 
to air for 
field 
control) 
50 
minutes 
 20 min 24 
minutes 
00:40 00:40 0 min   30 min 00:23   18 min  11 min 32 min 
Date and 
hour of the 
recovery: 
13/06/201
1 14h40 
 13/06/2011
: 15:28 
13/06/201
1 13:55 
13.6.2011
, 12:42 
13.6.2011
, 12:42 
6/13/1
1 
12:25 
  13.06.201
1 13:22 
13/06/201
1 13:22 
13/06/201
1 
13/06/201
1 
6/13/11
, 14:17 
 13/06/201
1 17:37 
13/06/201
1 at 12:43 
Comment 
on fouling: 
   no fouling      Exposed 
membrane
s were 
spotted 
and darker 
than 
unexposed 
ones 
-      Not much 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23a 23 30 36 37 39 40 43a 43 44 47 48 49 
Field 
deploym
ent 
device 
used: 
canister 
(exposm
eter) 
standar
d 
POCIS 
deploy
ment 
cage for 
3 
sampler
s 
Teflon 
Chemcat
cher 
case 
big 
cage 
provid
ed by 
WRI 
standa
rd big 
cage 
standa
rd big 
cage 
CFIS 
device 
Small 
SPMD 
deploy
ment 
cage 
standard 
POCIS 
cage 
Standar
d 
POCIS 
deploy
ment 
cage for 
3 
sampler
s 
standard 
small cage 
for 3 
samplers 
Wet 
mounte
d on 
open 
cage 
Wet mounted on 
open cage 
standar
d POCIS 
deploy
ment 
cage 
standard 
POCIS 
deployment 
cage for 3 
samplers 
Big 
cage 
(provid
ed by 
WRI) 
standar
d POCIS 
deploy
ment 
cage for 
6 
sampler
s 
Extracti
on 
techniqu
e: 
elution 
methanol 
SPE, 3 
mL of 
MeOH 
and 3 
mL 
MeOH:e
thyl 
acetate, 
75:25 
sonicatin
g disk in 
5 mL 
Acetone 
followed 
by 5 mL 
methano
l at room 
temperat
ure. 
Extracts 
combine
d.  
sorbe
nt 
rinsed 
with 
+/- 
10 ml 
milli Q 
into 
empty 
glass 
colum
n with 
PTFE 
frit, 
drying 
10 
minut
es (-
50 
kPa), 
elutio
n with 
3x 
4ml 
metha
nol 
liquid 
extrac
tion 
(2x 
15ml 
MeOH) 
liquid 
extrac
tion 
Solvent 
extracti
on 
(MeOH) 
3 x 15 
min 
ultrason
ic 
extracti
on with 
5 ml in 
1.aceto
ne 
2.MeOH 
3.mixtu
re of 
both 
(1:1)  
2 x 10mL 
90% 
methanol 
(15 min 
in 
ultrasoni
c bath), 
then 
evaporati
on of 
solvent, 
reconstit
ution and 
analysis 
5 mL 
MeOH - 
5 mL 
MeOH/
DCM 
(50/50) 
- 5 mL 
DCM 
elution 
with 
Methanol 
and 
dichlorome
thane 
Extracti
on by 
soxhlet 
with 
acetonit
ril 
Elution with 15 
ml 
methyltertiarybu
tylether followed 
by 20 ml DCM 
and finally with 
15 ml methanol 
3x 
ultrason
ic 
extracti
on 
(70%) 
MeOH 
In column 
extraction 
with 80/20 
Dichlorometha
ne/IPA 
7 mL 
Acetone
, 7 mL 
Methan
ol 
SPE 
Date of 
extracti
on: 
27/06/20
11 
 22/08/2
011 
29-
Sep-
11 
  08/03/2
011 
05/07/2
011 
20/10/20
11 
12.09.2
011 
12/09/201
1 
20/10/2
011 
20/10/2011 13/12/2
011 
12/12/2011 19/08/2
011 
25/07/2
011 
Date of 
instrum
ental 
analysis: 
23/08/20
11 
 05/09/2
011 
18-
Oct-
11 
  08/03/2
011 
28/09/2
011 
21/10/20
11 
15.09.2
011 
24/09/201
1 
27/10/2
011 
27/10/2011 05/01/2
012 
10/01/2012 22/08/2
011 
23/09/2
011 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 2
1 
23a 23 30 36 37 39 40 43a 43 44 47 48 49 
Cleanup 
method: 
no none Filtratio
n 
throug
h PFTE 
filter 
(0.45u
m) 
 no no Extrat 
filtered 
with 
0.2 μm 
PVDF 
membr
ane  
NaSO4, 
0.45 µm 
cellulose 
acetate 
membran
e 
no No 
cleanup 
no none No  No clean up  / 
Instrume
ntal 
method: 
UPLC/MS
/MS 
HPLC-
MS/MS 
LCMS LC-
MS 
LC/MS/M
S 
LC/MS/M
S 
HPLC-
MS/MS  
LC-
MS/MS 
LC-MS/MS LC-MS-
MS 
LC-MS/MS LC-MSMS LC-
MSMS 
LC/MS/MS, 
ESI+, 
column: 
Betasil 
C18, Mobile 
phase: 
gradient 
water 5mM 
NH4COOH, 
MeOH 5mM 
NH4COOH 
LCMS QQQ 
and GCMS 
(for 
Atrazine) 
online 
SPE 
(Oasis 
HLB) 
HPLC-
MS/MS 
LC-
MS/
MS 
Injection 
solvent: 
MEOH Water:Me
CN, 
90:10 
50% 
metha
nol/ 
water 
mil
li Q 
MeOH/w
ater 
MeOH/w
ater 
Methan
ol/ 
Water 
MeOH 75% 
methanol/
25% 5mM 
ammoniu
m acetate 
MeOH Methanol Acetontril
e water 
Acetonitr
ile-water 
methanol:
water 5mM 
NH4COOH 
(1:1) 
In mobile 
phase 
except for 
Atrazine 
which was in 
Hexane 
HPLC 
grade 
Water, 
Methan
ol 
Wate
r 
Recovery 
and 
internal 
standard
s used: 
Simazine 
d10 
No 
correctio
n with 
recoverie
s, use of 
internal 
standards 
IS: 
25ng 
d-
simazin
e, RS: 
12ng 
d-
atrazin
e 
 IS = C13 
labelled 
Simazin, 
RS not 
used 
IS = C13 
labelled 
Simazin, 
RS not 
used 
Atrazin
e-D5 
Acenapht
ene-D10; 
HCB-
13C6 
yes Simazine 
d10, 
Hexazino
ne d6, 
Diuron 
d6, 
Atrazine 
d5, 
Terbutyla
zine d5, 
Irgarol d9 
alachlor-
d13, 
atrazine-d5, 
hydroxyatra
zine-d5, 
carbofuran-
d3, 
cyanazine-
d5, dea-d7, 
diuron-d6, 
hexazinone-
d6, irgarol-
d9, 
isoproturon-
d6, 
simazine-
d10, 
terbutylazin
e-d5 
Diverse 
stantand
ards but 
not 
targets, 
receoveri
es vary 
Several 
standard
s used 
but 
generaal
y not 
the 
target 
compou
nds, 
Therefor
e no 
correctio
ns were 
made. 
internal 
standards: 
Atrazine 
D5, 
Isoproturon 
D6, 
Simazine 
D5, 
Terbutryn 
D5 
YES - 
Deuterated 
(D5) 
Atrazine, 
(D6) Diuron 
and 
(D3)Carbend
azim 
Labeled 
IS used 
for 
every 
compo
und 
analyse
d 
/ 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23a 23 30 36 37 39 40 43a 43 44 47 48 49 
REMARKS:       The extracts obtained were 
diluted to analyze. Dilutions 
were performed: 1:2, 1:10 
and 1:20.  
  - - No corrections for 
suppression 
made 
No corrections for 
suppression 
made 
 Matrix interference made 
quantification of Atrazine 
problematic 
 / 
 
Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
1
7 
18 19 21 23
a 
2
3 
30 36 37 39 40 43a 43 44 47 4
8 
49 
Data evaluation aspects 
Method for 
estimation 
of water 
concentrat
ion from 
passive 
sampler: 
 Data in 
ng/g, 
determinati
on of TWA 
concentrati
ons with 
application 
of ku 
(Lissalde et 
al. 2011) 
and PRC 
(Mazzella 
et al. 
2010) data 
Eds were 
deployed in 
association 
with PFMs. 
Water 
concentrati
ons of 
identified 
chemicals 
were 
estimtated 
from the 
mass 
accumulate
d in the 
sampler 
using 
laboratory 
derived 
sampling 
rates 
adjusted in 
situ with 
the 
calibrated 
loss of 
plaster 
from the 
PFMs 
accordi
ng to 
Mazzell
a et al. 
ES&T, 
vol. 44, 
no5, 
2010 
eq 2 
and 6, 
DIAd5 
PRC 
Log 
Ksw 
3.85 
  One the 
pesticide 
amount 
in the 
receiving 
phase, 
determin
ed in the 
analysis, 
% 
recoverie 
and 
sample 
volume 
(determi
ned by 
meas of 
data in 
the 
electronic 
board) is 
applyed 
to 
calculate 
the 
TWAC. 
flow-
depend
ent 
regressi
on over 
literatur
e values 
(if Rs 
not 
availabl
e) 
TWA 
calculat
ed 
accordi
ng to 
Alvarez 
2004 
Calculati
on with 
followin
g 
formula 
: Cs x 
0,2 = 
Cw Rs t 
(Vrana 
et al., 
2005) 
PRC 
aproach 
using 
Salbutam
ol-d3, 
Caffein-
C13 and 
DIA-d5 
Fitting 
PRC 
dissipati
on with 
model 
and a 
flowfact
or as 
adjustab
le 
paramet
er. Then 
this flow 
factor is 
applied 
to 
calculate 
the Cw 
Uptake of 
Clotrimaziol
e, 
Carbamezap
ine, 
Thiabendazo
l and 
Fluoranthen
e transfered 
to sampled 
volume 
using Cw 
from SR 
sampling 
N.Mazzella, 
S. Lissalde, 
S. Moreira, 
F. Delmas, P. 
Mazellier, 
J.N. Huckins: 
Environ. Sci. 
Technol. 
2010, 44, 
1713–1719. 
For Diuron: 
N. Mazzella, 
J.-F. 
Dubernet, F. 
Delmas: 
Journal of 
Chromatogra
phy A 2007, 
1154,) 42–
51 
Estimati
on of 
water 
calculati
on not 
used 
 To obtain 
laboratory Rs: Plot 
of the 
concentration 
factor as a function 
of the time until 
the t1/2: 
CF=Cs/Cw=(Rs*t)/
(Ms). Use of this 
lab Rs in order to 
obtain in situ TWA 
concentrations 
using the equation 
Cw=(Cs*Ms)/(Rs*t
) 
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Table AII- 1 (continued) Participant passive samplers of polar pesticides: method information 
LAB 
No. 
17 18 19 21 23
a 
23 30 36 37 39 40 43a 43 44 4
7 
48 49 
Sampling 
rates used 
(literature 
value/ow
n 
calibration
): 
litterat
ure 
Lissal
de et 
al. 
2011 
own 
calibrat
ion 
literat
ure 
value 
Mazze
lla 
2007, 
Mazze
lla 
2008 
Alvar
ez et 
al. 
2007 
Analyte 
recovery: 
Atrazine 
(97%), 
Diuron 
(94%) and 
Terbuthyla
zine 
(92%).  
Sample 
volume 2 
L. 
literature 
values for 
pesticides 
and 
pharmaceut
icals 
own 
calibrat
ion 
Sampling 
rates from 
Lissalde et 
al., 2011 
were used 
own 
calibrat
ion 
From 
PRCs 
using 
Rusina Est 
2010 and 
Booij and 
Smedes 
EST 2010 
From 
calibratio
n with SR 
results 
Sampled 
volume 
2.2, 2.8 
and 3.1 L 
Rs[L/d]- 
literature 
values: 
Environ.Sci. 
Technol.- Rs 
(DEA)=0,167, 
Rs 
(DET)=0,205, 
Rs(Atrazine)=0
,239, Rs(S-
Metolalchlor)=0
,225. 
J.Chromatograp
hy A: Rs 
(Diuron)=0.247
. Rs for 
carbendazim 
not found. 
N/
A 
own, 
unpublis
hed data 
(betwee
n 0.078 
and 
0.094) 
Own calibration: 
ATRA=0,1891 
L/d; 
CARB=0,2949 
L/d; 
DIU=0,1976 L/d 
Ksw used:  No no log 
Ksw 
3.85 
No No no 
necessary.  
NO - - - Smedes 
et al EST 
2009 
none  N/
A 
 / 
PRCss 
applied 
(YES/NO):  
no YES no yes No No No  NO no NO YES Yes NO No NO  NO 
Were the 
calibration 
data 
adjusted 
to reflect 
exposure 
conditions 
(temperat
ure, flow, 
pH...?) 
no Yes flow/ 
salinity 
through 
the use 
of the 
PFM 
no No No No  average 
flow was 
estimated 
with PFM: 
O'Brien et 
al., 
Chemosphe
re 83 (9), 
2011 
no NO PRC Flow 
corrected 
(not 
Temperat
ure) 
Only an 
attempt 
to correct 
for flow 
No N/
A 
 No (laboratory 
calibration: 
temperature=20
,7°C; pH=7,6; 
conductivity=42
9 µS/cm; 
DOC=13,3 
mg/L; flow=11 
cm/s) 
REMARKS:     Results of 
instrument 
control and of 
samplers 
provided by 
the organizer 
are in the first 
report form. 
Only 2 
CFIS 
devices 
have been 
analyzed 
because 
one 
broken 
and stoped 
in the 
sampling .  
PRC not 
used for 
Ctwa-
calculation 
 concentrat
ions in 
sorbent 
were 
calculated 
with a 
nominal 
mass of 
0,2g 
- Preliminar
y Kpw 
used, 
some 
estimated 
some 
determine
d 
Not very 
confident 
on 
samplingr
ate 
applied 
   / 
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Annex III. Provided passive samplers of pharmaceuticals: method information 
 
TableAIII-1 Provided passive samplers of pharmaceuticals: method information 
LAB No. 17 19 23a 23 29 31 32 36 39 40 43a 43 44 47 48 49 50a 50 
Passive sampler (PS) 
PS type : POCIS, pharmaceutical version 
Receiving phase material: sorbent Oasis HLB, 60 um  
Receiving phase mass (g): 0.200 g; mass of sorbent separated from samplers after exposure is given on each SPE cartridge 
Membrane material : Polyethersulphone; SUPOR 100 Membrane Disc Filters (0.1 um, 90 mm diameter) 
Active sampler surface area (or membrane area) (cm2): 45.8 cm2 
Performance and Reference Compound (PRC) * 
Passive samplers with PRC : Deisopropylatrazine (DIA) d5 
 concentration cca. 4ug/g sorbent 
Transport and storage 
Storage conditions before deployment (°C)**: Fridge (4 degrees C) 
 
  
  
 
171 
TableAIII- 2 Provided passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23
a 
23 2
9 
3
1 
3
2 
3
6 
39 40 43a 43 44 47 48 49 50
a 
50 
Storage 
conditions 
after 
sampler 
recovery 
(°C)**: 
 Fridge (4 
degrees 
C)  
      -20 -20°C   freezer   Storage in 
freezer at 
-20°C 
  
Date of 
return 
shipment 
from the 
organiser 
to the 
participant 
laboratory:
** 
 21/07/20
11 
      18.07.20
11 
18/07/20
11 
~31/8/201
1 
~31/8/201
1 
   07/07/20
11 
  
Date of 
receipt by 
the 
participant 
laboratory 
** : 
29/07/20
11 
26/07/20
11 
 21/06/20
11 
    19.07.20
11 
19/07/20
11 
~2/9/2011 ~2/9/2011 10/25/1
1 
03/08/20
11 
22/07/20
11 
08/07/20
11 
Augus
t, 5th 
Augus
t, 5th 
REMARKS:         - - Dates are 
approxima
te 
Dates are 
approxima
te 
   /   
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TableAIII- 2 (continued) Provided passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 32 36 39 40 43a 43 44 47 48 49 50a 50 
Sampler deployment and recovery 
Date and 
hour of the 
deployment 
** : 
30/05/2011 30/5/2011; 
11:10am, 
11:10am, 
11:50am 
 30.5.2011, 
10:35 
    30.05.2011 
11:30 
samplers 
88, 83 : 
30/05/2011  
12:25 ; 
sampler 53 
: 
30/05/2011 
11:50 
20/06/2011 20/06/2011 (16)  
5/30/11, 
10:35   
(20)  
5/30/11, 
10:35         
(59) 
5/30/11, 
11:50 
 Sampler 
43: 
30.05.2011 
11:10 
Sampler 
54: 
30.05.2011 
11:50 
Sampler 
75: 
30.05.2011 
12:25 
Sample 67: 
30/05/2011 
at 11:50; 
sample 84: 
30/05/2011 
at 12:25; 
sample 95: 
30/05/2011 
at 12:25 
  
Air Temp 
on 
deployment 
(°C)** 
 21-22  00:00     00:00:00 samplers 
88, 83 : 22 
; sampler 
53 : 22 
  (16) 
20°C                  
(20) 
20°C                        
(59) 
21°C 
 Sampler 
43: 21; 
Sampler 
54, 75: 22 
Sample 67: 
22°C; 
sample 84: 
22,5°C; 
sample 95: 
22,5°C 
  
Duration of 
the 
deployment 
(exposure 
to air for 
field 
control)** 
 35mins, 
35mins, 
40mins 
 00:45:00     30 min samplers  
88, 83 : 
00:35 ; 
sampler 53 
: 00:40 
  (16) 45 
min               
(20) 45 
min                      
(59) 40 
min 
 Sampler 
43: 35min 
Sampler 
54: 30min 
Sampler 
75: 35min 
Sample 67: 
40 min; 
sample 84: 
35 min; 
sample 95: 
35 min 
  
Air Temp 
on 
recovery 
(°C)** 
 20-21  00:00     00:00:00 samplers 
88, 83 : 21 
; sampler 
53 : 20 
  (16) 
18°C                  
(20) 
18°C                        
(59)  
20°C 
 Sampler 
43, 54: 21; 
Sampler 
75: 22 
Sample 67: 
21°C; 
sample 84: 
21,5°C; 
sample 95: 
21,5°C 
  
Duration of 
the 
recovery 
(exposure 
to air for 
field 
control)** 
 9, 9, 16 
mins 
 00:40:00     30 min samplers 
88, 83 : 
00:30 ; 
sampler 53 
: 00:17 
  (16) 39 
min               
(20) 39 
min                      
(59) 17 
min 
 Sampler 
43: 9min 
Sampler 
54: 17min 
Sampler 
75: 30min 
Sample 67: 
17 min; 
sample 84: 
30 min; 
sample 95: 
30 min 
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TableAIII- 2 (continued) Provided passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 2
9 
31 32 36 39 40 43a 43 44 4
7 
48 49 50
a 
5
0 
Date 
and 
hour of 
the 
recove
ry ** : 
13/06/201
1 
13/6/2011
; 10:34, 
10:34, 
10:43am 
 13.6.201
1, 9:16 
    13.06.2011 
10:00 
sample
rs 88, 
83 : 
13/06/
2011  
11:30 
; 
sample
r 53 : 
13/06/
2011 
10:43 
04/07/2011 04/07/201
1 
(16) 
6/13/11,  
9:16     
(20) 
6/13/11,  
9:16           
(59) 
6/13/11, 
10:43 
 Sampler 43: 
13.06.2011 
10:34 
Sampler 54: 
13.06.2011 
10:43 
Sampler 75: 
13.06.2011 
11:30 
Sample 
67: 
13/06/2
011 at 
10:43; 
sample 
84: 
13/06/2
011 at 
11:30; 
sample 
95: 
13/06/2
011 at 
11:30 
  
Comm
ent on 
fouling
*: 
        Exposed 
membranes 
were 
spotted 
and darker 
than 
unexposed 
ones 
-      Not 
much 
  
Field deployment device used 
Type of 
deploy
ment 
device 
(canist
er, 
cage...
) : 
standard POCIS deployment cage for 6 samplers 
Analytical aspects 
Extract
ion 
techniq
ue: 
elut
ion 
Me
OH 
Elution 
of 
cartridg
es with 
3mL 
methan
ol, 2 ml 
acetonit
rile, 2 
ml 
acetone 
 liquid 
extracti
on 
same 
as 
NIVA 
sampl
ers 
 SPE 3 x 15 
min 
ultraso
nic 
extracti
on with 
MeOH 
5 mL 
MeOH - 
5 mL 
MeOH/D
CM 
(50/50) 
- 5 mL 
DCM 
elution with 
Methanol 
and 
dichloromet
hane 
Elution with 4 ml 
methyltertiarybutyl
ether followed by 8 
ml methanol 
Elution with 4 
ml 
methyltertiarybu
tylether followed 
by 8 ml 
methanol 
3x5 
ml 
100
% 
MeO
H 
SPE column 
extraction with 
80/20/0.1 
(Dichloromethane/I
PA/TFA) 
5 mL 
Meth
anol 
SPE SPE SPE 
  
 
174 
TableAIII- 2 (continued) Provided passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 2
3a 
23 2
9 
3
1 
32 36 39 40 43a 43 44 47 48 49 50a 50 
Date of 
extracti
on: 
08/08/
2011 
29/08/
2011 
    17/08/
2011 
15/11/
2011 
12.09.201
1 
12/09/2
011 
20/10/2
011 
20/10/2
011 
13/12/2011 09/12/201
1 
19/08/2
011 
25/07/2011 october, 
13th 
october, 
13th 
Date of 
instrum
ental 
analysis: 
11/08/
2011 
05/09/
2011 
      19.09.201
1 
12/09/2
011 
27/10/2
011 
27/10/2
011 
06/01/2012 07/01/201
2 
22.08.2
011 
(29.11.
2011 
for DIA) 
23/09/2011 
for all the 
pharmaceut
icals except 
for 
atenolol: 
09/09/2011 
novemb
er, 11th 
novemb
er, 11th 
Cleanup 
method: 
no   no   no 
cleanup 
NaSO4, 
0.45 
µm 
cellulos
e 
acetate 
membr
ane 
No 
cleanup 
no No No  No clean 
up 
 / - - 
Instrum
ental 
method: 
uplc/ms
ms 
LCMS  LC/MS/MS   HPLC-
MS/MS 
LC-
MS/MS 
LC-MS-MS 
(ESI + 
and -) 
LC-
MS/MS 
LC-
MSMS 
LC-
MSMS 
LC/MS/MS,ES
I+/ESI-, 
column: 
Zorbax 
Eclipse XDB 
C18, Mobile 
phase: 
gradient: 
water 0,2% 
CH3COOH, 
MeOH 0,2% 
CH3COOH 
LCMS 
QQQ  
online 
SPE 
(Oasis 
HLB) 
HPLC-
MS/MS 
LC-MS/MS HPLC-
MS/MS 
HPLC-
MS 
Injectio
n 
solvent: 
MEOH 50% 
methan
ol/ 
water 
 MeOH/wate
r 
  MeOH:
H2O 
MeOH Milli-Q 
Water 
(ESI+) or 
ACN (ESI-
) 
Methanol Acetonit
rile-
water 
Acetonit
rile-
water 
MeOH:water 
0,2% 
CH3COOH 
(1:1) 
In mobile 
phase  
HPLC 
grade 
Water, 
Methan
ol 
Water for 
all the 
pharmaceut
icals except 
for 
atenolol: 
Water/Acet
onitrile 
(99/1) + 
metoprolol 
impurity A 
methano
l 
methano
l 
Recover
y and 
internal 
standard
oxazep
am d5 
No 
recover
y 
correcti
 IS = C13 
labelled 
Sulfametho
xazol, RS 
  none  Carbamaz
epine 
d10, 
Diazepam 
diazepa
m-d5, 
diclofena
c-d4, 
Several 
standar
ds used 
but 
Several 
standar
ds used 
but 
Int.stand.: 
Diclofenac 
D4, Ibuprofen 
D3,Carbamaz
YES - 
Deuterate
d 
(D7)Ateno
Labeled 
IS used 
for 
every 
/ only 
check on 
internal 
standard
only 
check on 
internal 
standard
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s used: on not used d5, 
Atenolol 
d7, 
Nordiazep
am d5, 
Ketoprofe
n d3, 
Naproxen 
d3, 
Ibuprofen 
d3, 
Diclofenac 
d4 
ibuprofe
n-d3, 
ketoprof
en-d3, 
naproxe
n-d3, 
nordiaze
pam-d5 
generaa
ly not 
the 
target 
compou
nds, 
Therefo
re no 
correcti
ons 
were 
made. 
generaa
ly not 
the 
target 
compou
nds, 
Therefo
re no 
correcti
ons 
were 
made. 
epine D10 lol, (D10) 
Carbamaz
epine, 
(D5) 
Diclofenac
, (D3) 
Ibuprofen 
compou
nd 
analyse
d 
s s 
REMARK
S: 
        - - No 
correcti
ons for 
suppres
sion 
made 
No 
correcti
ons for 
suppres
sion 
made 
 Matrix 
interferenc
e made 
quantificat
ion of 
Atenolol 
problemati
c. 
Ibuprofen 
was not 
present 
above our 
detection 
limits 
 / DIA-d5 
is not 
used for 
quantific
ation 
DIA-d5 
is not 
used for 
quantific
ation 
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TableAIII- 2 (continued) Provided passive samplers of pharmaceuticals: method information 
LAB 
No. 
1
7 
19 23a 23 2
9 
31 32 36 39 40 43a 43 44 47 48 49 50a 50 
Data evaluation aspects 
Method 
for 
estimatio
n of 
water 
concentr
ation 
from 
passive 
sampler: 
m/R
st 
Cw = 
Ns/(Rs
*t) 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
Sam
e as 
for 
POC
IS 
fro
m 
NIV
A 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
The 
rough 
estimat
ion of 
4,2 L is 
based 
upon a 
report 
by 
Roberts 
& 
Balaam 
·       
Roberts
, P.H., 
Balaam
, J.L, 
2006. 
Offline 
extracti
on and 
passive 
samplin
g. 
Modelk
ey 
progres
s report 
SSPI-
CT-
2003-
511237
-2. 
 
They 
found 
water 
extracti
ons 
betwee
n 50 
and 
300 ml 
Literat
ure 
values 
Calcula
tion 
with 
followin
g 
formula 
: Cs x 
0,2 = 
Cw Rs t 
(Vrana 
et al., 
2005) 
PRC 
aproach 
using 
Salbuta
mol-d3, 
Caffein-
C13 and 
DIA-d5 
Uptake of 
Clotrimazio
le, 
Carbameza
pine, 
Thiabendaz
ol, 
transfered 
to sampled 
volume 
using Cw 
from SR 
sampling 
Uptake of 
Clotrimazio
le, 
Carbameza
pine, 
Thiabendaz
ol, 
transfered 
to sampled 
volume 
using Cw 
from SR 
sampling 
 S.L. 
Bartelt-
Hunt, 
D.D.Snow, 
T. Damon-
Powel at 
all:Environ
mental 
Toxicology 
and 
Chemistry, 
Vol. 30, No. 
6, pp. 
1412–1420, 
2011. For 
diclofenac 
was used Rs 
from: S.L. 
Mac Leod, 
E.L. Mc 
Clure, Ch.S. 
Wong: 
Environmen
tal 
Toxicology 
and 
Chemistry, 
Vol. 26, No 
Estima
tion of 
water 
calcula
tion 
not 
used 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
To obtain 
laboratory Rs: 
Plot of the 
concentration 
factor as a 
function of the 
time until the 
t1/2: 
CF=Cs/Cw=(Rs*
t)/(Ms). Use of 
this lab Rs in 
order to obtain 
in situ TWA 
concentrations 
using the 
equation 
Cw=(Cs*Ms)/(Rs
*t) 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
please 
give a 
short 
descrip
tion 
and 
relevan
t 
referen
ces 
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TableAIII- 2 (continued) Provided passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23
a 
23 2
9 
3
1 
3
2 
36 39 40 43a 43 44 4
7 
4
8 
49 50a 50 
Sampling 
rates 
used 
(literatur
e 
value/ow
n 
calibratio
n): 
littérat
ure 
Literature (Li et 
al, 2010; 
MacLeod et al , 
2007; Togola et 
al 2007). 
Atenolol = 0.094, 
carbamazepine=
0.561, 
diazempam=0.28
, 
diclofenac=0.166
, 
ibuprofen=0.348, 
Naproxen=0.392 
 MacLe
od, 
McClur
e, 
Wong 
2007, 
Rs just 
for 
Pharm. 
POCIS 
   literature 
values for 
pesticides 
and 
pharmaceuti
cals 
Own 
calibration 
for 
Carbamaze
pine and 
Diclofenac, 
literature 
values 
(Togola 
and 
Budzinski, 
2007- Li et 
al., 2009) 
for other 
compounds 
own 
calibrati
on 
From 
calibrati
on with 
SR 
results, 
Sample
d 
volume 
= 3.0, 
3.6, 3.4  
L 
From 
calibrati
on with 
SR 
results, 
Sample
d 
volume 
= 3.0, 
3.6, 3.4  
L 
literature 
values 
Rs[L/d]: 
ibuprofen 
0,400; 
carbamaz
epin 
0,288 
;diclofena
c 0,166 
(flowing 
Rs) 
N/
A 
 Own 
calibration: 
ATE=0,021
8 L/d; 
CARBA=0,1
876 L/d; 
DICLOF=0,2
248 L/d; 
KETO=0,12
13 L/d; 
NAPRO=0,0
838 L/d 
Journal of 
Chromatogr
aphy A, 
1216 (2009) 
623-630 and 
Enviromenta
l Toxicology 
and 
Chemistry, 
Vol. 29, No. 
4, pp.751-
762,2010 
and 
Estuarine, 
Coastal and 
Shelf 
Science xxx 
(2011) 1-11 
(article in 
press) 
Journal of 
Chromatogr
aphy A, 
1216 (2009) 
623-630 and 
Enviromenta
l Toxicology 
and 
Chemistry, 
Vol. 29, No. 
4, pp.751-
762,2010 
Sampler/w
ater 
partition 
(distributio
n) 
coefficients 
used: 
 No      NO - - none none  N/
A 
 /   
Performanc
e reference 
compounds 
applied 
(YES/NO):  
no No  No    NO NO YES NO NO No NO  NO  No 
Were the 
calibration 
data 
adjusted to 
reflect 
exposure 
conditions 
(temperatu
re, flow, 
pH...?) 
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Annex IV. Participant passive samplers of polar pharmaceuticals: method 
information 
 
Table AIV- 1 Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
PS type : POCIS 
pharmaceutic
al version 
Empore 
Disk 
POCIS, 
pharmaceutic
al version 
POCIS, 
pesticide 
version 
POCI
S 
POCIS Filled 
with OASIS 
HLB Material 
Chemcatch
er (3rd 
generation) 
polar 
configurati
on 
POCIS, 
pharmaceutic
al version 
POCI
S 
Altesil 
translucent 
silicone 
rubber (4 
sheets of 
100cm2 
each) 
Speedisk
s (2 
disks 
form one 
sampler) 
POCIS, 
pharmaceutic
al version 
POCI
S 
Empore 
SDB-RPS 
with PES-
Membran
e (0.1um) 
POCIS, 
pharmaceutic
al version 
Home 
made or 
commerci
al PS : 
commercial Commercia
l 
commercial commerci
al 
home 
made 
Home made 
with parts 
from 
Environment
al Sampling 
Technologies 
homemade Home made Hom
e 
made 
Home made J.T. 
Baker, 
Bakerbon
d 
Speedisk
, H2O 
Philic 
DVB, 
Art.nr.: 
8072-07 
commercial Hom
e 
made 
 Home made 
       Chemcatch
er bodies: 
University 
of 
Portsmouth 
(UK) 
- Hom
e 
made 
     Home made 
Supplier : Exposmeter Phenomen
ex 
EST EST  Environment
al Sampling 
Technologies
, St Joseph, 
MO, USA 
Empore 
disk: VWR, 
Dresden 
(D); LDPE: 
University 
of 
Portsmouth 
- - Altecweb.co
m 
JT Baker ExposMeter 
AB, Sweden 
 Infochro
ma 
/ 
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Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Receivi
ng 
phase 
materi
al: 
OASIS HLB SDB-RPS 
Reverse 
Phase 
Sulfonated 
Oasis HLB Biobeads, 
Ambersorb 
and Isolute 
ENV+ 
OASIS HLB Waters 
OASIS HLB 
Varian 
Empore 
SDB-RPS 
extraction 
disk 47 
mm 
Oasis HLB 
sorbent, 60 
µm 
Oasis HLB 
60µm 
custom 
Bulk 
WAT10606
8 
AlteSilT
M 
translu
cent 
materia
l, 
0.5±0.
05 mm 
thickne
ss 
DVB Oasis 
HLB 
OASIS HLB Styrene-
divenyl-
benzene 
modified 
with 
sulfonic 
acid groups 
(SDB-RPS) 
sorbent 
Oasis HLB, 
60 μm  
Receivi
ng 
phase 
mass 
(g): 
0,2 
approxima
tively  
0.398 0.22 0.22 0.2 0.200 0.327 0.2 200 mg 14 0.95 0,200
g 
227mg 0.331 0.2 
Receivi
ng 
phase 
volume 
(cm3) 
 1.73494     0.344  - 12     / 
Membr
ane 
materi
al : 
PES Polyethers
ulfone 
(0.45um) 
SUPOR 450 
filters PALL 
Life 
Sciences 
Polyethersul
phone 
Polyethersul
phone 
polyethersul
phone 
Polyethers
ulfone 
Pall Supor 
200 
polyethers
ulfone 
Polyethersulp
hone; SUPOR 
100 
Membrane 
Disc Filters 
(0.1 μm, 90 
mm 
diameter) 
PES 
Supor-
100, 0,1 
µm, 
90mm, 
100/PK 
Product#6
0311 
Silicon 
rubber 
Glassfi
bre 
Filter 
±0.5 
mm 
 Pall 
Polyethers
ulfone 
Supor 100, 
0.10um 
pore size 
Polyethers
ulfone 
(PES) 
Polyethersulp
hone; SUPOR 
100 
Membrane 
Disc Filters 
(0,1 μm, 90 
mm 
diameter) 
Active 
sample
r 
surface 
area 
(or 
membr
ane 
area) 
(cm2): 
45.8 16 47.5 47.5 45.8 45.8 cm2 15.9 42.47 45,78 cm² 400 35 45,8c
m2 
45.8cm2 12.6 45.8 
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Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Performance Reference Compounds (PRC) 
Commerc
ial 
passive 
samplers 
with PRC: 
no  No No no Atrazine 
desethylpr
opyl D5 
provided 
by the 
organizer 
 NO no  No PRCs No   No 
or home 
made PS 
spiked 
with PRC:  
no    no prc  Diuron-
D6; 
Carbamaz
epime-D10 
(each 500 
ng/disk) 
NO Home 
made PRC 
: DIA-d3, 
Salbutamo
l-d3, 
Caffein-
C13 
(10µg/g) 
Home 
spiked,D1
0-
biphenyl, 
PCBs: 
CB001, 
CB002, 
CB003, 
CB010, 
CB014, 
CB021, 
CB030, 
CB050, 
CB055, 
CB078, 
CB104, 
CB145, 
CB204 
No PRCs  None used  No 
Transport and storage 
Date of 
shipment 
to the 
organiser
: 
 approx 7 
May 2011  
07/06/201
1 
07/06/201
1 
? End of 
May, 2011 
 13.05.201
1 
13/05/201
1 
~10/05/20
11 
~10/05/20
11 
5/26/11  10/05/201
1 
16/05/201
1 
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Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Date of 
receipt 
by the 
study 
organiser
: 
26,04,11 14 May 
2011 
(Handover 
at 
conference
) 
  ? End of 
May, 2011 
 16.05.201
1 
16/05/201
1 
~13/05/20
11 
~13/05/20
11 
5/26/11  11/05/201
1 
19/05/201
1 
Storage 
condition
s before 
deployme
nt (°C): 
_20 °C Fridge (4 
degrees C)  
  -20 -20 C in a 
freezer 
 room 
temperatu
re 
-20°C 4°C 
immersed 
in water 
4°C 
immersed 
in water 
freezer  4 Storage in 
fridge at 
4°C 
Storage 
condition
s after 
sampler 
recovery 
(°C): 
 Fridge (4 
degrees C)  
  -20 -20 C in a 
freezer 
 -20 -20°C minus 
20°C 
minus 
20°C 
freezer   Storage in 
freezer at 
-20°C 
Date of 
return 
shipment 
from the 
organiser 
to the 
participa
nt 
laborator
y: 
 21/07/201
1 
   July 14th, 
2011 
 15.06.201
1 
15/06/201
1 
~31/8/201
1 
~31/8/201
1 
6/23/11  15/06/201
1 
07/07/201
1 
Date of 
receipt 
by the 
participa
nt 
laborator
y: 
 26/07/201
1 
21/06/201
1 
21/06/201
1 
 July 16th, 
2011 
 16.06.201
1 
16/06/201
1 
~2/9/2011 ~2/9/2011 6/23/11 03/08/201
1 
16/06/201
1 
08/07/201
1 
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Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Sampler deployment and recovery 
Date and 
hour of 
the 
deployme
nt: 
30/05/201
1 15h55 
30/05/201
1; 19:50 
30.5.2011
, 16:15 
30.5.2011
, 16:15 
 June 13th, 
2011 
12:43 PM 
 30.05.201
1 15:10 
30/05/201
1 15:10 
30/05/201
1 
30/05/201
1 
5/30/11, 
14:30 
 30/05/201
1 20:20 
30/05/201
1 at 16:28 
Air Temp 
on 
deployme
nt (°C) 
23 21 23 23  22   23 23   23°C  20 23.5 
Duration 
of the 
deployme
nt  
25 
minutes 
27 min 00:15 00:15  13.844 
days 
 20 min 00:35:00   25min  30 min 29 min 
Air Temp 
on 
recovery 
(°C) 
23 23 22 22  17  22 23   23°C  23 22 
Duration 
of the 
recovery  
50 
minutes 
20 min 00:40 00:40    30 min 00:23:00   18 min  11 min 32 min 
Date and 
hour of 
the 
recovery: 
13/06/201
1 14h40 
13/06/201
1: 15:28 
13.6.2011
, 12:42 
13.6.2011
, 12:42 
 June 13th, 
2011 8:58 
AM 
 13.06.201
1 13:22 
13/06/201
1 13:22 
13/06/201
1 
13/06/201
1 
6/13/11, 
14:17 
 13/06/201
1 17:37 
13/06/201
1 at 12:43 
Comment 
on 
fouling: 
       Exposed 
membrane
s were 
spotted 
and darker 
than 
unexposed 
ones 
-      Not much 
Field 
deployme
nt device 
used: 
canister Teflon 
Chemcatc
her case 
standard 
big cage 
standard 
big cage 
canister? Prepared 
stainless 
steel 
cages 
Small 
SPMD 
deploymen
t cage 
Standard 
POCIS 
deployme
nt cage for 
3 
samplers 
standard 
small cage 
for 3 
samplers 
Wet 
mounted 
on open 
cage 
Wet 
mounted 
on open 
cage 
standard 
POCIS 
deploymen
t cage 
standard 
POCIS 
deploymen
t cage for 
3 samplers 
Big cage 
(provided 
by WRI) 
standard 
POCIS 
deployme
nt cage 
for 6 
samplers 
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Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Extractio
n 
techniqu
e: 
elution 
MeOH 
5 mL 
Acetone 
followed 
by 5 mL 
methanol; 
sonication; 
at room 
temperatu
re 
liquid 
extraction 
liquid 
extraction 
Elution 
with MeOH 
(acidic and 
basic 
MeOH too) 
Extraction 
with 
methanol, 
rotovap, 
N-evap, 
place in 
MeOH/H2
O  
3 x 15 min 
ultrasonic 
extraction 
with 5 ml 
in 
1.acetone 
2.MeOH 
3.mixture 
of both 
(1:1)  
5 mL 
MeOH - 5 
mL 
MeOH/DC
M (50/50) 
- 5 mL 
DCM 
elution 
with 
Methanol 
and 
dichlorom
ethane 
Extraction 
by soxhlet 
with 
acetonitril 
Elution 
with 15 ml 
methyltert
iarybutylet
her 
followed 
by 20 ml 
DCM and 
finally with 
15 ml 
methanol 
3x 
ultrasonic 
extraction 
(70% 
MeOH) 
SPE 
column 
extraction 
with 
80/20/0.1 
(Dichloro
methane/I
PA/TFA) 
7 mL 
Acetone, 7 
mL 
Methanol 
SPE 
Extractio
n: 
27/06/201
1 
22/08/201
1 
  06.01.201
2 
10.12. 
2011 
05/07/201
1 
12.09.201
1 
12/09/201
1 
20/10/201
1 
20/10/201
1 
13/12/201
1 
09/12/201
1 
19/08/201
1 
25/07/20
11 
Date of 
instrume
ntal 
analysis: 
11/08/201
1 
05/09/201
1 
  10.01.201
2 
December 
13th, 
2011 
28/09/201
1 
19.09.201
1 
26/09/201
1 
27/10/201
1 
27/10/201
1 
06/01/201
2 
07/01/201
2 
22/08/201
1 
23/09/20
11 
atenolol: 
09/09/20
11 
Cleanup 
method: 
no Filtration 
through 
PFTE filter 
(0.45um) 
no no None Included 
in 
separate 
File 
NaSO4, 
0.45 µm 
cellulose 
acetate 
membrane 
No 
cleanup 
no none No  No clean 
up 
 / 
Instrume
ntal 
method: 
uplc/msms LCMS LC/MS/MS LC/MS/MS LC/MS Included 
in 
separate 
File 
LC-MS/MS LC-MS-MS 
(ESI + 
and -) 
LC-MS/MS LC-MSMS LC-MSMS LC/MS/MS
,ESI+/ESI
-, Zorbax 
Eclipse 
XDB C18, 
Mobile 
phase: 
gradient: 
water 
0,2% 
CH3COOH, 
MeOH 
0,2% 
CH3COOH 
LCMS QQQ  online SPE 
(Oasis 
HLB) 
HPLC-
MS/MS 
LC-MS/MS 
Injection 
solvent: 
MEOH 50% 
methanol/ 
water 
MeOH/wat
er 
MeOH/wat
er 
MeOH/wat
er 50:50 
10:90 
Methanol:
Water 
MeOH Milli-Q 
Water 
(ESI+) or 
ACN (ESI-
) 
Methanol Acetontrile 
water 
Acetonitril
e-water 
MeOH:wat
er 0,2% 
CH3COOH 
(1:1) 
In mobile 
phase  
HPLC 
grade 
Water, 
Methanol 
Water 
except for 
atenolol: 
Water/Ace
tonitrile 
(99/1) 
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Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Recovery 
and 
internal 
standard
s used: 
oxazepam 
d5 
No 
recovery 
correction 
IS = C13 
labelled 
Sulfameth
oxazol, RS 
not used 
IS = C13 
labelled 
Sulfameth
oxazol, RS 
not used 
YES Included 
in 
separate 
File 
Acenaphte
ne-D10; 
HCB-13C6 
Carbamaz
epine d10, 
Diazepam 
d5, 
Atenolol 
d7, 
Nordiazep
am d5, 
Ketoprofe
n d3, 
Naproxen 
d3, 
Ibuprofen 
d3, 
Diclofenac 
d4 
diazepam-
d5, 
diclofenac-
d4, 
ibuprofen-
d3, 
ketoprofen
-d3, 
naproxen-
d3, 
nordiazep
am-d5 
Diverse 
stantandar
ds but not 
targets, 
receoverie
s vary 
Several 
standards 
used but 
generaaly 
not the 
target 
compound
s, 
Therefore 
no 
correction
s were 
made. 
Int.stand.: 
Diclofenac 
D4, 
Ibuprofen 
D3,Carba
mazepine 
D10 
YES - 
Deuterate
d 
(D7)Atenol
ol, (D10) 
Carbamaz
epine, 
(D5) 
Diclofenac
, (D3) 
Ibuprofen 
Labeled IS 
used for 
every 
compound 
analysed 
/ 
REMARKS
: 
     Methods 
included in 
separate 
file. 
 - - No 
correction
s for 
suppressio
n made 
No 
correction
s for 
suppressio
n made 
 Matrix 
interferenc
e made 
quantificat
ion of 
Atenolol 
problemati
c. 
Ibuprofen 
was not 
present 
above our 
detection 
limits 
 / 
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Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Data evaluation aspects 
Method 
for 
estimatio
n of 
water 
concentr
ation 
from 
passive 
sampler: 
m/Rst Cw = 
Ns/(Rs*t) 
please 
give a 
short 
description 
and 
relevant 
references 
please 
give a 
short 
description 
and 
relevant 
references 
Use of 
mean of 
literature 
Rs values 
available 
for each 
compound
, assuming 
linear 
uptake 
over 14 
days 
Please see 
separate 
file 
"NORMAN 
Report.doc
x". 
flow-
dependent 
regression 
over 
literature 
values (if 
Rs not 
available) 
Calculation 
with 
following 
formula : 
Cs x 0,2 = 
Cw Rs t 
(Vrana et 
al., 2005) 
PRC 
aproach 
using 
Salbutamo
l-d3, 
Caffein-
C13 and 
DIA-d5 
Fitting PRC 
dissipation 
with model 
and a 
flowfactor 
as 
adjustable 
parameter
. Then this 
flow factor 
is applied 
to 
calculate 
the Cw 
Uptake of 
Clotrimazi
ole, 
Carbamez
apine, 
Thiabenda
zol and 
Fluoranthe
ne 
transfered 
to sampled 
volume 
using Cw 
from SR 
sampling 
 S.L. 
Bartelt-
Hunt, 
D.D.Snow, 
T. Damon-
Powel at 
all:Environ
mental 
Toxicology 
and 
Chemistry, 
Vol. 30, 
No. 6, pp. 
1412–
1420, 
2011. For 
diclofenac 
was used 
Rs from: 
S.L. Mac 
Leod, E.L. 
Mc Clure, 
Ch.S. 
Wong: 
Environme
ntal 
Toxicology 
and 
Chemistry, 
Vol. 26, 
No 
Estimation 
of water 
calculation 
not used 
please 
give a 
short 
description 
and 
relevant 
references 
To obtain 
laboratory 
Rs: Plot of 
the 
concentrat
ion factor 
as a 
function of 
the time 
until the 
t1/2: 
CF=Cs/Cw
=(Rs*t)/(
Ms). Use 
of this lab 
Rs in order 
to obtain 
in situ 
TWA 
concentrat
ions using 
the 
equation 
Cw=(Cs*M
s)/(Rs*t) 
Sampling 
rates 
used 
(literatur
e 
value/ow
n 
calibratio
n): 
literature Own 
calibration
.Own 
calibration 
Atrazine is 
used as a 
reference 
point. 
Other 
PPCPs are 
assigned a 
relative to 
atrazine 
ratio 
based on 
their 
sampling 
rates 
  Mean of 
literature 
values 
Sampling 
rates in 
separate 
file 
"NORMAN 
report.doc
x" 
literature 
values for 
pesticides 
and 
pharmace
uticals 
Own 
calibration 
for 
Carbamaz
epine and 
Diclofenac, 
literature 
values 
(Togola 
and 
Budzinski, 
2007- Li et 
al., 2009) 
for other 
compound
s 
own 
calibration 
From PRCs 
using 
Rusina Est 
2010 and 
Booij and 
Smedes 
EST 2010 
From 
calibration 
with SR 
results 
Sampled 
volume 
2.2, 2.8 
and 3.1 L 
literature 
values: 
ibuprofen 
0,400; 
carbamaze
pin 0,288 
; 
diclofenac 
0,166 
(flowing 
Rs) 
N/A own, 
unpublishe
d data 
Carbamaz
epine: 
0.100 L/d 
Diclofenac
: 0.056 
L/d 
Own 
calibration
: 
ATE=0,02
18 L/d; 
CARBA=0,
1876 L/d; 
DICLOF=0
,2248 L/d; 
KETO=0,1
213 L/d; 
NAPRO=0,
0838 L/d 
  
 
186 
(RsPPCP/R
s Atr) from 
our own 
calibration 
study. The 
laboratory 
Rs of 
atrazine is 
adjusted 
using the  
Table AIV- 1 (continued) Participant passive samplers of pharmaceuticals: method information 
LAB 
No. 
17 19 23a 23 29 31 36 39 40 43a 43 44 47 48 49 
Sampler/
water 
partition 
(distribut
ion) 
coefficien
ts used: 
 No   No  NO - - Smedes et 
al EST 
2009 
none  N/A  / 
Performa
nce 
reference 
compoun
ds 
applied 
(YES/NO
):  
no No   NO No NO NO YES Yes NO No NO  NO 
Were the 
calibratio
n data 
adjusted 
to reflect 
exposure 
condition
s 
(tempera
ture, 
flow, 
pH...?) 
no Flow and 
salinity 
throught 
the PFM 
  not really  average 
flow was 
estimated 
with PFM: 
O'Brien et 
al., 
Chemosph
ere 83 (9), 
2011 
NO PRC Flow 
corrected 
(not 
Temperatu
re) 
Only an 
attempt to 
correct for 
flow 
No N/A  No 
(laborator
y 
calibration
: 
temperatu
re=20,7°C
; pH=7,6; 
conductivit
y=429 
µS/cm; 
DOC=13,3 
mg/L; 
flow=11 
cm/s) 
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Annex V. Provided passive samplers of steroids: method information 
 
Table AV- 1 Provided passive samplers of steroids: method information 
LAB No. 19 20 23 26 33 36 37 39 43a 43 44 45 49 51 
PS type : POCIS, pharmaceutical version 
Receiving phase material: sorbent Oasis HLB, 60 μm  
Receiving phase mass (g): 0.200 g; mass of sorbent separated from samplers after exposure is given on each SPE cartridge 
Membrane material : Polyethersulphone; SUPOR 100 Membrane Disc Filters (0.1 μm, 90 mm diameter) 
Active sampler surface area (or membrane area) (cm2): 45.8 cm2 
Performance and Reference Compound (PRC) * 
Passive samplers with PRC : NO 
 
Table AV- 2 Provided passive samplers of steroids: method information 
LAB 
No. 
19 20 23 26 33 36 37 39 43a 43 44 45 49 51 
Transport and storage 
Storage 
conditions 
before 
deployme
nt (°C)**: 
Fridge 4 
degrees C 
4 -20     4     Storage in 
fridge at 
4°C 
 
Storage 
conditions 
after 
sampler 
recovery 
(°C)**: 
Fridge 4 
degrees C 
-20 -20  -20   -20   freezer  Storage in 
freezer at -
20°C 
 
Return 
shipment  
21/07/2011 September 
5 2011 
20/07/2011  13/07/2011   18/07/2011 ~31/8/201
1 
~31/8/201
1 
  07/07/2011  
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Table AV- 2 (continued) Provided passive samplers of steroids: method information 
LAB 
No. 
19 20 23 26 33 36 37 39 43a 43 44 45 49 51 
Date of 
receipt by 
the 
participan
t 
laboratory 
** : 
26/07/2011 September 
11 2011 
20/07/2011  15/07/2011   19/07/2011 ~2/9/2011 ~2/9/2011 10/25/11  08/07/2011  
REMARKS:  Samples 
stored at 
4C upon 
receipt 
  none    Dates are 
approximat
e 
Dates are 
approximat
e 
  /  
Sampler deployment and recovery 
Date and 
hour of 
the 
deployme
nt ** : 
20/6/2011; 
10:34, 
11:44, 
12:00 
6/20/2011  
approx. 
11:00 
20.6.2011, 
12:00 
20/062011 
10.34 
(sampl.4)  
and 11.03 
(sampl 9) 
PS [27] and 
[33]: 
20/06/2011 
10:34; PS 
[77]: 
20/06/2011 
11:44 
20/06/11-
04/07/2012 
 20.06.2011 
11:03 
20/06/2011 20/06/2011 (57) 
6/20/11 
11:03          
(64) 
6/20/11 
11:03     
(111) 
6/20/11  
12:00 
Sampler 1, 
2 and 11: 
20.06.2011  
09:55:00 
Sample 25: 
20/06/2011 
at 10:34; 
sample 72: 
20/06/2011 
at 11:44; 
sample 97: 
20/06/2011 
at 12:00 
 
Air Temp 
on 
deployme
nt (°C)** 
17,17, 20 22 20 17 PS [27] and 
[33]: 17 °C 
; PS [77]: 
20 °C 
  17   (57) 17°C                       
(64) 17°C                 
(111)  20°C 
Sampler 1, 
2 and 11: 
15 °C 
Sample 25: 
17°C; 
sample 72: 
20°C; 
sample 97: 
20°C 
 
Duration 
of the 
deployme
nt 
(exposure 
to air for 
field 
control)** 
39, 44, 30 approx. 35 
minutes 
0.02083333
3 
25 min 
(sampl 4) 
and 46 min 
(sampl 9) 
PS [27] and 
[33]: 39 
min; PS 
[77]: 44 
min 
  30 min   (57) 46 min                    
(64) 46 min              
(111)  30 
min 
Sampler 1, 
2 and 11: 
13.990 
Sample 25: 
39 min; 
sample 72: 
44 min; 
sample 97: 
30 min 
 
Air Temp 
on 
recovery 
(°C)** 
17-19 21 19 18 PS [27] and 
[33]: 17 
°C; PS 
[77]: 19 °C 
  17   (57) 18°C                       
(64) 18°C                  
(111) 17°C 
Sampler 1, 
2 and 11:  
17 °C 
Sample 25: 
17°C; 
sample 72: 
18,5°C; 
sample 97: 
19°C 
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Table AV- 2 (continued) Provided passive samplers of steroids: method information 
LAB 
No. 
19 20 23 26 33 36 37 39 43a 43 44 45 49 51 
Duration 
of the 
recovery 
(exposure 
to air for 
field 
control)** 
40, 30, 55 
mins 
approx. 45 
minutes 
0.03819444
4 
20 min 
(sampl 4) 
and 30 min 
(sampl 9) 
PS [27] and 
[33]: 40 
min; PS 
[77]: 30 
min 
  30 min   (57) 30 min                    
(64) 30 min                
(111) 55 
min 
Sample 25: 
40 min; 
sample 72: 
30 min; 
sample 97: 
55 min 
 
Date and 
hour of 
the 
recovery 
** : 
4/7/2011; 
10:15, 
11:30, 
12:00 
7/4/2011  
approx. 
11:30 
4.7.2011, 
12:00 
4//2011 
9,40 (sampl 
4) and 
11,00 
(sampl 9) 
PS [27] and 
[33]: 
04/07/2011 
10:15; PS 
[77]: 
04/06/2011 
11:30 
  04.07.2011 
11:00 
04/07/2011 04/07/2011 (57) 7/4/11 
11:00           
(64) 7/4/11 
11:00       
(111) 
7/4/11  
12:00 
Sampler 1, 
2 and 11: 
04.07.2011  
09:40:00 
Sample 25: 
04/07/2011 
at 10:15; 
sample 72: 
04/07/2011 
at 11:30; 
sample 97: 
04/07/2011 
at 12:00 
 
Comment 
on 
fouling**: 
 None visible      Exposed 
membranes 
were 
spotted and 
darker than 
unexposed 
ones 
   - Not much  
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Table AV- 2 (continued) Provided passive samplers of steroids: method information 
LAB 
No. 
19 20 23 26 33 36 37 39 43a 43 44 45 49 51 
Analytical aspects 
Extraction 
technique: 
Elution of 
cartridges 
with 3 mL 
methanol, 2 
mL 50:50 
acetone 
hexane 
Cold 
Benchtop 
with 
Dichloromet
hane 
liquid 
extraction 
Solvent 
elution 
Extraction 
with 
acetone 50 
ml 
SPE  50 mL 
8:1:1 
DCM:toluen
e:methanol 
5 mL MeOH 
- 5 mL 
MeOH/DCM 
(50/50) - 5 
mL DCM 
Elution with 
4 ml 
methylterti
arybutyleth
er followed 
by 8 ml 
methanol 
Elution with 
4 ml 
methylterti
arybutyleth
er followed 
by 8 ml 
methanol 
3x5ml 
acetonitrile 
MeOH, 40 
ml 
SPE Solid phase 
extraction 
Date of 
extraction
: 
01/09/2011 November 
4 2011 
 07/12/2011 13/10/2011 09/07/2011 July 18, 
2011 
23.08.2011 20/10/2011 20/10/2011 09/12/2011 25/07/2011 25/07/2011 October 5 
2011 
Date of 
instrumen
tal 
analysis: 
16/09/2011 December 6 
2011 
 03/01/2012 14-
15,17/10/2
011 
10/09/2011 July 19, 
2011 
30.09.2011 27/10/2011 27/10/2011 12/12/2011 04/08/2011 30/08/2011 November 
11 2011 
Cleanup 
method: 
Liquid-
liquid 
extraction 
with water 
to remove 
derivatising 
agent 
None SPE, florisil, 
dansylation 
No cleanup none  1-g 
Florisil® 
cartridge 
SPE clean-
up + 
derivatisati
on  
C.Liscio et 
al: 
Environmen
tal 
Pollution, 
2009, 157, 
2716 
No cleanup No No florisil 
(elution 
with 1% 
acetone in 
CH2Cl2) 
no / None 
Instrumen
tal 
method: 
GCMS GC/MS LC/MS/MS GC/MS/SIS 
ion trap 
LC-MS-MS GC-MS LC-ESI-
MS/MS 
LC-MS-MS LC-MSMS LC-MSMS LC/MS/MS, 
ESI-, 
Column: 
Synergi 
Hydro-RP, 
Mobile 
phase: 
gradient: 
water, 
acetonitrile 
LC-MS/MS LC-MS/MS Liquid 
chromatogr
aphy-
Tandem 
mass 
spectrometr
y 
Injection 
solvent: 
50% 
hexane/ 
acetone 
Methanol MeOH/H2O MSTFA 50% 
CH3OH 
50% H2O 
Hexane MeCN MeOH/ultra
pure water 
(50/50) 
Acetonitrile
-water 
Acetonitrile
-water 
Acetonitrile EtOH Water/Acet
onitrile 
(60/40) + 
estradiol 
acetate 
Methanol 
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Table AV- 2 (continued) Provided passive samplers of steroids: method information 
LAB 
No. 
19 20 23 26 33 36 37 39 43a 43 44 45 49 51 
Recovery 
and 
internal 
standards 
used: 
Derivatised 
with 
silyating 
agent 
(BSTFA + 
TMCS) 
d4 17a 
Ethynylestr
adiol, 
Tribromobip
henyl 
IS=deutera
ted beta-
estradiol 
Bisphenol-
d16 
Estrone d4 
as internal 
std 
PG-d and 
BPA-d 
E2-D, EE2-
D 
E2 d5, EE2 
d4, E1 d4 
Several 
standards 
used but 
generaaly 
not the 
target 
compounds
, Therefore 
no 
corrections 
were made. 
Several 
standards 
used but 
generaaly 
not the 
target 
compounds
, Therefore 
no 
corrections 
were made. 
Int. stand. 
Estrone D4, 
17b-
Estradiol 
D5, 17a-
Ethinylestra
diol D4 
D4-Estrone 
13C2-17-
beta-
Estradiol 
D4-17-
alpha-
Ethinylestra
diol 
/ 13C-
sulfametha
zine 
(positive) 
and 
bisphenol A 
(Negative) 
REMARKS:      The long 
storage of 
derivatised 
extacts at -
20°C could 
partly have 
caused 
degradation   
  No 
corrections 
for 
suppression 
made 
No 
corrections 
for 
suppression 
made 
  / No recovery 
standard 
was used 
Data evaluation aspects 
Method 
for 
estimation 
of water 
concentrat
ion from 
passive 
sampler: 
please give 
a short 
description 
and 
relevant 
references 
Li, Helm, 
and 
Metcalfe 
ETC 2010 
please give 
a short 
description 
and 
relevant 
references 
Ardisoglou 
et al. 
Environmen
tal Pollution 
156 (2008) 
316-324 
Alvarez et 
al, Environ, 
Toxicol. 
Chem. 23 
(2004) 
1640-1648 
please give 
a short 
description 
and 
relevant 
references 
 Calculation 
with 
following 
formula : 
Cs x 0,2 = 
Cw Rs t 
(Vrana et 
al., 2005) 
Uptake of 
Clotrimaziol
e, 
Carbameza
pine, 
Thiabendaz
ol, 
transfered 
to sampled 
volume 
using Cw 
from SR 
sampling 
Uptake of 
Clotrimaziol
e, 
Carbameza
pine, 
Thiabendaz
ol, 
transfered 
to sampled 
volume 
using Cw 
from SR 
sampling 
 S.L. 
Bartelt-
Hunt, 
D.D.Snow, 
T. Damon-
Powel at 
all:Environ
mental 
Toxicology 
and 
Chemistry, 
Vol. 30, No. 
6, pp. 
1412–1420, 
2011. 
Averaged 
sampling 
rate from 2 
publications 
was used: 
1. Z. Zhang 
et al., Anal 
Chim Acta 
607, 37-44 
2. A. 
Arditsoglou 
et al, Env 
Pollution 
156, 316-
324 
To obtain 
laboratory 
Rs: Plot of 
the 
concentrati
on factor as 
a function 
of the time 
until the 
t1/2: 
CF=Cs/Cw=
(Rs*t)/(Ms)
. Use of this 
lab Rs in 
order to 
obtain in 
situ TWA 
concentrati
ons using 
the 
equation 
Cw=(Cs*Ms
)/(Rs*t) 
Not 
available 
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Table AV- 2 Provided passive samplers of steroids: method information 
LAB 
No. 
19 20 23 26 33 36 37 39 43a 43 44 45 49 51 
Sampling 
rates used 
(literature 
value/ow
n 
calibration
): 
 Rs=0.853(1
7a-
Ethynylestr
adiol), 
0.699(Estro
ne), 
0.693(17B-
Estradiol) 
Arditsoglou, 
Voutsa 
2008 
Literature 
Valur 
Arditsoglou 
et al. 
Environmen
tal Pollution 
156 (2008) 
316-324 
(for E1 Rs 
0.1199) 
Arditsoglou, 
A., Voutsa, 
D., 2008,  
Environ 
Pollut 
156:316-
324. 
Averaged 
T. Rujiralai, 
I.D Bull, 
neville 
Llewellyn 
R.P 
Evershed. 
J. Environ. 
Monit., 
2011, 13, 
1427. 
Own 
calibration 
From 
calibration 
with SR 
results 
From 
calibration 
with SR 
results,Sam
pled 
volumes on 
line 10 in 
result 
sheet. 
Literature 
values:Rs(1
7beta 
estradiol) = 
0,406[L/d]; 
Rs 
(estrone]= 
0,394[L/d]; 
Rs 
(Ethynylest
radiol] = 
0,335[L/d]  
Estrone:  
 
 
17-beta-
Estradiol:  
17-alpha-
Ethynilestra
diol: 
Own 
calibration: 
E1=0.2296 
L/d, a-
E2=0.2394 
L/d, b-
E2=0.2208 
L/d, 
E3=0.1854 
L/d, 
EE2=0.260
5 L/d 
 
Sampler/
water 
partition 
(distributi
on) 
coefficient
s used: 
  No Literature 
value 
   - none none   /  
Performan
ce 
reference 
compound
s applied 
(YES/NO):  
  No NO NO   NO NO NO No no NO  
Were the 
calibration 
data 
adjusted 
to reflect 
exposure 
conditions 
(temperat
ure, flow, 
pH...?) 
 No No NO no  no NO Only an 
attempt to 
correct for 
flow 
Only an 
attempt to 
correct for 
flow  
No no No 
(laboratory 
calibration: 
temperatur
e=20.7°C, 
pH=7.6, 
conductivity
=429 
µS/cm, 
DOC=13.3 
mg/L, 
flow=11 
cm/s) 
 
REMARKS:  Cw=ng(tota
l)/(Rs*total 
days) 
      Not very 
confident 
on 
samplingrat
e applied 
Not very 
confident 
on 
samplingrat
e applied 
  /  
  
 
193 
Annex VI. Participant passive samplers of steroids: method information 
Table A VI- 1 Participant passive samplers of steroids: method information 
LAB 
No. 
19 20 23 26 33 36 39 43a 43 49 
PS type : Empore Disk Polyoxymethylen
e 
POCIS, 
pharmaceutical 
version 
POCIS, 
Pharmaceutical 
version 
POCIS, pesticide 
version 
POCIS POCIS, 
pharmaceutical 
version 
Altesil 
translucent 
silicone 
rubber (4 
sheets of 
100cm2 
each) 
Speedisks 
(2 disks 
form one 
sampler) 
POCIS, 
pharmaceutical 
version 
Home 
made or 
commercia
l PS : 
Commercial Home made commercial Commercial PS commercial Home made Home made Home made J.T. 
Baker, 
Bakerbon
d 
Speedisk, 
H2O Philic 
DVB, 
Art.nr.: 
8072-07 
Home made 
Supplier : Phenomenex N/A EST Exposmeter AB EST (St. Joseph, 
USA). 
no - Altecweb.co
m 
JT Baker / 
Receiving 
phase 
material: 
SDB-RPS 
Reverse Phase 
Sulfonated 
Polyoxymethylen
e 
sorbent Oasis HLB sorbent Oasis 
HLB, μm 
triphasic 
admixture 
Isolute ENV+polyestyrene 
divinylbencene+ambersor
b 1500 carbon dispersed 
on S-X3 Biobeads 
Oasis HLB sorbent, 
60 µm 
AlteSilTM 
translucent 
material, 
0.5±0.05 
mm 
thickness 
DVB sorbent Oasis HLB, 
60 μm  
Receiving 
phase 
mass (g): 
0.398 about 2 0.22 0,200g:  0.200 g m1-m6 = 0.0951; 0.0966; 
0.1011; 0.1002; 0.0998; 
0.1017 g 
0.200 14 0.95 0.2 
Receiving 
phase 
volume 
(cm3) 
1.73494 about 1.7    30 cm3 (mL) 
DCM:EtAc:MeOH (2:2:1) 
- 12  / 
Membrane 
material : 
Polyethersulfon
e (0.45um) 
SUPOR 450 
filters PALL Life 
Sciences 
Polyoxymethylen
e 
Polyethersulphon
e 
Polyethersulphon
e 
Polyethersulphone
; 0.1 μm 
Polyethersulfone 0.1 um Polyethersulphone
; SUPOR 100 
Membrane Disc 
Filters (0.1 μm, 90 
mm diameter) 
Silicon rubber Glassfibre 
Filter ±0.5 
mm 
Polyethersulphone
; SUPOR 100 
Membrane Disc 
Filters (0.1 μm, 90 
mm diameter) 
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Table A VI- 1 (continued) Participant passive samplers of steroids: method information 
LAB No. 19 20 23 26 33 36 39 43a 43 49 
Active sampler 
surface area (or 
membrane area) 
(cm2): 
16 about 620 47.5 
cm2 
45,8 
cm2 
45.8 1734 cm2 (d=47 mm) 42.47 400 35 45.8 
Performance Reference Compounds (PRC) 
Commercial passive 
samplers with PRC: 
 N/A No NO NO  NO  No PRCs No 
or home made PS 
spiked with PRC:  
 d4 17B Estradiol   NO Home made PS spiked with PRC 
(E2-d3, EQ-d4 and NP-d4) 
NO Home spiked,D10-biphenyl, PCBs: CB001, CB002, CB003, 
CB010, CB014, CB021, CB030, CB050, CB055, CB078, 
CB104, CB145, CB204 
No PRCs No 
Transport and storage 
Date of shipment to 
the study organiser: 
approx 7 May 
2011 
June 2 2011 07/06/2011 15/04/2011 31/05/2011  13.05.2011 ~10/05/2011 ~10/05/2011 16/05/2011 
Date of receipt by the 
study organiser: 
14 May 2011 
(Handover at 
conference) 
June 8 2011 07/06/2011  02/06/2011  16.05.2011 ~13/05/2011 ~13/05/2011 19/05/2011 
Storage conditions 
before deployment 
(°C): 
Fridge 4 degrees 
C 
4 -20  4  room temperature minus 20°C 4°C immersed 
in water 
Storage in fridge 
at 4°C 
Storage conditions 
after sampler 
recovery (°C): 
Fridge 4 degrees 
C 
-20 -20  -20  -20 minus 20°C minus 20°C Storage in freezer 
at -20°C 
Date of return 
shipment from the 
organiser to the 
participant 
laboratory: 
21/07/2011 September 5 
2011 
20/07/2011  13/07/2011  18.07.2011 ~31/8/2011 ~31/8/2011 07/07/2011 
Date of receipt by the 
participant 
laboratory: 
26/07/2011 September 11 
2011 
20/07/2011  15/07/2011  19.07.2011 ~2/9/2011 ~2/9/2011 08/07/2011 
REMARKS:  Samples stored 
at 4C upon 
receipt 
  none  - Dates are 
approximate 
Dates are 
approximate 
/ 
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LAB No. 19 20 23 26 33 36 39 43a 43 49 
Date and hour of the 
deployment: 
20/6/2011; 
15:45 
20/06/2011 20.6.2011, 14:30 20/06/2012 
13,25 
20/06/2011 20/06/11-
04/07/11 
20.06.2011 13:50 20/06/2011 20/06/2011 20/06/2011 at 
13:00 
Air Temp on 
deployment (°C) 
20 22 20 20 20  20   20 
Duration of the 
deployment 
(exposure to air for 
field control) 
14:20-15:45 25 minutes 0.020833333 15 min 30 minutes  30 min   30 min 
Air Temp on recovery 
(°C) 
21 21 18 18 22  18   18 
Duration of the 
recovery (exposure to 
air for field control) 
15:17 - 16:15 10 minutes 0.020833333 20 min 20 minutes  20 min   30 min 
Date and hour of the 
recovery: 
4/7/2011; 15:17 04/07/2011 4.7.2011, 14:40 04/07/2011 04/07/2011  04.07.2011 14:30 04/07/2011 04/07/2011 04/07/2011 at 
13:30 
Comment on fouling:  None visible all POCISes were 
cracked on the 
arrival 
   Exposed membranes 
were spotted and 
darker than 
unexposed ones 
  Not much 
Field deployment 
device used: 
Teflon 
chemcatcher 
case 
Copper case big cage Canister small cage canister Standard POCIS 
deployment cage for 
3 samplers 
Wet mounted 
on open cage 
Wet mounted 
on open cage 
standard POCIS 
deployment cage 
for 6 samplers 
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Annex VII. Provided passive samplers of BDEs: method information 
 
Table A VII- 1 Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Passive sampler (PS)  
PS type : Silicone rubber sheets; (1 sampler = 3 x sheet 90x55 mm) 
Receiving phase material: AlteSilTM translucent material, 0.5±0.05 mm thickness 
Receiving phase mass (g): 8.91 g (Altesil density = 1.2 g/cm3) 
Receiving phase volume (cm3) 7.43 cm3  
Sampler surface area (or membrane area) (cm2): 297 cm2  
Performance and Reference Compound (PRC) *  
Passive samplers with PRC : D10-biphenyl, PCBs: CB001, CB002, CB003, CB010, CB014, CB021, CB030, CB050, CB055, CB078, CB104, 
CB145, CB204 
Transport and storage 
Date of 
shipment 
to the 
study 
organiser: 
  05/05/2011  Provided by 
the 
organiser. 
We didn't 
ship them. 
15/04/2011   23/06/2011      
Date of 
receipt by 
the study 
organiser 
** : 
  16/05/2011  See above.          
Storage 
conditions 
before 
deployme
nt (°C)**: 
Fridge 4 
degrees C 
 - 20 
degrees 
celsius 
 ~5          
Storage 
conditions  
Fridge 4 °C  - 20°C  ~5   4ºC  -18 4°C  freezer  
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Table A VII- 1(continued) Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Date of 
return 
shipment 
from the 
organiser 
to the 
participan
t 
laboratory
:** 
02/09/2011  13/07/2011  13/09/2011   31/08/2011  31.8.2011 September 
6th, 2011 
~31/8/201
1 
  
Date of 
receipt by 
the 
participan
t 
laboratory 
** : 
07/09/2011  15/07/2011 29/09/2011 20/09/2011   01/09/2011 06/09/2011 2.9.2011 September 
7th, 2011 
~2/9/2011 10/25/11 september, 
20th 
REMARKS:            Dates are 
approximat
e 
 Standard 
solution 
didn't 
contain the 
1 ml 
solution (it 
was 
empty). We 
put 1 ml 
hexaan in 
the empty 
vial for the 
solution of 
the 
standard. 
Sampler deployment and recovery 
Date and 
hour of 
the 
deployme
nt ** : 
11/07/2011  7-July-
2011 
between 
10:40 and 
11:38 
11.7.2011, 
11:00 
11/07/2011   11/07/2011   July 11st, 
2011 at 
10:48 
11/07/2011 11/07/2011  
Air Temp 
on 
deployme
nt (°C)** 
22  22 22 22   22ºC   22°C  19°C  
  
 
198 
Table A VII- 1 (continued) Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Duration 
of the 
deployme
nt 
(exposure 
to air for 
field 
control)** 
between 16 
and 25 
mins 
 +/- 15 
minutes 
0.0104166
67 
20mins   20 min   18 min 0 17min  
Air Temp 
on 
recovery 
(°C)** 
between 26 
and 29 
degrees C 
 29 30 29   26ºC   24°C 0 24°C  
Duration 
of the 
recovery 
(exposure 
to air for 
field 
control)** 
between 25 
and 65 
mins 
 +/- 40 
minutes 
1h 40mins   1 hour   65 min  0 65min  
Date and 
hour of 
the 
recovery 
** : 
22/08/2011  22-August-
2011 
between 
9:55 and 
12.50 
22.8.2011, 
13:55 
22/08/2011   22/08/2012   August 
22nd, 2011 
at 9:55 
22/08/2011 8/22/11 
11:10 
 
Comment 
on 
fouling**: 
  less fouling, 
cleaned 
with milli Q 
water and 
scourer 
           
Field 
deployme
nt device 
used 
              
Type of 
deployme
nt device 
(canister, 
cage...) : 
   holder Cage   Holder   Holder 1 Open cage   
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Table A VII- 1(continued) Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Extraction 
technique: 
2 x 200mL 
hexane; 
shaken at 
room temp 
for 2 x 
24hrs. 
Extracts 
combined 
 Soxhlet 
extraction 
with 
hexane:ace
ton (3:1) 
85 degrees 
16 hours 
Soxhlet Hot Soxhlet 
extraction 
Acetonitrile
/Methanol 
2:1 mix 
Solvent 
Dialisys 
Same as 
for NIVA 
samplers 
cold 
extraction 
with 
solvent 
3 x 15 min 
with 
Cyclohexan
:Acetone 
(90:10) in 
an 
ultrasonic 
bath 
Soxhlet, 
Methanol 
soxhlet 
Methanol 
Soxhlet  
with 
acetonitril 
liquid 
extraction, 
hexan 
solvent 
extraction 
Date of 
extraction
: 
 
26/10/2011 
 07/09/2011  08/11/2011 29/11/2012  17/10/2011 05/10/2011 16.1.2012 November 
17-18, 
2011 
20/10/2011 16/12/2011 december, 
6th 
Date of 
instrumen
tal 
analysis: 
08/01/2012  13/09/2011  21/11/2011 12/01/2012  November - 
December 
23/01/2012 19.1.2012 January, 
2012  
27/10/2011 20/12/2011 december, 
8th 
Cleanup 
method: 
GPC 
followed by 
acid silica 
treatment 
 1 gram 
40% 
sulfuricacid
-silica, 
rinse with 
4x 1ml 
hexane:dic
hlorometha
ne (4:1), 
add 
extract, 
elute with 
total 3 ml 
hexane:dic
hlorometha
ne (4:1)  
silicagel, 
alumina 
and active 
carbon 
columns 
C8 bonded 
silica (for 
the 
oligomers); 
3% 
deactivated 
silica after 
solvent 
exchange 
to iso-
hexane 
No cleanup  no used NaSO4, 
0.45 µm 
cellulose 
acetate 
membrane 
H2SO4 
modified 
silica, 
column 
chromatogr
aphy 
Solvent 
transfer, 
copper 
elution with 
hexane/diet
ylether 
over Florisil 
SPE 
silicagel 
 
Instrumen
tal 
method: 
HR-GCMS  GC-MS GC/MS/MS GC-MS for 
the PBDEs, 
GC-ECD for 
the PCB 
PRCs 
GC/MS/MS 
ion trap 
 GC-MS/MS Agilent 
6890N GC 
with 5973 
MS and 
Gerstel 
TDU (MPS 
2 
autosample
r) 
GC-HRMS 
(PBDEs, 
isotope 
dilution), 
GC-MS/MS 
(PRCs) 
GC/MS-SIM GC-MS GC–MS–
NCI 
GCMS-NCI 
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Table A VII- 1 Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Injection 
solvent: 
hexane  isooctane nonane iso-hexane Nonane  Hexane cyclohexan
e 
(desorption 
of 1 µL 
from glass 
wool) 
nonane n-hexane Hexane hexan hexane 
Recovery 
and 
internal 
standards 
used: 
IS for 
PBDEs:  
MBDE-
MXE(Wellin
gton), IS 
for PCBs: 
PCB 153 
 BDE58 C13 
labelled IS 
(28,47,99,1
53,154); 
RS=1234T
CDD, 
123789HxC
DD 
Fluorinated 
BDE160 
and C13 
BDE 209 
PCB 209 – 
13C-PCB15 
 no used Anthracene
-D10 
13C PBDEs 
(28, 47, 
99, 100, 
153, 154, 
183, 209), 
Syringe std 
13C (BDE 
77, 138) 
Acenaphten
e D10, 
PCBs: CB 
29, CB 112, 
CB 209.  
95% of 
PCB209 
none  
REMARKS:   PRC 
reported as 
peak area 
(no 
concentrati
ons 
calculated) 
     glass liner 
for injection 
into GC was 
filled with 
SiO2 to 
block 
oligomers 
  0  We 
received 
standard 
solution 
PBDE; 3 
cups with 
field  blanc 
BDE and 3 
cups with 
spiked 
blank BDE. 
We didn't 
received 
the 3 
samples PS 
BDE, so we 
can not 
report the 
results of 
those 
samples. 
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Table A VII- 1 Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Method 
for 
estimation 
of water 
concentrat
ion from 
passive 
sampler: 
Cw = 
Ns/(Rs*t) 
 Kees Booij 
and Foppe 
Smedes: 
Environ. 
Sci. 
Technol., 
2010, 44 
(17), pp 
6789–6794 
 Water 
concentrati
ons 
estimated 
with PRC 
calibration 
and model 
based on 
Booij, K.et 
al. Environ. 
Sci. 
Technol. 
44, 6789-
6794.  
 No PRC 
data, 
Ratio= m-
pah(org)/m
-pah(niva) 
x 
t(niva)/t(or
g) is diff in 
Rs for PAHs 
withlogKow 
> 6 
calculated 
with 
sampling 
rates 
calculated 
with PRCs 
release.  
Ctwa=ms/(
Ksw*V*ke*
t); ke 
obtained 
with logistic 
regression 
N=RsCwt Booij and 
Smedes, 
Environ. 
Sci. 
Technol. 
2010, 44, 
6789–6794.  
Fitting PRC 
dissipation 
with model 
and a 
flowfactor 
as 
adjustable 
parameter. 
Then this 
flow factor 
is applied 
to calculate 
the Cw 
I used the 
method 
from 
Alvarez 
D.A., 2010: 
Guidelines 
for the use 
of the 
semiperme
abile 
membrane 
device(SPM
D) and the 
polar 
organic 
chemical 
integrative 
sampler 
(POCIS) in 
environmen
tal 
monitoring 
studies. 
U.S. 
geological 
Survey, 
Techniques 
and 
Methods 1- 
 
Sampling 
rates used 
(literature 
value/ow
n 
calibration
): 
average Rs 
(approx 
15L/day) 
calculated 
from 
PCB030 Rs  
= 
ke.Ksw.Vs 
 own 
calculation 
 Sampling 
rates based 
on own 
calibration 
using PRCs 
(PCB1,2,3,1
0,14,21,30,
50,55,78,1
04,145&20
4) based 
on: Rusina, 
T.P et al. 
Environ. 
Sci. 
Technol. 
44, 362-
367. 
  BDE-
Rs(niva) x 
Ratio (ratio 
= 0.94 sd 
0.12) 
calculated 
with PRCs 
release in a 
lineal 
uptake 
zone 
NO  calculated 
from PRC 
release with 
littérature 
values 
distribution 
coefficients 
From PRCs 
using 
Rusina Est 
2010 and 
Booij and 
Smedes 
EST 2010 
For water 
concentrati
on 
estimation I 
used Excel 
sheet 
accessible 
from 
website 
http://www
.cerc.usgs.g
ov/Branche
s.aspx?Bra
nchld=8 
(see 
publication 
above) 
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Table A VII- 1 Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Sampler/
water 
partition 
(distributi
on) 
coefficient
s used: 
log Ksw = 
0.0128*MW
+2.09 
(from Booji 
& Smedes, 
ES&T, 
2010) 
 Foppe 
Smedes, 
BDE Log 
Kws = log 
Kow 
 Partitionin 
coefficients 
based on: 
Smedes, F 
et al. 
Environ. 
Sci. 
Technol. 
43, 7047-
7054 
 Ksw from 
extrapolate
d from 
Ksw-Kow 
values from 
Smedes et 
al 2010 
partition 
coefficients 
used in 
previous 
projects 
and works 
Smedes et 
al. EST 43, 
7047–7054, 
2009 
 KPDMS/Wat
er 
Smedes et 
al EST 2009 
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Table A VII- 1 Provided passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 25 26 29 30 36b 37 38 43 44 50 
Performan
ce 
reference 
compound
s applied 
(YES/NO):  
yes  yes  YES NO  No prcs yes YES No yes Yes Yes  
Were the 
calibration 
data 
adjusted 
to reflect 
exposure 
conditions 
(temperat
ure, flow, 
pH...?) 
  no  No, only 
based upon 
the loss of 
the PRCs 
compared 
to the 
undeployed
. 
NO   no NO   Flow 
corrected 
(not 
Temperatur
e) 
No  
REMARKS: The 
sampling 
rate 
(approx 
15L/d) was 
estimated 
from PCB 
30, the 
most 
nonpolar 
PCB with a 
measurable 
ke. We 
found also 
some 
reproducibl
e loss for 
the higher 
PCBs, such 
as PCB055, 
but less 
than 10%. 
Using the 
PCB055 
data we 
estimate a 
sampling 
rate of 
appro 
 PRC 
reported as 
peak area 
(no 
concentrati
ons 
calculated) 
     PRCs not 
quantified, 
retained 
fraction was 
obtained 
from peak 
areas, 
Altesil 
values valid 
for all 
following 
data sheets   
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Annex VIII. Participant passive samplers of BDEs: method information 
 
Table A VIII- 1 Participant passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
PS type : Polydimethylsilo
xane (PDMS) 
Polyethyl
ene 
silicone 
rubber 
sheets (3 
sheets = 
1 
sampler, 
9.5x5.5 
cm) 
standard 
SPMD 
(length 1 
m) 
SPMD AlteSil 
Altec 
silicone 0.5 
mm thick 
CFIS low-density 
polyethylene 
strips 
membrane 
enclosed silicone 
collector (MESCO) 
80 mm bare 
silicone rod (SR 
80/15) 
non-polar 
Chemcatc
her (3rd 
generatio
n)  
Silicone 
rubber 
sheets; (1 
sampler = 
3 x sheet 
90x55 
mm) 
MESCO Altesil 
translucen
t silicone 
rubber (6 
sheets of 
100cm2 
each) 
Home 
made or 
commerc
ial PS : 
Commercial Home 
made 
commerc
ial 
commerc
ial 
commerc
ial  
home 
made 
Home 
made 
homemade homemade homemade homemad
e PS with 
commerci
al body 
 PDMS 
Stir 
Bar 
(Twiste
r) 
Home 
made 
  - Foppe 
Smedes, 
Deltares, 
The 
Netherla
nds 
   Home 
made 
 Silicone rod: 
Goodfellow, Bad 
Nauheim (D)  
 Chemcatc
her body: 
University 
Portsmout
h (UK) 
   
Supplier 
: 
Purple Pig 
Australia 
- Foppe 
Smedes, 
Deltares, 
The 
Netherla
nds 
Exposme
ter AB 
Exposme
ter AB 
 LABAQ
UA 
Polymersynthes
werk Rheinberg 
(D) 
LDPE: 
Polymersynthese
werk Rheinberg 
(D) 
Silicone rod: 
Goodfellow, Bad 
Nauheim (D)  
Empore 
disk: 
VWR, 
Dresden 
(D); 
LDPE: 
University 
Portsmout
h 
Bundesam
t für 
Seeschifffa
hrt und 
Hydrograp
hie (BSH), 
Hamburg 
(D) 
RIC - 
Lille, 
France 
Altecweb.c
om 
Receivin
g phase 
material: 
Polydimethylsilo
xane (PDMS) 
Polyethyl
ene 
AlteSilTM 
transluce
nt 
material 
triolein Triolein Silicone/PD
MS 
Gerstel 
Twister 
20x0.5 
mm 
thickne
ss 
low-density 
polyethylene 
(100 µm * 1 m 
* 2.8 cm) 
PVNQ-
poly(dimethyl)silo
xane (PDMS) 
PVNQ-
poly(dimethyl)silo
xane (PDMS) 
Varian 
Empore 
C18 
extraction 
disk 47 
mm & 
Oktanol 
AlteSilTM 
translucen
t material, 
0.5±0.05 
mm 
thickness 
PDMS  AlteSilTM 
translucen
t material, 
0.5±0.05 
mm 
thickness 
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Table A VIII- 1 (continued) Participant passive samplers of BDEs: method information 
 
LAB No. 19 20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
Receiving 
phase mass 
(g): 
Average 
= 13.712 
2 10.2   8.5 0.1213 1.75 g ~ 50 mg ~ 50 mg 
(15 mm 
piece used 
for 
analysis) 
Oktanol: 
0.3735; 
C18:  
8.91 g 
(Altesil 
density = 
1.2 
g/cm3) 
44 mg 20 
Receiving 
phase volume 
(cm3) 
92 cm x 
2.5 cm x 
0.05 cm 
= 11.5 
2.2   1 mL 7.1 0.049 2.8 
cm3 
47 µL 47 µL (15 
mm piece 
used for 
analysis) 
450 µL 
Oktanol; 
144 µL C18  
7.43 cm3  47.10-3 16 
Membrane 
material : 
None Polyethylene   LDPE  No 
membrane 
none 50 µm low-
density 
polyethylene 
tubing 
- 40 µm 
LDPE 
membrane 
- Regenerated 
cellulose 
(Spectra/Por 6 
cutoff 1000 Da) 
Silicon 
rubber 
Active sampler 
surface area 
(or membrane 
area) (cm2): 
469.45 800 313  460 284 4.61 280 
cm2 
Silicone rod: 
1.005; LDPE 
over single 
silicone rod: 18 
1.005 17.35 297 cm2  5.4 600 
Commercial 
passive 
samplers with 
PRC: 
 - D10-biphenyl, 
PCBs: CB001, 
CB002, CB003, 
CB010, CB014, 
CB021, CB030, 
CB050, CB055, 
CB078, CB104, 
CB145, CB204 
deuterated 
PAHs 
13C-PCB1   - 
13C-PCB8  - 
13CPCB54  - 
13CPCB-37 
no No      PCBs: CB 30, 
CB 78, CB 104, 
CB 145, CB 
204.  
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Table A VIII- 1 (continued) Participant passive samplers of BDEs: method information 
LAB No. 19 20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
Performance Reference Compounds (PRC) 
Home made 
PS spiked 
with PRC:  
 2-
bromobiphenyl, 
4-BB, 5-BB 
   YES home made 
PS, 
electronic 
and 
analytical 
QC of the 
PS. 
YES YES YES YES   Home 
spiked,D10-
biphenyl, 
PCBs: CB001, 
CB002, 
CB003, 
CB010, 
CB014, 
CB021, 
CB030, 
CB050, 
CB055, 
CB078, 
CB104, 
CB145, CB204 
Date of 
shipment to 
the study 
organiser: 
08/06/2011 02-Jun-11 05-May-11 07/06/2011 15/04/11   23/06/2011 23/06/2011 23/06/2011 23/06/2011 23/06/2011 July 1st, 
2011 
~10/05/2011 
Date of 
receipt by 
organiser: 
09/06/2011 08-Jun-11 16-May-11 07/06/2011         July 5th, 
2011 
~13/05/2011 
Storage 
before 
deployment 
(°C): 
Fridge 4 
degrees C 
4 - 20 degrees 
celsius 
-20  -20 4 ºC      4°C minus 20°C 
Storage 
conditions: 
Fridge 4 
degrees C 
-20 - 20 degrees 
celsius 
-20  -20 4 ºC      4°C minus 20°C 
Date of 
return: 
02/09/2011 05-Sep-11 13-Jul-11 29/09/2011   31/08/2011      September 
6th, 2011 
~31/8/2011 
Date of 
return 
shipment 
from the 
organiser to 
the 
participant 
laboratory: 
02/09/2011 05-Sep-11 13-Jul-11 29/09/2011   31/08/2011      September 
6th, 2011 
~31/8/2011 
  
  
 
207 
Table A VIII- 1 (continued) Participant passive samplers of BDEs: method information 
LAB No. 19 20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
Date of receipt 
by the 
participant 
laboratory: 
07/09/2011 11-Sep-11 15-Jul-11 29/09/2011   01/09/2011 06/09/2011 06/09/2011 06/09/2011 06/09/2011 06/09/2011 September 
7th, 2011 
~2/9/2011 
REMARKS:  Organizer 
PBDE 
samplers 
not 
received 
          The 
membrane 
material was 
completely 
damaged.   
Dates are 
approximate 
Sampler deployment and recovery 
Date and hour 
of the 
deployment: 
11/7/2011; 
13:40 
11-Jul-11 11/07/2011 
12:25 
11.7.2011, 
12:25 
11/07/11 
13:56 
 11/07/2011 
11:23 
     July 11st, 
2011 at 
14:25 
11/07/2011 
Air Temp on 
deployment 
(°C) 
24 24 24 24 24  22      24°C  
Duration of the 
deployment 
(exposure to 
air for field 
control) 
16 mins 2.25 hours 25 minutes 00:15 26 min  01:15      20 min  
Air Temp on 
recovery (°C) 
31 31 30 30 30  31      31°C  
Duration of the 
recovery 
(exposure to 
air for field 
control) 
37 mins 7 minutes 40 minutes 00:20 15  00:12      11 min   
Date and hour 
of the 
recovery: 
22/8/2011; 
14:35 
22-Aug-11 22/08/2011 
13:30 
22.8.2011, 
13:55 
22/08/11 
14:30 
 22/08/2011 
15:48 
     August 22nd, 
2011 at 
15:37 
22/08/2011 
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Table A VIII- 1 (continued) Participant passive samplers of BDEs: method information 
 
LAB 
No. 
19 20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
Comment 
on 
fouling: 
 - less fouling, 
cleaned with milli Q 
water and scourer 
  less sticky 
fouling 
than on the 
organisers 
sampler 
        
Field 
deployme
nt device 
used: 
Stainless 
steel 
marine 
cage 
Wire - 
no cage 
standard SPMD 
deployment cage 
big 
cage 
canister canister/spi
der holder 
CFIS 
device, 
cage A4 
 10 x 60 
cm 
stainless 
steel 
mesh 
wrapped 
to 10 x 
30 cm 
10 x 60 
cm 
stainless 
steel 
mesh 
wrapped 
to 10 x 
30 cm 
Small SPMD 
deployment cage 
 conical 
fishing 
basket 
(mesh 
wire cage) 
Open cage 
Extractio
n 
technique
: 
2 x 
200mL 
hexane; 
shaken 
at room 
temp for 
2 x 
24hrs. 
Extracts 
combine
d 
Cold 
Bencht
op 
Extracti
on 
Soxhlet extraction 
with 
hexane:aceton 
(3:1) 85 degrees 
16 hours 
dialysi
s 
Solvent 
dialisys 
Pentane 
dialysis 
thermal 
desorpti
on 
3 x 15 min with 
Cyclohexan:Ace
tone (90:10) in 
an ultrasonic 
bath 
direct 
analysis 
with 
thermal 
desorptio
n unit 
(TDU) 
direct 
analysis 
with 
thermal 
desorptio
n unit 
(TDU) 
1 x 15 min 
Acetone, 2 x 15 
min 
ethylacetate:isoo
ctane (1:1) in 
ultrasonic bath 
3 x 15 min with 
Cyclohexan:Ace
tone (90:10) in 
an ultrasonic 
bath 
Sonication 
in 1,6 mL 
of solvents 
mixture 
(nC6:CH2
Cl2, 1:1) 
Soxhlet  with 
acetonitril 
Date of 
extractio
n: 
26/08/20
11 
09-Oct-
11 
07-Sep-11  29/11/1
1 
Dec-11 Novemb
er - 
Decemb
er 
05/10/2011 - - 06/10/2011 05/10/2011 January 3 
, 2011 
20/10/2011 
Date of 
instrume
ntal 
analysis: 
08/01/20
12 
05-
Dec-11 
13-Sep-11  12/01/1
2 
Jan-12 Novemb
er - 
Decemb
er 
19/01/2012 04/01/20
12 
04/01/20
12 
13/01/2012 19/01/2012 January, 
2012  
27/10/2011 
Cleanup 
method: 
GPC 
followed 
by acid 
silica 
treatmen
t 
- 1 gram 40% 
sulfuricacid-silica, 
rinse with 4x 1ml 
hexane:dichlorome
thane (4:1), add 
extract, elute with 
total 3 ml 
hexane:dichlorome
thane (4:1)  
silicag
el, 
alumin
a and 
active 
carbon 
colum
ns 
SFE with 
Silca 
deactivat
ed 
6%H20 
H2SO4 and 
GPC for d-
PAH PRCs 
none NaSO4, 0.45 
µm cellulose 
acetate 
membrane 
none none NaSO4, 0.45 µm 
cellulose acetate 
membrane 
NaSO4, 0.45 
µm cellulose 
acetate 
membrane 
None elution with 
hexane/dietyle
ther over 
Florisil 
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Table A VIII- 1 (continued) Participant passive samplers of BDEs: method information 
LAB 
No. 
19 20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
Instrumenta
l method: 
HR-GCMS GCMSMS GC-MS GC/MS/MS GC/MS/M
S ion trap 
GC/M
S 
TD-GC-MS Agilent 
6890N GC 
with 5973 
MS and 
Gerstel TDU 
(MPS 2 
autosampler
) 
Agilent 
6890N GC 
with 5973 
MS and 
Gerstel TDU 
(MPS 2 
autosampler
) 
Agilent 
6890N GC 
with 5973 
MS and 
Gerstel TDU 
(MPS 2 
autosampler
) 
Agilent 
7890C GC 
with Agilent 
5975C MS; 
15 m x 
0.25 mm x 
0.25 µm HP 
5 ultra inert 
Agilent 
6890N GC 
with 5973 
MS and 
Gerstel TDU 
(MPS 2 
autosampler
) 
GC/MS 
- SIM 
GC-MS 
Injection 
solvent: 
hexane Ethyl 
Acetate 
isooctane nonane Nonane  solventles
s method 
(TD) 
200 µL 
cyclohexane 
(desorption 
of 1 µL from 
glass wool) 
none none 500 µL n-
Octanol 
200 µL 
cyclohexane 
(desorption 
of 1 µL from 
glass wool) 
n-
hexan
e 
Hexane 
Recovery 
and internal 
standards 
used: 
IS: MBDE-
MXE 
(Wellington 
Laboratories)
, 
p-
terphenyl
, 13C12 
PBDE28, 
13C12 
PBDE47, 
13C12 
PBDE99, 
13C12 
PBDE153, 
13C12 
PBDE183, 
13C12 
PBDE209 
BDE58 C13 labelled IS 
(28,47,99,153,154)
; RS=1234TCDD, 
123789HxCDD 
PCB 209 – 
13C-
PCB15 
YES Chrysene-
d12, 
Fluorene-
d10 
Anthracene-
D10 
recovery 
obtained 
with blank 
silicone rods 
spiked with 
PBDEs 
recovery 
obtained 
with blank 
silicone rods 
spiked with 
PBDEs 
Anthracene
-D10 
Anthracene-
D10 
PCBs: 
CB 29, 
CB 
112, 
CB 
209.  
95% of 
PCB20
9 
REMARKS: For the Entox 
samplers: 
PDMS were 
deployed in 
pairs and 
combined 
into one 
sample. The 
weight of 
PDMS and 
surface area 
is the sum of 
the two 
strips 
together 
- PRC reported 
as peak area 
(no 
concentration
s calculated) 
    glass liner 
for injection 
into GC was 
filled with 
SiO2 to 
block 
oligomers 
1 MESCO = 
3 silicone 
rods 
  glass liner 
for injection 
into GC was 
filled with 
SiO2 to 
block 
oligomers 
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Table A VIII- 1 (continued) Participant passive samplers of BDEs: method information 
LAB 
No. 
1
9 
20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
Data evaluation aspects 
Method 
for 
estimatio
n of water 
concentra
tion from 
passive 
sampler: 
 Lohma
nn 
2011 
Kees 
Booij 
and 
Foppe 
Smedes
: 
Environ
. Sci. 
Technol
., 2010, 
44 
(17), 
pp 
6789–
6794 
please 
give a 
short 
descript
ion and 
relevant 
referenc
es 
semiempir
ical 
mehods 
(Huckins 
et al 
2006) 
Rusin
a et al 
metho
d, 
Ksw 
value
s 
from 
Smed
es et 
al 
2009 
calculat
ion with 
calibrat
ed 
samplin
g rate 
Ctwa=ms/(Ksw*V*
ke*t); ke obtained 
with logistic 
regression 
Ctwa=ms/(Ksw*V*
ke*t); ke obtained 
with logistic 
regression 
Ctwa=ms/(Ksw*V*
ke*t); ke obtained 
with logistic 
regression 
Ctwa=ms/(Ksw*V*
ke*t); ke obtained 
with logistic 
regression 
Ctwa=ms/(Ksw*V*
ke*t); ke obtained 
with logistic 
regression 
Booij 
and 
Smedes, 
Environ. 
Sci. 
Technol. 
2010, 
44, 
6789–
6794.  
Fitting 
PRC 
dissipati
on with 
model 
and a 
flowfact
or as 
adjusta
ble 
paramet
er. Then 
this flow 
factor is 
applied 
to 
calculat
e the 
Cw 
Sampling 
rates used 
(literature 
value/ow
n 
calibratio
n): 
  own 
calculat
ion 
literatur
e: 
Huckins
, Petty, 
Booij 
literature 
value 
Rs 
from 
NLS 
metho
d 
(Booi 
et al) 
own 
calibrati
on 
NO     calculat
ed from 
PRC 
release 
with 
littératu
re 
values 
distribut
ion 
coefficie
nts 
From 
PRCs 
using 
Rusina 
Est 
2010 
and 
Booij 
and 
Smedes 
EST 
2010 
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Table A VIII- 1 (continued) Participant passive samplers of BDEs: method information 
LAB No. 19 20 21 23 26 29 30 36a 36b 36c 36d 36 38 43 
               
Performance 
reference 
compounds 
applied 
(YES/NO):  
 Yes yes YES D 10 
phenantrene 
Yes YES, 
deuterated 
PAHs 
NO YES YES YES YES YES yes Yes 
Were the 
calibration data 
adjusted to 
reflect exposure 
conditions 
(temperature, 
flow, pH...?) 
 Temperature 
corrected 
following 
Lohmann 2011 
(using dH = 25 
kJ/mol; Average 
water 
temperature = 
18.71 degrees C) 
no no No  YES NO      Flow corrected 
(not 
Temperature) 
REMARKS:  - PRC reported as 
peak area (no 
concentrations 
calculated) 
    PRCs not 
quantified, 
retained 
fraction was 
obtained 
from peak 
areas  
PRCs not 
quantified, ke-
values were 
obtained from 
peak areas, 
Standard 
solution valid 
for all 
following data 
sheets  
PRCs not 
quantified, 
ke-values 
were 
obtained 
from peak 
areas  
PRCs not 
quantified, 
ke-values 
were 
obtained 
from peak 
areas  
PRCs not 
quantified, 
retained 
fraction was 
obtained 
from peak 
areas  
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Annex IX.  Provided passive samplers of bisphenol A: method information 
 
Table A IX- 1 Provided passive samplers of bisphenol A: method information 
LAB No. 19 20 23 26 39 19 20 23 26 39     
PS type : POCIS, pharmaceutical version 
Receiving phase material: sorbent Oasis HLB, 60 μm  
Receiving phase mass (g): 0.200 g; mass of sorbent separated from samplers after exposure is given on each SPE cartridge 
Membrane material : Polyethersulphone; SUPOR 100 Membrane Disc Filters (0.1 μm, 90 mm diameter) 
Active sampler surface area (or membrane area) (cm2): 45.8 cm2 
Performance and Reference Compound (PRC) * 
Passive samplers with PRC : NO 
 
Table A IX- 2 Provided passive samplers of bisphenol A: method information 
 
LAB No. 19 20 23 26 39 
Transport and storage 
Date of shipment to the study 
organiser: 
 June 2 2011  15/04/2011 - 
Date of receipt by the study 
organiser ** : 
 June 8 2011   - 
Storage conditions before 
deployment (°C)**: 
Fridge 4 degrees C 4   4 
Storage conditions after 
sampler recovery (°C)**: 
Fridge 4 degrees C -20   -20 
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LAB No. 19 20 23 26 39 
Date of return shipment from 
the organiser to the participant 
laboratory:** 
21/07/2011 September 5 2011   18/07/2011 
Date of receipt by the 
participant laboratory ** : 
26/07/2011 September 11 2011 20/07/2011  19/07/2011 
REMARKS:  Samples stored at 4C upon receipt   The extract from steroid samplers 
was used because there was not 
enough samplers to send triplicates 
for both compound classes 
 
Table A IX- 3 Provided passive samplers of bisphenol A: method information 
LAB No. 19 20 23 26 39 
Sampler deployment and recovery 
Date and hour of the 
deployment ** : 
20/6/2011; 10:34, 11:03 6/20/2011  approx. 10:30 20.6.2011, 12:00 20/06/2011 10.34 (sampl 4) and  
11.03 (sampl 9) 
20.06.2011 11:03 
Air Temp on deployment (°C)** 17 17 20 17 17 
Duration of the deployment 
(exposure to air for field 
control)** 
39 mins, 46 mins approx. 30 minutes 0.020833333 25 min (sampl 4) and  46 min 
(sampl 9) 
30 min 
Air Temp on recovery (°C)** 17,18 18 19 18 17 
Duration of the recovery 
(exposure to air for field 
control)** 
40 mins, 30 mins approx. 30 minutes 0.038194444 20 min (sampl 4) and 30 min 
(sampl 9) 
30 min 
Date and hour of the recovery 
** : 
4/7/2011; 10:15, 11:00am 7/4/2011  approx. 11:00 4.7.2011, 12:00 4/7/2011 9,40 (sampl 4) and 11,00  
(sampl 9) 
04.07.2011 11:00 
Comment on fouling**:  None visible   Exposed membranes were spotted 
and darker than unexposed ones 
Field deployment device used      
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LAB No. 19 20 23 26 39 
Type of deployment device 
(canister, cage...) : 
standard POCIS deployment cage 
for 6 samplers 
standard POCIS deployment cage 
for 6 samplers 
standard POCIS deployment cage 
for 6 samplers 
standard POCIS deployment cage 
for 6 samplers 
standard POCIS deployment cage 
for 6 samplers 
      
Analytical aspects      
Extraction technique: Elution of cartridges under gentle 
vacuum with 3 mL methanol, 2 mL 
acetone/ hexane 50:50 
Cold benchtop extraction with 
Dichloromethane 
liquid extraction Solvent elution 5 mL MeOH - 5 mL MeOH/DCM 
(50/50) - 5 mL DCM 
Date of extraction: 01/09/2011 November 22 2011  07/12/2011 23.08.2011 
Date of instrumental analysis: 05/09/2011 December 6 2011  03/01/2012 30.08.2011 
Cleanup method: Liquid-liquid extraction with water 
to remove derivatising agent 
None no No cleanup No cleanup 
Instrumental method: GCMS GC/MS GC/MS/MS GC/MS/SIS ion trap Derivatization - GC/MS 
Injection solvent: 50% hexane/ acetone Dichloromethane and Methanol heptane MSTFA Acetone 
Recovery and internal standards 
used: 
Derivatised using silylating agent 
(BFTSA + TMCS). Analysis with 
external calibration 
13C12 Bisphenol A,  
Tribromobiphenyl 
IS = C13 labelled BPA, RS not used Bisphenol – d16 BPA d4 
REMARKS:     The extract from steroid samplers 
was used because there was not 
enough samplers to send triplicates 
for both compound classes 
 
  
  
 
215 
Table A IX- 4 Provided passive samplers of bisphenol A: method information 
LAB No. 19 20 23 26 39 
Data evaluation aspects 
Method for estimation of water 
concentration from passive 
sampler: 
Cw = Ns/(Rs*t) Li, Helm, and Metcalfe ETC 2010 please give a short description and 
relevant references 
Arditsoglou et al Environmental 
Pollution 156 (2008) 
Calculation with following formula 
: Cs x 0,2 = Cw Rs t (Vrana et al., 
2005) 
Sampling rates used (literature 
value/own calibration): 
Literature: (Li et al, 2010). BPA = 
0.835 
Rs=0.835  Literature value Own calibration 
Sampler/water partition 
(distribution) coefficients 
used: 
No   Literature value - 
Performance reference 
compounds applied (YES/NO):  
No   NO NO 
Were the calibration data 
adjusted to reflect exposure 
conditions (temperature, flow, 
pH...?) 
No No  NO NO 
REMARKS:  Cw=ng(total)/(Rs*total days)    
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Annex X.  Participant passive samplers of bisphenol A: method information 
 
Table A X- 1 Participant passive samplers of bisphenol A: method information 
LAB No. 19 20 23 26 39 45 
PS type : Empore Disk Polyoxymethylene standard SPMD 
(length 1m) 
POCIS Pharmacautical 
Version 
POCIS, pharmaceutical version POCIS, pharmaceutical version 
Home made or commercial 
PS : 
Commercial Home made commercial Commercial PS Home made  
Supplier : Phenomenex N/A Exposmeter AB Exposmeter AB -  
Receiving phase material: SDB-RPS Reverse Phase 
Sulfonated 
Polyoxymethylene triolein Oasis HLB 60 μ Oasis HLB sorbent, 60 µm sorbent Oasis HLB, 60 μm  
Receiving phase mass (g): 0.398 about 2  0.2 0.200 0.200 g; mass of sorbent separated from 
samplers after exposure is given on each SPE 
cartridge 
Receiving phase volume 
(cm3) 
1.73494 about 1.7   -  
Membrane material : Polyethersulfone (0.45um) 
SUPOR 450 filters PALL Life 
Sciences 
Polyoxymethylene  Polyethersulphone Polyethersulphone; SUPOR 100 
Membrane Disc Filters (0.1 μm, 90 mm 
diameter) 
Polyethersulphone; SUPOR 100 Membrane 
Disc Filters (0.1 μm, 90 mm diameter) 
Active sampler surface 
area (or membrane area) 
(cm2): 
16 about 620  45.8 42.47 45.8 cm2 
Performance Reference 
Compounds (PRC) 
      
Commercial passive 
samplers with PRC: 
 N/A No NO NO NO 
or home made PS spiked 
with PRC:  
 d6 Bisphenol A  NO NO  
Transport and storage 
Date of shipment to the 
study organiser: 
approx 7 May 2011 June 2 2011 07/06/2011 15/04/2011 13.05.2011  
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Table A X- 1 (continued) Participant passive samplers of bisphenol A: method information 
 
LAB No. 19 20 23 26 39 45 
Date of receipt by the study organiser: 14 May 2011 (Handover at 
conference) 
June 8 2011 07/06/2011  16.05.2011  
Storage conditions before deployment (°C): 4 degrees C 4 -20  room 
temperature 
 
Storage conditions after sampler recovery (°C): 4 degrees C -20 -20  -20  
Date of return shipment from the organiser to the 
participant laboratory: 
21/07/2011 September 5 2011 20/07/2011  18.07.2011  
Date of receipt by the participant laboratory: 26/07/2011 September 11 2011 20/07/2011  19.07.2011  
REMARKS:  Samples stored at 4C upon 
receipt 
  -  
Date and hour of the deployment: 20/6/2011; 15:45 20/06/2011 20.6.2011, 
14:30 
20/06/2011 
13,25 
20.06.2011 
13:50 
Sampler 21: 20.06.2011  
09:55:00 
Sampler 38: 20.06.2011  
10:34:00 
Sampler 86: 20.06.2011  
11:44:00 
Air Temp on deployment (°C) 20 22 20 20 20 Sampler 21: 15 °C 
Sampler 38: 17 °C 
Sampler 86: 17 °C 
Duration of the deployment (exposure to air for field 
control) 
1 hr 25 mins 25 minutes 0.020833333 15 min 30 min Sampler 21: 13.990 
Sampler 38: 13.987 
Sampler 86: 13.990 
Air Temp on recovery (°C) 22 21 18 18 18 Sampler 21: 17 °C 
Sampler 38: 17 °C 
Sampler 86: 18 °C 
Duration of the recovery (exposure to air for field control) 58 mins approx. 45 minutes 00:30:00 20  min 20 min  
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Table A X- 1 (continued) Participant passive samplers of bisphenol A: method information 
 
LAB No. 19 20 23 26 39 45 
Date and hour of the recovery: 4/7/2077; 15:17 04/07/2011 4.7.2011, 14:40 04/07/2011 04.07.2011 14:30 Sampler 21: 04.07.2011  
09:40:00 
Sampler 38: 04.07.2011  
10:15:00 
Sampler 86: 04.07.2011  
11:30:00 
Comment on fouling:  None visible   Exposed membranes were 
spotted and darker than 
unexposed ones 
- 
Field deployment device used: Teflon chemcatcher case Copper case big cage canister Standard POCIS deployment 
cage for 3 samplers 
standard POCIS 
deployment cage for 6 
samplers 
Extraction technique: 5 mL Acetone followed by 5 mL 
methanol; sonication; at room 
temperature 
Cold benchtop with 
Dichloromethane 
dialysis Solvent elution 5 mL MeOH - 5 mL MeOH/DCM 
(50/50) - 5 mL DCM 
MeOH, 40 ml 
Date of extraction: 25/08/2011 November 6 2011  07/12/2011 23.08.2011 02/08/2011 
Date of instrumental analysis: 16/09/2011 December 6 2011  03/01/2012 30.08.2011 04/08/2011 
Cleanup method: Liquid-liquid extraction with water 
to remove derivatising agent 
None dialysis No cleanup No cleanup no 
Instrumental method: GCMS CG/MS GC/MS/MS GC/MS/SIS ion trap Derivatization - GC/MS LC-MS/MS 
Injection solvent: 50% hexane/ acetone Dichloromethane and 
Methanol 
heptane MSTFA Acetone EtOH 
Recovery and internal 
standards used: 
Derivatised using silylating agent 
(BFTSA + TMCS). Analysis with 
external calibration 
13C12 Bisphenol A, 
Tribromobiphenyl 
IS = C13 labelled 
BPA, RS not used 
Bisphenol-d16 BPA d4 D16-Bisphenol A 
Method for estimation of water 
concentration from passive 
sampler: 
 Experimental value from 
Endo et al., ES&T 2011 
 Arditsoglou et al. 
Environmental Pollution 156 
(2008) 316-324 
Calculation with following formula 
: Cs x 0,2 = Cw Rs t (Vrana et 
al., 2005) 
Averaged sampling rate 
from 2 publications was 
used: 
1. Z. Zhang et al., Anal 
Chim Acta 607, 37-44 
2. A. Arditsoglou et al, 
Env Pollution 156, 316-
324 
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Table A X- 1 (continued) Participant passive samplers of bisphenol A: method information 
LAB No. 19 20 23 26 39 45 
Data evaluation aspects 
       
Sampling rates used (literature value/own calibration):    literature 
value 
Own 
calibration 
0.14 L/day. Literature, 
averaged  
Sampler/water partition (distribution) coefficients used:  Kpom/w=2.63  literature 
value 
-  
Performance reference compounds applied (YES/NO):   YES  NO NO no 
Were the calibration data adjusted to reflect exposure conditions (temperature, 
flow, pH...?) 
 Yes, to reflect a pH of 7.66  NO NO no 
REMARKS:  Adjusted for % equilibrium reached based on 
PRC 
  -  
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Annex XI.  Provided passive samplers of triclosan: method information 
 
Table A XI- 1 Provided passive samplers of triclosan: method information 
LAB No. 19 20 23            
PS type : POCIS, pharmaceutical version 
Receiving phase material: sorbent Oasis HLB, 60 μm  
Receiving phase mass (g): 0.200 g; mass of sorbent separated from samplers after exposure is given on each 
SPE cartridge 
Membrane material : Polyethersulphone; SUPOR 100 Membrane Disc Filters (0.1 μm, 90 mm diameter) 
Active sampler surface area (or membrane 
area) (cm2): 
45.8 cm2 
Performance and Reference Compound (PRC) * 
Passive samplers with PRC : NO 
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Table A XI- 2 Provided passive samplers of triclosan: method information 
LAB No. 19 20 23 
Transport and storage 
Date of shipment to 
the study organiser: 
 June 2 2011  
Date of receipt by the 
study organiser ** : 
 June 8 2011  
Storage conditions 
before deployment 
(°C)**: 
Fridge 4 degrees C 4  
Storage conditions 
after sampler recovery 
(°C)**: 
Fridge 4 degrees C -20  
Date of return 
shipment from the 
organiser to the 
participant 
laboratory:** 
21/07/2011 September 5 2011  
Date of receipt by the 
participant laboratory 
** : 
26/07/2011 September 11 2011 20/07/2011 
REMARKS:  Samples stored at 4C 
upon receipt 
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Table A XI- 2 (continued) Provided passive samplers of triclosan: method information 
LAB No. 19 20 23 
Sampler deployment and recovery 
Date and hour of the 
deployment ** : 
20/6/2011; 11:03 6/20/2011  approx. 
10:30 
20.6.2011, 12:00 
Air Temp on 
deployment (°C)** 
17 17 20 
Duration of the 
deployment (exposure 
to air for field 
control)** 
45mins approx. 30 minutes 0.020833333 
Air Temp on recovery 
(°C)** 
18 18 19 
Duration of the 
recovery (exposure to 
air for field control)** 
30 mins approx. 30 minutes 0.038194444 
Date and hour of the 
recovery ** : 
4/7/2011; 11:00am 7/4/2011  approx. 11:00 4.7.2011, 12:00 
Comment on 
fouling**: 
 None visible  
Field deployment 
device used 
   
Type of deployment 
device (canister, 
cage...) : 
standard POCIS 
deployment cage for 6 
samplers 
standard POCIS 
deployment cage for 6 
samplers 
standard POCIS 
deployment cage for 6 
samplers 
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Table A XI- 2 (continued) Provided passive samplers of triclosan: method information 
LAB No. 19 20 23 
Analytical aspects    
Extraction technique: Elution of cartridges 
under gentle vacuum 
with 3 mL methanol, 2 
mL acetone/ hexane 
50:50 
Cold benchtop extraction 
with Dichloromethane 
liquid extraction 
Date of extraction: 40787 November 22 2011  
Date of instrumental 
analysis: 
40791 December 6 2011  
Cleanup method: No clean up None no, derivatization - 
acetylation 
Instrumental method: LCMS GC/MS GC/MS/MS 
Injection solvent: 50% methanol/ water Dichloromethane heptane 
Recovery and internal 
standards used: 
none 13C12 Triclosan, d14-
para Terphenyl 
IS = C13 labelled 
triclosan, RS not used 
REMARKS:    
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Table A XI- 2 (continued) Provided passive samplers of triclosan: method information 
LAB No. 19 20 23 
Data evaluation 
aspects 
   
Method for estimation 
of water 
concentration from 
passive sampler: 
Cw=Ns/(Rs*t) Li, Helm, and Metcalfe 
ETC 2010 
please give a short 
description and relevant 
references 
Sampling rates used 
(literature value/own 
calibration): 
Literature (Li et al, 
2010). Triclosan=1.929 
Rs=2.150  
Sampler/water 
partition 
(distribution) 
coefficients used: 
No   
Performance 
reference compounds 
applied (YES/NO):  
No   
Were the calibration 
data adjusted to 
reflect exposure 
conditions 
(temperature, flow, 
pH...?) 
No No  
REMARKS:  Cw=ng(total)/(Rs*total 
days) 
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Annex XII.  Participant passive samplers of triclosan: method information 
Table A XII- 1 Participant passive samplers of triclosan: method information 
LAB No. 19 20 23 
PS type :    
Home made or commercial PS : Empore Disk Polyethylene standard SPMD (length 1m) 
 Commercial Home made commercial 
Supplier : Phenomenex N/A Exposmeter AB 
Receiving phase material: SDB-RPS Reverse Phase Sulfonated Polyethylene triolein 
Receiving phase mass (g): 0.398 about 1.7  
Receiving phase volume (cm3) 1.73494 about 2  
Membrane material : Polyethersulfone (0.45um) SUPOR 450 filters PALL Life Sciences Polyethylene  
Active sampler surface area (or membrane area) (cm2): 16 about 700  
Performance Reference Compounds (PRC) 
Commercial passive samplers with PRC:  N/A D10 Phenantrene 
or home made PS spiked with PRC:   d6 Bisphenol A  
Transport and storage 
Date of shipment to the study organiser: approx 7 May 2011  June 2 2011 07/06/2011 
Date of receipt by the study organiser: 14 May 2011 (Handover at conference) June 8 2011 07/06/2011 
Storage conditions before deployment (°C): Fridge 4 degrees C 4 -20 
Storage conditions after sampler recovery (°C): Fridge 4 degrees C -20 -20 
Date of return shipment from the organiser to the participant laboratory: 21/07/2011 September 5 2011 20/07/2011 
Date of receipt by the participant laboratory: 26/07/2011 September 11 2011 20/07/2011 
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LAB No. 19 20 23 
REMARKS:  Samples stored at 4C upon receipt  
Sampler deployment and recovery    
Date and hour of the deployment: 20/6/2011; 15:45 40714.70486 20.6.2011, 14:30 
Air Temp on deployment (°C) 20 22 20 
Duration of the deployment (exposure to air for field control) 1 hr 25 mins 25 minutes 00:30:00 
Air Temp on recovery (°C) 22 21 18 
Duration of the recovery (exposure to air for field control) 58 mins 10 minutes 00:30:00 
Date and hour of the recovery: 4/7/2011; 15:17 04/07/2011 4.7.2011, 14:40 
Comment on fouling:  None visible  
Table A XI- 1 Participant passive samplers of triclosan: method information 
LAB No. 19 20 23 
Field deployment device used: Teflon Chemcatcher case Wire, No cage standard big cage for POCISes and SPMDs 
Extraction technique: 5 mL Acetone followed by 5 mL methanol; sonication; at room temperature Cold benchtop extraction with Ethyl Acetate dialysis 
Date of extraction: 01/09/2011 November 22 2011  
Date of instrumental analysis: 05/09/2011 December 6 2011  
Cleanup method: no clean up None no, derivatization - acetylation 
Instrumental method: LCMS CG/MS GC/MS/MS 
Injection solvent: 50% Methanol/ water Dichloromethane and Methanol heptane 
Recovery and internal standards used: None 13C12 Bisphenol A, 13C12 Triclosan IS = C13 labelled triclosan, RS not used 
REMARKS:    
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Table A XI- 2 Participant passive samplers of triclosan: method information 
LAB No. 19 20 23 
Data evaluation aspects 
Method for estimation of water concentration from passive sampler: No sampling rates available for triclosan 
in Empore Disks 
Equation 5, as well as initial partitioning from Sacks and 
Lohmann, ES&T 2011 
please give a short description and 
relevant references 
Sampling rates used (literature value/own calibration):   literature: Huckins, Petty, Booij 
Sampler/water partition (distribution) coefficients used:  Kpe/w = 3.14 calculated from Kow and Le Bas V 
(Mackay et al.) 
Performance reference compounds applied (YES/NO):   YES YES D10 phenantrene 
Were the calibration data adjusted to reflect exposure conditions 
(temperature, flow, pH...?) 
 Yes, to reflect a pH of 7.66 no 
REMARKS:  Adjusted for % equilibrium reached based on d6 
Bisphenol A PRC 
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Annex XIII. Provided passive samplers of fluorinated surfactants: method information 
 
Table XIII- 1 Provided passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 44 52      
PS type : POCIS, pharmaceutical version 
Receiving phase material: sorbent Oasis HLB, 60 μm  
Receiving phase mass (g): 0.200 g; mass of sorbent separated from samplers after exposure is given on each 
SPE cartridge 
Membrane material : Polyethersulphone; SUPOR 100 Membrane Disc Filters (0.1 μm, 90 mm diameter) 
Active sampler surface area (or membrane 
area) (cm2): 
45.8 cm2 
Performance and Reference Compound (PRC) * 
Passive samplers with PRC : NO 
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Table XIII- 2 Provided passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 44 52 
Transport and storage 
Storage 
conditions 
before 
deployment 
(°C)**: 
4  -20   4   4°C 
Storage 
conditions 
after 
sampler 
recovery 
(°C)**: 
 - 20 degrees 
celsius 
-20   -20  freezer -20°C 
Date of 
return 
shipment 
from the 
organiser to 
the 
participant 
laboratory:*
* 
 13/07/2011 20/07/2011   18.07.2011 ~31/8/2011  18.7.2011 via 
TNT; shipment 
GD 31269940 
WW 
Date of 
receipt by 
the 
participant 
laboratory 
** : 
13/07/2011 15/07/2011 20/07/2011   19.07.2011 ~2/9/2011 10/25/11 19.7.2011 
REMARKS:       Dates are 
approximate 
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Table XIII- 2 (continued) Provided passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 44 52 
Date and 
hour of the 
deployment 
** : 
20/06/2011 20-June-2011 
between 9:55 
and 12:00  
20.6.2011, 
12:00 
  20.06.2011 
11:03 
20/06/2011 (15) 6/20/11, 
9:55       (52) 
6/20/11,10:17        
(101) 
6/20/11, 
12:00 
20.6.2011 
Air Temp on 
deployment 
(°C)** 
16 17 20   17  (15) 15°C                   
(52) 17°C                    
(101) 20°C 
17 
Duration of 
the 
deployment 
(exposure to 
air for field 
control)** 
25 min +/- 30 
minutes 
0.020833333   30 min  (15)  25 min               
(52)  46 min                 
(101) 30 min 
 
Air Temp on 
recovery 
(°C)** 
17 18 19   17  (15) 17°C                   
(52) 18°C                    
(101) 19°C 
18 
Duration of 
the recovery 
(exposure to 
air for field 
control)** 
20 min +/- 30 
minutes 
0.038194444   30 min  (15) 20 min                
(52) 30 min                  
(101) 55 min 
 
Date and 
hour of the 
recovery ** : 
04/07/2011 4-July-2011 
between 9:40 
and 12:00 
4.7.2011, 
12:00 
  04.07.2011 
11:00 
04/06/2011 (15) 7/4/11, 
9:40        (52) 
7/4/11, 11:00         
(101) 7/4/11, 
12:00 
4.7.2011 
Comment on 
fouling**: 
 no fouling    Exposed 
membranes were 
spotted and darker 
than unexposed 
ones 
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Table XIII- 2 (continued) Provided passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 44 52 
Extraction 
technique: 
placed in pre-
cleaned 6 cc 
cartridges. 
Eluted 4 ml 
methanol + 
0.1% 
ammonia 
followed 4 ml 
methanol. 
sorbent rinsed 
with +/- 10 ml 
milli Q into 
empty glass 
column with 
PTFE frit, 
drying 10 
minutes (-50 
kPa), elution 
with 3x 4ml 
methanol 
liquid 
extraction 
Same as for 
NIVA samplers 
according to 
Alvarez 2004 
10 mL MeOH - 
10 mL 
MeOH/DCM 
(50/50) - 10 
mL DCM 
Elution with 4 
ml 
methyltertiary
butylether 
followed by 8 
ml methanol 
3x5ml 70% 
MeOH 
Elution with 
methanol (15 
ml) 
Date of 
extraction: 
30/08/2011 13/09/2011   20/10/2011 18.08.2011 20/10/2011 13/12/2011 27/07/2011 
Date of 
instrumental 
analysis: 
31/09/11     24.08.2011    
Cleanup 
method: 
none 100 mg 
Envicarb 
No  no No cleanup No SupelcoEnvi-
Carb (6ml) 
 
Instrumental 
method: 
LC MS LC-MS LC/MS/MS  LC-MS/MS LC-MS-MS LC-MSMS LC/MS/MS, 
ESI-, 
Column:Zorba
xEclipseXDB-
C18 RR, 
Mobile phase: 
gradient:water
0,2% 
CH3COOH, 
MeOH 0,2% 
CH3COOH 
HPLC-MS-MS 
Injection 
solvent: 
50:50 
methanol:wat
er 
methanol MeOH/H2O  75% 
methanol/25
% 5mM 
ammonium 
acetate 
MeOH/ultrapur
e water 
(50/50) 
Acetonitrile-
water 
MeOH Methanol / 
Water (50/50) 
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Table XIII- 2 (continued) Provided passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 44 52 
Recovery 
and internal 
standards 
used: 
C labelled 
solution 
mixture 
(MPFAC MXA, 
Wellington 
Laboratories, 
Guelph, 
Ontario, 
Canada) 
13C8PFOA, 
13C8PFOS 
IS=C13 
labelled PFOS 
and PFOA 
 yes 13C4-PFOA, 
13C4-PFOS 
Several 
standards 
used but 
generaaly not 
the target 
compounds, 
Therefore no 
corrections 
were made. 
Int.stand.: 
Perfluorooctan
oic acid 4C13, 
Perfluorooctan
e sulfonic acid 
4C13 
PFOS 13C4 
and PFOA 
13C4 
REMARKS: M8PFOA used 
as instrument 
performance 
standard and 
to check 
recovery of 
Internal 
standards 
   sample PP 
PFOS 2 
(provided 
sampler) lost 
 No corrections 
for 
suppression 
made 
  
Data evaluation aspects 
Method for 
estimation of 
water 
concentratio
n from 
passive 
sampler: 
please give a 
short 
description 
and relevant 
references 
not calculated, 
uptake 
rate/sampling 
rate unknown 
please give a 
short 
description 
and relevant 
references 
No Cw 
calculated as 
no Rs 
available 
 - Uptake of 
Clotrimaziole, 
Carbamezapin
e, 
Thiabendazol, 
transfered to 
sampled 
volume using 
Cw from SR 
sampling 
please give a 
short 
description 
and relevant 
references 
please give a 
short 
description 
and relevant 
references 
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Table XIII- 2 (continued) Provided passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 44 52 
Sampling 
rates used 
(literature 
value/own 
calibration): 
N/A     No sampling 
rates were 
found in the 
literature 
From 
calibration 
with SR 
results, see 
line 7 
 not available 
Sampler/wat
er partition 
(distribution
) coefficients 
used: 
N/A     - none   
Performance 
reference 
compounds 
applied 
(YES/NO):  
No no   no NO NO   
Were the 
calibration 
data 
adjusted to 
reflect 
exposure 
conditions 
(temperatur
e, flow, 
pH...?) 
No no   no - Only an 
attempt to 
correct for 
flow  
  
REMARKS:  not calculated, 
uptake 
rate/sampling 
rate unknown 
  bad recovery 
and calibration 
problems, 
TWA data not 
shown 
 Not very 
confident on 
samplingrate 
applied 
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Annex XIV. Participant passive samplers of fluorinated surfactants: method 
information 
Table XIV- 1 Participant passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 
PS type : Modified POCIS POCIS POCIS, pesticide 
version 
POCIS POCIS POCIS, pharmaceutical version Speedisks (2 disks 
form one sampler) 
Home made or 
commercial PS : 
Home made  home made commercial home made home made Home made J.T. Baker, Bakerbond 
Speedisk, H2O Philic 
DVB, Art.nr.: 8072-07 
   EST   - JT Baker 
Supplier :        
Receiving phase 
material: 
Strata XAW sorbent 
(Phenomenex), 33 μm  
Sepra ZT, 
Phenomenex, 30 um, 
85A 
Biobeads, Ambersorb 
and Isolute ENV+ 
OASIS HLB Oasis HLB Oasis HLB sorbent, 60 µm DVB 
Receiving phase mass 
(g): 
0.6 300 0.22 0.2 0.1 0.200 0.95 
Receiving phase 
volume (cm3) 
     -  
Membrane material : Polyethersulphone; SUPOR 100 
Membrane Disc Filters (0.45 μm, 
47 mm diameter) 
polyethersulfone, Pall 
corporation 
Polyethersulphone polyethersulphone polyethersulphone 
STERLITECH 0.45um 
Polyethersulphone; SUPOR 100 
Membrane Disc Filters (0.1 μm, 
90 mm diameter) 
Glassfibre Filter ±0.5 
mm 
Active sampler 
surface area (or 
membrane area) 
(cm2): 
16.0 45.8 47.5 45.8 14.1 42.5 35.0 
Performance 
Reference Compounds 
(PRC) 
       
Commercial passive 
samplers with PRC: 
None  No no  NO No PRCs 
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Table XIV- 1 (continued) Participant passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 
or home made PS spiked with PRC:  None   no no NO No PRCs 
Transport and storage 
Date of shipment to the study organiser: 08/06/2011 05/05/2011 07/06/2011   13.05.2011 ~10/05/2011 
Date of receipt by the study organiser:  16-May-11 07/06/2011   16.05.2011 ~13/05/2011 
Storage conditions before deployment (°C): 4 - 20 degrees celsius -20 -20  room temperature 4°C immersed in water 
Storage conditions after sampler recovery (°C):  - 20 degrees celsius -20 -20  -20 minus 20°C 
Date of return shipment from the organiser to the participant laboratory:  13/07/2011 20/07/2011   18.07.2011 ~31/8/2011 
Date of receipt by the participant laboratory: 13/07/2011 15/07/2011 20/07/2011   19.07.2011 ~2/9/2011 
REMARKS:      - Dates are approximate 
Date and hour of the deployment: 20/06/2011 20/06/2011 20.6.2011, 
14:30 
  20.06.2011 13:50 20/06/2011 
Air Temp on deployment (°C) 20.5 20 20   20  
Duration of the deployment (exposure to air for field control) 85 min 25 minutes 00:30   30 min  
Air Temp on recovery (°C) 22 18 18   18  
Duration of the recovery (exposure to air for field control) 58 min 15 minutes 00:30   20 min  
Date and hour of the recovery: 04/07/2011 04/07/2011 4.7.2011, 
14:40 
  04.07.2011 14:30 04/07/2011 
Comment on fouling:  no fouling 2nd and 3rd 
POCISes 
were cracked 
on the arrival 
  Exposed membranes 
were spotted and 
darker than 
unexposed ones 
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Table XIV- 1 (continued) Participant passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 
Sampler deployment and recovery 
Field deployment 
device used: 
Entox deployment cage, 3x 
POCIS per cage 
big cage provided by WRI big cage canister/holder standard POCIS cage Standard POCIS 
deployment cage for 3 
samplers 
Wet mounted on open cage 
Extraction 
technique: 
placed in pre-cleaned 6 cc 
cartridges. Eluted 4 ml 
methanol + 0.1% ammonia 
followed 4 ml methanol. 
sorbent rinsed with +/- 10 ml 
milli Q into empty glass column 
with PTFE frit, drying 10 
minutes (-50 kPa), elution with 
3x 4ml methanol 
liquid 
extraction 
Elution with 
MeOH 
2 x 10mL 90% methanol (15 
min in ultrasonic bath), then 
evaporation of solvent, 
reconstitution and analysis 
10 mL MeOH - 10 mL 
MeOH/DCM (50/50) - 
10 mL DCM 
Elution with 15 ml 
methyltertiarybutylether followed by 
20 ml DCM and finally with 15 ml 
methanol 
Date of 
extraction: 
30/08/2011 13/09/2011  01/09/2011 20/10/2011 18.08.2011 20/10/2011 
Date of 
instrumental 
analysis: 
31/09/11 21-Sep-11  Oct-11 21/10/2011 24.08.2011 27/10/2011 
Cleanup method: none 100 mg Envicarb No none no No cleanup No 
Instrumental 
method: 
LC MS LC-MS LC/MS/MS LC/MS LC-MS/MS LC-MS-MS LC-MSMS 
Injection 
solvent: 
50:50 methanol:water methanol MeOH/H2O  75% methanol/25% 5mM 
ammonium acetate 
MeOH/ultrapure water 
(50/50) 
Acetonitrile-water 
Recovery and 
internal 
standards used: 
C labelled solution mixture 
(MPFAC MXA, Wellington 
Laboratories, Guelph, Ontario, 
Canada) 
13C8PFOA, 13C8PFOS IS=C13 
labelled PFOS 
and PFOA 
YES yes 13C4-PFOA, 13C4-
PFOS 
Several standards used but 
generaaly not the target compounds, 
Therefore no corrections were made. 
REMARKS: M8PFOA used as instrument 
performance standard and to 
check recovery of Internal 
standards 
     No corrections for suppression made 
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Table XIV- 1 (continued) Participant passive samplers of fluorinated surfactants: method information 
LAB No. 19 21 23 29 37 39 43 
Data evaluation aspects 
Method for estimation of 
water concentration from 
passive sampler: 
Huckins et 
al. ES&T 
1999 
not calculated, 
uptake 
rate/sampling rate 
unknown 
please give a short 
description and 
relevant references 
No Cw 
calculated as 
no Rs available 
TWA calculated 
according to 
Alvarez 2004 
- Uptake of Clotrimaziole, 
Carbamezapine, Thiabendazol and 
Fluoranthene transfered to sampled 
volume using Cw from SR sampling 
Sampling rates used 
(literature value/own 
calibration): 
Own 
calibration 
   own calibration No sampling rates were found in the 
literature 
From calibration with SR results, see 
line 7 
Sampler/water partition 
(distribution) coefficients 
used: 
Own 
calibration 
   - - none 
Performance reference 
compounds applied 
(YES/NO):  
NO no   no NO NO 
Were the calibration data 
adjusted to reflect exposure 
conditions (temperature, 
flow, pH...?) 
NO no   no - Only an attempt to correct for flow  
REMARKS:  not calculated, 
uptake 
rate/sampling rate 
unknown 
  bad recovery and 
calibration 
problems, TWA 
data not shown 
Cartridges with HLB sorbent were not 
completely dry (mass of about 0,25 g) 
so concentrations in sorbent were 
calculated with a nominal mass of 0,2g 
Not very confident on samplingrate 
applied 
 
 
 
 
  
 
How to obtain EU publications 
 
Our publications are available from EU Bookshop (http://bookshop.europa.eu), 
where you can place an order with the sales agent of your choice. 
 
The Publications Office has a worldwide network of sales agents. 
You can obtain their contact details by sending a fax to (352) 29 29-42758. 
 
 
 
 
Europe Direct is a service to help you find answers to your questions about the European Union 
Free phone number (*): 00 800 6 7 8 9 10 11 
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed. 
 
A great deal of additional information on the European Union is available on the Internet. 
It can be accessed through the Europa server http://europa.eu 
  
 
2 
 
doi:10.2788/6757 
ISBN 978-92-79-54192-6 
L
B
-N
A
-2
7
6
5
5
-E
N
-N
 
JRC Mission 
 
As the Commission’s  
in-house science service,  
the Joint Research Centre’s  
mission is to provide EU  
policies with independent,  
evidence-based scientific  
and technical support  
throughout the whole  
policy cycle. 
 
Working in close  
cooperation with policy  
Directorates-General,  
the JRC addresses key  
societal challenges while  
stimulating innovation  
through developing  
new methods, tools  
and standards, and sharing  
its know-how with  
the Member States,  
the scientific community  
and international partners. 
 
Serving society  
Stimulating innovation  
Supporting legislation 
 
